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RESUMO 
A Malária é uma doença causada por espécies parasitas do género Plasmodium 
pertencentes ao filo Apicomplexa. Estes parasitas causam doença no seu hospedeiro quando 
invadem e se desenvolvem dentro de eritrócitos e apresentam um ciclo de vida deveras 
complexo, incluindo uma fase de transmissão por um mosquito fêmea do género Anopheles. A 
infecção deste vector depende de células precursoras sexuais designadas gametócitos que se 
desenvolvem na corrente sanguínea do hospedeiro vertebrado. Nesta fase, os parasitas 
apresentam dimorfismo sexual, evidente quer a nível morfológico, quer molecular. Por forma a 
colonizar com sucesso o intestino médio do mosquito, os gametócitos femininos armazenam de 
forma quiescente ácidos ribonucleicos mensageiros (mRNAs) específicos em 
ribonucleoproteínas mensageiras (mRNPs) através de um mecanismo molecular designado 
repressão da tradução. Após uma refeição sanguínea, estes transcriptos são traduzidos no 
zigoto em desenvolvimento, iniciando desta forma as alterações morfológicas e funcionais que 
permitem aos parasitas formar o oocineto dotado de motilidade e estabelecer um oocisto 
replicativo por debaixo do epitélio do intestino médio. 
 Previamente à transição entre zigoto e oocineto, a repressão da tradução de 
determinados mRNAs depende dum complexo multiproteico onde as proteínas DOZI e CITH 
são componentes centrais. Quando estes estão ausentes, os mRNAs outrora silenciados são 
sobexpressos, prevenindo assim a expressão não oportuna de proteínas na corrente 
sanguínea do hospedeiro que poderia gerar anticorpos de bloqueio da transmissão da Malária. 
Parasitas depletados em DOZI ou CITH realizam fertilização, mas ficam impossibilitados de 
prosseguir mais além no seu desenvolvimento. Os primeiros genes traducionalmente 
reprimidos a serem identificados foram p25 e p28; estes codificam para as duas mais 
abundantes proteínas de superfície do oocineto envolvidas na sobrevivência do oocineto, na 
penetração do epitélio do intestino médio e no desenvolvimento dos oocistos. A repressão da 
tradução destes mRNAs depende de uma região rica em uridinas nas suas regiões não 
traduzidas (UTRs), nomeadamente na UTR 5’ de p25 e na UTR 3’ de p28. Para além disto, 
estes genes são também dos alvos líder no desenvolvimento de vacinas de bloqueio da 
transmissão da Malária. Tais vacinas baseiam-se na presença de anticorpos contra antigénios 
de Plasmodium que, quando ingeridos por um mosquito durante uma refeição sanguínea, se 
ligam ao parasita em desenvolvimento, prevenindo assim a infecção do vector. É portanto 
evidente que a repressão da tradução é crucial para a produção cronometrada de moléculas do 
parasita que de outra forma poderiam gerar anticorpos de bloqueio da transmissão com 
consequências deletérias para a transmissão de Plasmodium. 
 Existem evidências de que a repressão da tradução também ocorre em esporozoítos 
nas glândulas salivares do mosquito. Os esporozoítos são a forma infecciosa do parasita 
responsável pela transmissão da doença do mosquito para um hospedeiro não infectado. A 
deleção do gene puf2 em P. berghei, a espécie causadora de Malária em roedores, resulta em 
alterações transcripcionais e traducionais que normalmente têm lugar em estádios hepáticos do 
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parasita. Estas modificações moleculares precedem alterações morfológicas reminiscentes da 
transição esporozoíto-forma exoeritrocítica quando o parasita ainda se encontra no interior das 
glândulas salivares do mosquito, sugerindo que a quiescência do esporozoíto depende do 
controlo pós-transcripcional de certos mRNAs e da função da proteína Pumilio 2 ou Puf2. 
 O presente trabalho centra-se nos factores que controlam a progressão do ciclo de vida 
do parasita no mosquito, desde o despontar do desenvolvimento sexual ainda no interior do 
eritrócito, à formação do esporozoíto e à invasão do fígado. O mesmo caracteriza a função de 
novos produtos génicos traducionalmente reprimidos de P. berghei e determina a sua 
contribuição para o desenvolvimento do parasita no interior do mosquito e, consequentemente, 
para a sua transmissão. Este estudo debruça-se essencialmente em três genes principais – 
epsf, dhhc10 e limp – e suas correspondentes proteínas. Todos estes genes são sobexpressos 
em gametócitos de parasitas Δdozi. É aqui demonstrado que os mesmos são traducionalmente 
reprimidos em gametócitos femininos, que os seus transcritos interagem com DOZI e CITH e, 
uma vez traduzidos, as respectivas proteínas se localizam nos corpos cristalóides do oocineto, 
organelos efémeros e enigmáticos cuja função não é ainda totalmente conhecida. 
 EPSF (Essential Protein for Sporozoite Formation) é uma proteína conservada entre os 
membros do filo Apicomplexa mas a sua função era até à data desconhecida. Esta proteína 
apresenta, embora com baixa probabilidade bioinformática, um domínio semelhante a TPM, 
que em plantas é conhecido por participar no ciclo de síntese/degradação de proteínas do 
fotossistema II no cloroplasto. DHHC10 é um membro de uma família evolutivamente 
conservada de palmitoil-S-acil-transferases (PATs) caracterizada pela presença de um domínio 
rico em cisteínas compreendendo o motivo Asp-His-His-Cys (DHHC), ou por vezes DHYC. 
Estas proteínas são responsáveis pela adição de palmitato (ácido gordo de cadeia C-16) a 
resíduos de cisteína de outras proteínas, uma modificação pós-traducional reversível que 
modifica a afinidade dos seus alvos para membranas lipídicas. Por sua vez, LIMP é uma 
pequena proteína (110 aminoácidos de comprimento) exclusiva do género Plasmodium e não 
exibe qualquer domínio funcional identificável. 
 Os mutantes Δepsf estabelecem números normais de oocistos que permanecem 
vacuolizados e não desenvolvem esporozoítos. Os mesmos atingem dimensões superiores aos 
oocistos wild-type (WT) sem concomitante replicação de ácido desoxirribonucleico (DNA) ou 
expressão de circumsporozoite protein. Consequentemente, os parasitas Δepsf não 
apresentam qualquer capacidade de transmissão. 
 Os mutantes Δdhhc10 apresentam um fenótipo muito semelhante ao nível dos 
oocistos, não obstante neste caso a replicação do seu DNA não ser afectada. Apesar da 
palmitoilação de proteínas e a relevância de DHHC-PATs para a biologia das fases sanguíneas 
de Plasmodium terem sido foco de muita atenção recentemente, nada é sabido actualmente 
acerca da importância desta modificação pós-traducional no desenvolvimento do parasita no 
seu vector. Através do uso de inibidores e de modificação genética este estudo demonstra pela 
primeira vez que a palmitoilação é crucial para processos biológicos que têm lugar em diversas 
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fases da infecção do mosquito: é indispensável para a transformação do zigoto em oocineto e 
define a eficiência de invasão de hepatócitos por esporozoítos, sendo no entanto redundante 
para a motilidade do tipo gliding e para o atravessamento de células hospedeiras. Ao remover 
dhhc10 é demonstrado neste trabalho que esta DHHC-PAT é basilar para a correcta 
localização de outros componentes dos corpos cristalóides e para a própria formação destes 
organelos. 
 Tal como para outras proteínas localizadas nos corpos cristalóides (membros da família 
proteica de adesinas LCCL), EPSF e DHHC10 têm um papel essencial na esporogonia de P. 
berghei (formação de esporozoítos dentro dos oocistos) e portanto na progressão do ciclo de 
vida do parasita no mosquito. Os dados aqui apresentados reforçam a noção de que proteínas 
residentes dos corpos cristalóides são vitais para a esporulação dos oocistos. LIMP também se 
localiza nos corpos cristalóides do oocineto mas, contrariamente a EPSF e DHHC10, a sua 
função nada tem que ver com a formação de esporozoítos. De facto, os oocistos Δlimp são 
igualmente eficientes na produção de esporozoítos quanto parasitas WT. 
 Este ensaio estabelece LIMP como um novo factor de motilidade do tipo gliding 
específico de parasitas da Malária. O mesmo é importante para uma eficiente infectividade do 
oocineto e essencial para a motilidade do esporozoíto, assim com para a sua capacidade de 
aderir, atravessar e invadir células do fígado. A ausência desta proteína reduz a transmissão 
para o mosquito em metade, a invasão das glândulas salivares em dez vezes e torna os 
parasitas incapazes de infectar ratinhos naïve, quer por picada de mosquito, quer por injecção 
intravenosa de esporozoítos. Por um lado, os parasitas depletados em LIMP não dispõem de 
qualquer motilidade. Por outro, a fusão deste factor com a proteína fluorescente GFP resulta 
num movimento imperfeito caracterizado por velocidade reduzida e frequente alongamento do 
esporozoíto, particularidades relacionadas com uma redução da reciclagem de locais de 
adesão entre o parasita e o substrato. Conjuntamente com a localização de LIMP na 
membrana plasmática do esporozoíto, os actuais resultados sugerem que LIMP desempenha 
um papel crítico no estabelecimento/dissolução de locais de adesão durante o movimento do 
parasita e invasão de células hospedeiras. 
 De forma geral, a presente dissertação sublinha a relevância da repressão da tradução 
e dos seus mRNAs alvo para a biologia de Plasmodium e demonstra que os genes 
traducionalmente reprimidos são cruciais para a transmissão do parasita e sua sobrevivência 
em múltiplas fases do seu desenvolvimento no interior do mosquito. Este trabalho indicia novas 
abordagens conceptuais no combate à Malária, nomeadamente a inibição da formação de 
corpos cristalóides e a interferência com a maquinaria de motilidade do parasita. 
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SUMMARY 
Malaria is caused by parasite species of the genus Plasmodium belonging to the 
phylum Apicomplexa. Plasmodium parasites cause disease when they infect red blood cells of 
the mammalian host and present a very complex life cycle that includes transmission by a 
female anopheline mosquito vector. The infection of this vector depends on sexual precursor 
cells called gametocytes that develop in the blood stream of the vertebrate host. At this stage, 
parasites display sexual dimorphism that is evident at both morphological and molecular levels. 
In order to successfully colonise the mosquito midgut, female gametocytes quiescently store 
specific messenger ribonucleic acids (mRNAs) in messenger ribonucleoproteins (mRNPs) by a 
molecular mechanism designated translational repression (TR). Following a blood meal, these 
transcripts are translated in the developing zygote, thereby initiating the morphological and 
functional changes that allow the parasites to form the motile ookinete and establish a 
replicating oocyst underneath the midgut epithelium cell layer. 
Prior to the zygote-to-ookinete transformation (ZOT), TR of selected mRNAs depends 
on a multiprotein complex where DOZI and CITH are core components. When absent, the 
otherwise silenced mRNAs are downregulated, preventing mistimed protein expression in the 
mammalian host’s blood stream that could allow for the generation of malaria transmission 
blocking antibodies. Parasites lacking DOZI or CITH take part in fertilisation but cannot develop 
further. The first Plasmodium translationally repressed genes to be identified were p25 and p28; 
they encode for the two major ookinete surface proteins involved in ookinete survival, 
penetration of midgut epithelium and development into oocysts. TR of these mRNAs depends 
on uridine-rich regions in their untranslated regions (UTRs), namely in the 5’ UTR of p25 and in 
the 3’ UTR of p28. Additionally, these have also been the gold standard and leading target 
candidates for malaria transmission blocking vaccines (MTBVs). These vaccines rely on the 
presence of antibodies against Plasmodium antigens that, when taken up by a mosquito during 
a blood meal, bind to the developing parasite preventing infection of the vector. It is then evident 
that TR is paramount for the timely production of parasite molecules that otherwise could raise 
transmission blocking antibodies with deleterious consequences for Plasmodium transmission. 
TR is also believed to take place in salivary gland sporozoites, the mammalian-infective 
parasite form that is responsible for disease transmission from the mosquito to the human or 
rodent host. Deletion of puf2 in the rodent malaria parasite species P. berghei results in 
transcriptional and translational alterations that normally take place in hepatic stages. These 
molecular modifications precede morphological changes reminiscent of sporozoite-to-liver stage 
transformation while still in the mosquito salivary glands, suggesting that sporozoite quiescence 
relies on post-transcriptional control of certain mRNAs and on the function of the protein Pumilio 
2 or Puf2. 
We are interested in the factors that drive parasite life cycle progression in the mosquito 
vector, from the onset of sexual development in the erythrocyte to sporozoite formation and liver 
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cell invasion. In the present study we characterised the function of novel putative translationally 
repressed gene products of P. berghei and determine their contribution to parasite development 
within the mosquito and consequently to malaria transmission. Three main genes (and 
corresponding proteins) are addressed herein – epsf, dhhc10 and limp – all of which were found 
downregulated in the Δdozi parasite line. We show here that they are translationally repressed 
in female gametocytes, are bound by DOZI and CITH and are targeted to the ookinete 
crystalloid bodies (CBs) upon translation, a short-lived and enigmatic organelle with unclear 
function. 
EPSF (Essential Protein for Sporozoite Formation) is conserved among apicomplexans 
but its function was so far unknown. This protein contains, although with low probability, a 
bioinformatically annotated TPM-similar domain that in plants has been implicated in the 
synthesis/degradation cycle of photosystem II proteins in the chloroplast. DHHC10 is a member 
of an evolutionarily conserved family of palmitoyl-S-acyl-transferases (PATs) characterised by 
the presence of an Asp-His-His-Cys (DHHC) motif (sometimes DHYC) within a cysteine-rich 
domain. These proteins are responsible for the addition of palmitate (C-16-long chain fatty 
acids) to cysteine residues of other proteins, a reversible post-translational modification (PTM) 
that tethers its targets to lipid membranes. On the other hand, LIMP is a small (110 amino 
acids-long) protein unique to Plasmodium spp. and exhibits no identifiable functional domains. 
Δepsf mutants establish normal oocyst numbers but fail to develop sporozoites, remain 
vacuolated and continue to increase in size without concomitant deoxyribonucleic acid (DNA) 
replication or circumsporozoite protein expression. Consequently, Δepsf parasites are 
completely blocked in transmission. 
Δdhhc10 mutants show a very similar oocyst phenotype despite the fact that DNA 
replication does not seem to be affected in this case. Although protein palmitoylation and the 
relevance of DHHC-PATs in Plasmodium biology have recently been the focus of much interest 
in blood stage parasites, nothing is know about the importance of such PTM in parasite 
development within its mosquito vector. Using drug inhibitor and gene deletion studies we show 
for the first time that palmitoylation is crucial for the execution of developmental and cell 
biological processes during several phases of mosquito stage infection: it is indispensable for 
ZOT and defines the efficiency of sporozoite invasion of the host hepatocyte while being 
redundant for rapid protein turn-over during gliding motility and cell traversal. By deleting 
dhhc10 we demonstrate that this DHHC-PAT is key to the correct targeting of other CB 
components and to the formation of the ookinete CB itself. 
Similar to other CB-associated proteins (the members of the LCCL protein family of 
adhesins), both EPSF and DHHC10 have an essential role for P. berghei sporogony (formation 
of sporozoites within oocysts) and therefore for progression of the parasite life cycle in the 
mosquito. Our data thus further establishes the vital function of CB-resident proteins in oocyst 
sporulation. LIMP is also localised to the ookinete CBs but, on the contrary to EPSF and 
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DHHC10, is not involved in the formation of sporozoites. In fact, Δlimp oocysts are equally 
efficient as wild-type (WT) parasites in producing midgut sporozoites. 
We establish LIMP as a novel malaria-specific gliding motility factor that is important for 
efficient ookinete infectivity and essential for sporozoite motility and capability to adhere, 
traverse and invade host liver cells. The absence of this protein reduces transmission to the 
mosquito vector by half, salivary gland invasion 10-fold and renders parasites unable to infect 
naïve mice by mosquito bite or when injected intravenously. While LIMP-depleted parasites 
display no gliding motility, in situ green fluorescent protein (GFP) tagging of this protein resulted 
in a limping movement characterised by reduced speed and frequent stretching, which has 
been correlated with reduced turnover of parasite-substrate adhesion sites. Together with the 
plasma membrane localisation of LIMP in sporozoites, our results suggest that LIMP plays a 
critical role in regulating the attachment/detachment of adhesion sites during gliding motility and 
invasion of host target cells. 
Overall, this dissertation highlights the relevance of TR and its target mRNAs for 
Plasmodium biology and demonstrates that translationally repressed gene products are crucial 
for parasite transmission and survival at multiple steps of its development within the mosquito. 
This work raises new conceptual approaches to combat malaria, namely by inhibiting the 
formation of CBs and interfering with the parasite gliding motility machinery. 
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INTRODUCTION 
 
I – APICOMPLEXA 
The phylum Apicomplexa is composed of a large group of unicellular, eukaryotic 
protozoa and contains obligate intracellular parasites causing disease to humans, livestock, wild 
animals and invertebrates, such as those belonging to the genera Plasmodium, Toxoplasma, 
Cryptosporidium, Babesia and Theileria [1]. The hallmark of the phylum from which the name 
Apicomplexa derives is the presence of an apical complex involved in motility and host cell 
adhesion and penetration and composed of secretory organelles such as rhoptries and 
micronemes and one or more polar rings [2]. Polar rings are circular structures from which 
subpellicular microtubules emanate and were thus postulated to be a microtubule organizing 
centre (MTOC) [3]. Some members such as Toxoplasma possess a set of spirally arranged 
tubulin fibers forming a truncated cone structure called conoid [4]. This organelle is thought to 
play a mechanical role in invasion of host cells [2]. Another characteristic feature of most 
apicomplexans is the apicoplast, a non-photosynthetic plastid thought to be derived from the 
engulfment of a red alga in a secondary endosymbiotic event [5, 6]. As a result, the apicoplast 
presents not two, but four membranes, with the outermost and second outermost membranes 
deriving from the parasite and algal plasma membranes, respectively [5, 6]. The overall function 
of this organelle is still elusive but evidence exists that it is involved in type II fatty acid, 
isoprenoid, iron-sulphur cluster and haem synthesis [6]. 
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II – PLASMODIUM AND MALARIA 
Although the global malaria burden has decreased in last few years, it still exerts a 
severe negative impact on the social and economic development of most African and South-
East Asian countries. According to World Health Organization estimates, there were 219 million 
malaria cases worldwide in 2010, including 660 thousand deaths. Most of the cases (80%) and 
deaths (91%) occur in sub-Saharan Africa. Strikingly, 86% of the malaria deaths took place in 
children under 5 years of age. Plasmodium falciparum, the deadliest human parasite species, 
was responsible for 90% of the total malaria cases in that year [7]. 
Malaria is caused by parasites species of the genus Plasmodium belonging to the 
phylum Apicomplexa and is a complex disease including several different symptoms and clinical 
manifestations. The invasion of the liver and development of the parasite within hepatocytes are 
disease-free phases of the parasitic infection. The pathogenic process starts when parasites 
infect the red blood cells (RBCs) of its host. The first and most common signs of malaria 
infection are periodic fever peaks and chills. These symptoms occur at the time of erythrocyte 
rupture, a necessary step for the subsequent infection of new RBC and continuation of parasite 
asexual multiplication, and are believed to be caused by the release of malarial toxins. 
Consecutive RBC burst typically leads to anaemia [8]. Severe forms of disease exist and 
include cerebral malaria (CM), acute lung injury, acute respiratory distress syndrome, 
pregnancy-associated malaria (PAM) and severe anaemia (SA) [9]. In addition to SA, which 
affects mostly children under the age of 3, CM, accompanied by characteristic seizures and 
sometimes coma, is one of the leading causes of death in non-immune patients and African 
children [8]. The onset of this severe condition depends on high blood parasitaemias [8] but also 
on the concomitant sequestration of CD8-expressing T cells and infected RBCs (iRBCs) in the 
brain, as determined in animal models [10]. In P. falciparum, the endothelial cytoadherence 
feature of iRBCs depends on the expression of PfEMP1 (Erythrocyte Membrane Protein 1) at 
the surface of the iRBC, a protein encoded by the var family of genes [11, 12]. Non-immune 
women are particularly susceptible to PAM, which may lead to abortions and stillbirths. Other 
frequent consequences of PAM for the newborns are low birth weight, caused by intrauterine 
growth retardation and/or premature delivery, neonatal infection and mortality. These pregnancy 
outcomes are likely to be associated with the accumulation of iRBCs in the placental 
vasculature [8]. In agreement with this idea, VAR2CSA, a PfEMP1 variant, is implicated in iRBC 
sequestration in the placenta [13]. 
Malaria parasites are transmitted from and to mammalian hosts (human, simian and 
rodent) during the blood meal of female anopheline mosquitoes (Anopheles spp.), which feed 
on blood in order to produce and lay eggs. On the other hand, culicine mosquitoes such as 
Aedes spp. and Culex spp. are, similarly to Anopheles spp., capable of transmitting P. 
gallinaceum and P. relictum to avian vertebrate hosts but have never been reported transmitting 
mammalian parasites [14]. Out of the numerous Plasmodium species known to date, only four 
routinely cause disease in humans: P. falciparum, P. vivax, P. malariae and P. ovale [15]. 
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Traditionally viewed as a zoonotic infectious agent, P. knowlesi has recently been reported in 
humans [16, 17]. Five major anopheline species act as human malaria vectors in Africa: A. 
gambiae, A. arabiensis, A. funestus, A. nili and A. moucheti. They all belong to species 
complexes that are very difficult to distinguish based on morphological characters. The 
predominance and overlap of these species largely depends on the geographic region and 
ecosystems but in certain areas as much as all five species co-habit and transmit parasites to 
humans [18]. 
The malaria parasite was first discovered in Algiers by Alphonse Laveran, a French 
army surgeon who observed flagellated cells moving in a blood sample from a malaria patient. 
He was observing what today is known as the exflagellation of male gametocytes [19]. The 
erythrocytic cycle and the name Plasmodium were established a few years later by Ettiore 
Marchiafava and Angelo Celli [20]. The vectorial capacity of Anophelles mosquitoes for 
Plasmodium parasites was only discovered in 1902 by Ronal Ross, a British medical doctor 
working at the Presidency General Hospital in Calcutta at the time. By carefully examining 
histological sections of stomachs from mosquitoes fed on malaria patients four days before he 
found perfectly round parasite forms: the oocyst [21]. One year later he describes the complete 
parasite ‘metamorphosis’ in the mosquito, including the ookinete to oocyst development, the 
release of sporozoites into the haemocoel and their journey to the salivary glands, using P. 
relictum (then called Proteosoma) infecting sparrows and larks [22]. This major scientific 
breakthrough earned Sir Ross the second Nobel Prize for Physiology or Medicine in 1902. 
However, it was only in the second half of the 20
th
 century that the whole malaria life cycle 
became complete, when the English protozoologist Cyril Garnham (in collaboration with is 
colleague Hugh Shortt) unravelled the exoerythrocytic stage of species infecting non-human 
primate hosts [23-25] and later on of the human malaria parasites P. vivax [26, 27], P. 
falciparum [28], P. ovale [29] and P. malariae [30]. 
The Plasmodium life cycle is complex. Within the RBCs, the majority of parasites follow 
an asexual multiplication cycle termed schizogony [31], while some develop into non-dividing 
sexual precursor cells called gametocytes [32, 33]. Following a mosquito blood meal, the 
ingested male (micro) and female (macro) gametocytes form male and female gametes, 
respectively; these mate inside the mosquito midgut and the resulting zygote develops into an 
ookinete. This motile parasite form escapes from the midgut peritrophic matrix, a chitin-
containing sheath secreted by midgut cells to contain the blood meal [34], traverses the midgut 
epithelium and establishes a sessile oocyst that produces thousands of sporozoites. Oocyst 
rupture results in the release of motile sporozoites that migrate through the haemocoel to the 
mosquito salivary glands where they await another blood meal [35, 36].  After being injected into 
the skin of the vertebrate host (e.g., human or mouse model), the parasites migrate to the blood 
stream and reach the liver where they traverse a few cells before definitely establishing 
themselves within a hepatocyte [37]. There, a single sporozoite develops into an exoerythrocytic 
from (EEF), which releases thousands of newly formed, RBC-infective merozoites into the 
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Figure 1 – Life cycle of Plasmodium falciparum. 
The complete life cycle including the liver and blood stages of infection in the human host, as well as the 
gut and salivary gland phases in the mosquito vector are depicted. [Adapted from Bannister and Mitchell, 
Trends Parasitol 2003, 19(5): 209-13] 
bloodstream [38]. Some species such as the non-human primate parasite P. cynomolgi and the 
human parasites P. vivax and P. ovale are capable of producing liver dormant cells called 
hypnozoites, responsible for malaria relapses (with concomitant blood parasitaemias) months or 
even years after the infectious bite took place. The discovery of this deviation to the standard 
life cycle is also due to the work of Garnham as well as other British and American scientists 
[39, 40]. Please see Figure 1 for a diagram of the complete life cycle of P. falciparum.  
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Figure 2 – Dynamics of Plasmodium development in the mosquito vector. 
The sequence of developmental events (top) is accompanied by drastic fluctuations in parasite density 
(bottom). The plot should is merely an indication of changes in density over time and should not be 
regarded as an indication of absolute parasite numbers. [Adapted from Baton and Ranford-Cartwright, 
Trends Parasitol 2005, 21(12): 573-80] 
The developmental time frame of each one of Plasmodium life cycle steps is highly 
variable and species-dependent. For example, in P. berghei, a rodent malaria species, the 
exoerythrocytic phase takes about 48 hours, but can last up to 16 days depending on the 
parasite species [38]. The completion of the asexual blood cycle is achieved in 24 hours in P. 
berghei [41], P. chabaudi (another species infecting rodents) [42] and P. knowlesi [43]. In P. 
falciparum this cycle takes approximately 48 hours [44-46] but is isolate-dependent. 
Gametocyte maturation takes 7-8 days in the case of P. falciparum, passing through five 
morphological stages [32, 36], and 26-30 hours in P. berghei, only slightly longer than the 
duration of the asexual cycle [32]. Fertilisation occurs within approximately one hour after 
mosquito blood feeding and zygote-to-ookinete transformation (ZOT) in different Plasmodium 
species varies from 10 to 30 hours. The entire duration of parasite development within the 
mosquito, from the ingestion of infected blood to the presence of infective sporozoites in the 
salivary glands, is complete in approximately 14 days at 26 
○
C in the case of P. falciparum [36] 
and takes at least 18 days at 20 
○
C in the case of P. berghei. 
Two major bottlenecks exist in the malaria life cycle, each one of them followed by 
extensive population expansion: they occur during transmission to and from the mosquito 
vector. While it is estimated that less than 5% of the 10–10,000 female gametocytes ingested 
during a blood meal successfully develops into oocysts [35, 36] (Figure 2), not more than a few 
hundred sporozoites are injected in the skin of the host during mosquito probing prior to a 
subsequent blood feeding [35, 38, 47]. In between, a less pronounced population constraint 
takes place during development within the mosquito: only a quarter of the sporozoites that are 
released from the oocysts to the mosquito hemolymph successfully reach the salivary glands, 
which can harbour up to 100,000 parasites [35]. Therefore, intervention strategies targeting 
such density limiting stages are likely to be successful, as substantially less parasitic cells need 
to be eliminated at those specific moments. Recently, a studied performed in laboratory-
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controlled vector populations has shown that the administration of the transmission blocking 
(TB) drug atovaquone to infected mice reduces parasite burden and prevalence of infection in 
mosquitoes by 57 and 32%, respectively. Even so, this mild effect was capable of eliminating 
malaria from both the mosquito and mouse populations in only three cycles of transmission at 
low mosquito biting rates, i.e., one or two potentially infectious mosquito bites per mouse in 
each generation. At higher transmission rates, parasites were however not eliminated from 
either population, indicating that more efficacious TB strategies would be needed to achieve 
malaria elimination in this scenario [48]. 
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III – PLASMODIUM GENE REGULATION 
The Plasmodium proteome is tightly regulated throughout its intricate life cycle, with 
high percentages of stage-specific proteins [49-51]. How exactly malaria parasites control gene 
expression to achieve such specificity is still being unravelled but involves molecular 
mechanisms at the transcriptional, post-transcriptional and translational level. One very relevant 
observation with great impact on how these organisms regulate gene expression is that they do 
not possess the core RNA interference (RNAi) machinery components, such as Argonaute and 
Dicer [52]. 
The mutually exclusive expression of var genes has been extensively studied and 
depends to a great extent on epigenetic regulators such as chromatin-remodelling proteins, 
histone modification marks, histone variants and long non-coding RNAs (lncRNAs) [53]. 
Conserved eukaryotic epigenetic factors have been correlated with gene expression on a P. 
falciparum genome-wide scale. The dynamic occupancy pattern of eight euchromatic and 
heterochromatic histone marks in either histone H3 (H3K4me3, H3K9ac, H3K14ac and 
H3K56ac) or H4 (H4K8ac, H4K16ac, H4K20me1 and H4K4,8,12,16ac) displayed a strong 
positive correlation with transcript levels across the parasite genome and intraerythrocytic 
development cycle. Interestingly, and similarly to what is observed in plants, these histone 
modifications were mainly associated with the 5’ end of coding sequences and not with 
intergenic regions [54]. Non-coding RNAs (ncRNAs) may also contribute to epigenetic 
regulation of transcription by possibly binding to general histone-modifying enzymes and 
providing them with target specificity [55]. Recently, an unprecedented type of post-
transcriptional gene regulation mechanism involving RNase II-mediated degradation of nascent 
RNAs was shown to contribute to the silencing of upsA-type var genes in P. falciparum, known 
to be associated with obstruction of brain blood vessels in cerebral malaria human patients [56]. 
Evidence suggests that nuclear positioning of specific loci participates in the 
activation/silencing of genes. For instance, silent var genes are observed in perinuclear clusters 
while they move towards the nucleus centre upon activation. Nonetheless, general active 
transcription sites are also observed at the nuclear periphery [57]. Overall P. falciparum genome 
architecture has also been recently implicated in gene regulation, with a strong correlation 
between the transcription of specific genes and their spatial localisation within the three-
dimensional genome structure [58]. 
Unlike most eukaryotes, not many transcription factors (TFs) are known in the genomes 
of Plasmodium parasites. Only one family of TFs is known in malaria parasites, the 
Apicomplexan Apetala2 (ApiAP2) family [59], with 27 predicted members in P. falciparum and 
26 in P. berghei (PlasmoDB version 11.1). Toxoplasma gondii strains on the other hand encode 
up to 68 of such proteins in their genomes ([60, 61] and ToxoDB version 11.0). This is a family 
of plant TFs characterised by the presence of at least one AP2 domain, a DNA binding domain 
of approximately 60 amino acids [62]. 
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Given the scarcity of TFs, locus-specific, promoter-based transcriptional control of gene 
expression was long thought not to be the dominant mode of gene regulation in Plasmodium. A 
significant delay between the transcript and protein maximum abundances for a vast 
percentage of the malarial genes pointed towards this view [63]. Instead, post-transcriptional 
mechanisms would play a major role in achieving a tight regulation of gene expression [64]. But 
recent and current work done on the ApiAP2 gene family is challenging this theory. 
Remarkably, the AP2 domains of different ApiAP2 proteins show specific affinities for 
distinct DNA motifs enriched in the upstream region of functionally-related genes, underscoring 
the importance of both cis- and trans-acting factors in parasite gene regulation [65]. In recent 
years, specific ApiAp2 TFs have been ascribed to defined biological processes and life cycle 
stage transitions. The ApiAP2 member PfSIP2 (SPE2-interacting protein) was shown to co-
localise with PfHP1 (heterochromatin protein 1) and to bind almost exclusively to 
heterochromatic domains upstream of subtelomeric var genes containing the SPE2 DNA motif. 
Interestingly, this work described for the first time the participation of an ApiAP2 TF in the 
formation of heterochromatin (tightly condensed form of DNA) and thus in gene silencing in P. 
falciparum blood stages [66]. Also in P. falciparum, it was recently demonstrated that sexual 
commitment is dependent on the DNA-binding protein PfAP2-G [67], which in turn is negatively 
controlled by PfHP1 [68] and PfHda2 (histone deacetylase 2) [69]. Both these epigenetic 
regulators contribute to the maintenance of heterochromatin at the pfap2-g locus. Similarly, the 
P. berghei ortholog PbAP2-G was also shown to be a master regulator of sexual differentiation 
in this rodent malaria parasite species, while a second transcription factor, PbAP2-G2, 
modulates the numbers of gametocytes, as its absence does not result in the complete 
abolishment of gametocytogenesis [70]. AP2-O (Apetala2 in ookinetes) on the other hand was 
shown to regulate the expression of P. berghei ookinete-specific genes, particularly invasion-
related factors, by binding to a DNA motif in their 5’ upstream regions [71]. The AP2 domain of 
another ApiAP2 TF in P. berghei, AP2-Sp (Apetala2 in sporozoites), was found to bind to a 
conserved cis element in the promoter region of known sporozoite-specific genes. In agreement 
with this finding, ablation of AP2-Sp led to the development of abortive oocysts in mosquito 
midguts, demonstrating its essentiality for sporozoite formation, most likely through the 
transcriptional activation of genes necessary for sporozoite morphogenesis [72]. On the other 
hand, AP2-L is essential for the development of malaria liver stages and responsible for the 
expression of uis3, uis4, exp1 and lisp1, genes encoding for proteins of the parasitophorous 
vacuole membrane (PVM) surrounding intrahepatic parasites. Although AP2-L-depleted 
parasites invade hepatocytes normally, they arrest development during liver schizogony [73]. 
Lastly, a non-ApiAP2 intraerythrocytic stage TF of P. falciparum but well conserved within the 
Plasmodium genus was shown to activate the expression of pf1-cys-prx [74], a 
trophozoite/schizont-specific peroxiredoxin family member [75, 76]. This TF was named PREBP 
(PRE Binding Protein) based on its ability to bind to DNA stretches including the 102 base pair-
long Prx Regulatory Element (PRE) and contains four K-homology (KH) domains [74] 
characteristic of single-stranded DNA and RNA binding proteins [77, 78]. 
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Regardless of the continuously growing evidence that TFs are master regulators of 
parasite virulence and development, co-transcriptional and post-transcriptional mechanisms of 
gene regulation are critical players in controlling gene expression in Plasmodium. One example 
of co-transcriptional mechanisms is pre-mRNA alternative splicing. Approximately 53% of P. 
falciparum genes are predicted to contain introns ([79] and PlasmoDB version 11.1) and many 
of these give rise to alternative mRNA splice variants, which arise through use of alternative 5’ 
and/or 3’ splice sites, intron retention/creation or exon skipping. Splicing can also be observed 
in the 5’ and 3’ untranslated regions (UTRs) of certain genes [80, 81]. In some cases, these 
alternative splicing events generate mature mRNAs containing premature stop codons [81], 
which might encode for non-functional proteins or instead, protein variants with distinct functions 
and subcellular localisations [82]. One important post-transcriptional mechanism of malaria 
gene expression control is translational repression (TR), by which specific mRNAs are kept 
translationally quiescent in the parasite cytoplasm in association with protein repressor 
complexes until the right environmental cues trigger their release from such complexes and 
initiate protein synthesis. TR in Plasmodium and as a general evolutionarily conserved 
mechanism will be described in greater detail in the next section of this Introduction. 
Finally, a polysome profiling study along the parasite erythrocytic cell cycle identified a 
delay between the peak of mRNA abundance in steady-state versus that associated with 
polysomes for over 30% of P. falciparum genes, implying a strong translational control of gene 
expression. Abundant and widespread transcription of ncRNAs which could influence translation 
efficiency was also highlighted in the same work [83]. Over 300 antisense, ncRNAs were also 
detected in another study on P. falciparum blood stages and believed to act as silencers of the 
cognate genes in the transition from asexual to sexual development [84]. 
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IV – TRANSLATIONAL REPRESSION 
 
IV.1 – TRANSLATIONAL REPRESSION IS AN ANCIENT AND CONSERVED MECHANISM 
TR is a broad molecular concept that consists in inhibiting the translation of certain 
genes/transcripts. It is an evolutionarily conserved post-transcriptional gene regulatory process 
exerted by both prokaryotic and eukaryotic organisms which general principle is to interfere with 
the formation of translational initiation complexes. 
In bacteria this can be achieved by three mechanisms: a temperature-induced mRNA 
conformational change that generates a cis-acting mRNA sequence responsible for preventing 
ribosomal 30S subunit access to the ribosome binding site (RBS), binding of a protein to its own 
mRNA in a negative loop feedback effect and binding of a trans-acting allosteric repressor to 
the mRNA. The first two mechanisms are called competitive mechanisms as they compete with 
the ribosome for binding to the RBS. The latter one is an entrapment mechanism, as the 
repressor does not impair interaction of ribosomal subunits with the RBS, but instead induces 
entrapped ternary complexes that inhibit the formation of stable translational initiation 
complexes [85, 86]. 
In eukaryotes, TR is accomplished through the binding of microRNAs or RNA binding 
proteins to target mRNAs [87-89]. Although not fully dissected, a model for the involvement of 
microRNAs in TR suggests they interact with GW182 and Argonaute proteins leading to: (i) 
competition with the translation initiation factor eIF4G for association with poly(A)-binding 
protein (PABP), (ii) prevention of 60S-40S ribosomal subunit interaction to form 80S ribosomes, 
(iii) ribosome stalling along the mRNA, (iv) premature translation termination and/or (v) co-
translational degradation of synthesised proteins [89]. One of the best studied families of 
translational repressors is the Puf family of RNA binding proteins. This is an evolutionarily 
conserved family present in highly divergent eukaryotic organisms, from yeast to zebrafish, 
Xenopus, mouse, humans and plants, but also in the invertebrates Drosophila, Anopheles and 
Caenorhabditis elegans. Puf proteins are related to the Pumilio protein of Drosophila and the 
fem-3 mRNA binding factor of C. elegans (founder members of the family) and typically contain 
eight tandem Pumilio homology domains (PUM-HDs). They control mRNA translation by 
promoting its repression or degradation and generally interact with transcripts by binding to 
conserved motifs [UGUA/G(N)1-2AUA] on their UTRs, often the 3’ UTR, the so called Pumilio 
binding elements (PBEs) [90-93]. 
TR allows a bi-dimensional regulation of gene expression (i.e., both in time and in 
space). For example, in the case of Drosophila, hunchback mRNA (encoding for a transcription 
factor critical for embryonic patterning) is specifically repressed in posterior regions of the fly 
embryo. This is mediated by the binding of a protein complex containing Pumilio and Nanos 
proteins to the Nanos response elements (NREs) on hunchback 3’ UTR and ensures that 
Hunchback protein is exclusively expressed at the anterior pole of the embryo [94, 95]. The 
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maternally-derived mRNA oskar is also target of TR, in this case through the interaction with the 
repressor Bruno, which binds to Bruno response elements (BREs) present on the 3’ UTR of 
oskar [96, 97]. On the other hand, the maternally inherited xCR1 mRNA is both temporally and 
spatially regulated. The transcript is present in the egg but only translationally activated at the 
16- to 32-cell stage embryo, and although the mRNA is equally distributed throughout all 
Xenopus embryonic cells, it is not translated in the vegetal half of the embryo and consequently 
protein accumulates in the animal half. The repression of xCR1 translation in vegetal cells is 
conferred by a region in its 3’ UTR that contains both PBEs and binding sites for the CUG-BP1 
protein, a homologue of the Drosophila Bruno [98]. The binding of Pumilio proteins to PBEs in 
the RINGO mRNA of Xenopus oocytes has also been shown to lead to its TR [99], and the 
interaction of CUG-BP1 (also known as EDEN-BP) with the 3’ UTR of certain mRNAs is known 
to negatively regulate mRNA translation in Xenopus embryos [100]. 
 
IV.2 – TRANSLATIONAL REPRESSION IN PLASMODIUM 
In Plasmodium, TR was first described more than 20 years ago [101], and several 
subsequent studies highlighted its importance [49, 102-104]. As in multicellular eukaryotes [105, 
106], TR in Plasmodium is particularly important in sexual differentiation and is exerted in 
female inherited mRNAs [107, 108]. In 1993, Paton and colleagues reported the transcript of 
p28 to be abundant in P. berghei gametocytes, while the corresponding protein was only 
observed after gametocyte in zygotes and ookinetes [101]. However, it was only in 2006 that 
the exact mechanism responsible for the lag between transcription and translation of certain 
genes became clear. Known and predicted translationally repressed mRNAs were shown to 
physically interact in cytoplasmic messenger ribonucleoproteins (mRNPs) with the RNA binding 
protein DOZI (Development Of Zygote Inhibited) [107], a member of the DEAD(Asp-Glu-Ala-
Asp)-box family of RNA helicases [109] particularly enriched in female gametocytes [50]. DOZI 
homologues in other organisms include Dhh1p in Saccharomyces cerevisiae, CGH-1 in C. 
elegans, Me31B in Drosophila melanogaster and DDX6/Rck54 in humans. DDX6 RNA helicase 
homologues are implicated in both mRNA silencing in mRNP complexes [110, 111] and 
diversion of mRNAs to processing (P)-bodies, cellular centres of mRNA degradation [112]. P-
bodies are not necessarily the end point of mRNAs, as P-body-associated transcripts can still 
return to translation [113]. In parasite mutants lacking DOZI, ookinete development is 
completely abolished. Although fertilization takes place and zygotes are formed, they all abort 
development before meiosis, which can be explained by the degradation of more than 370 
transcripts including several essential for ookinete biology [107]. Among those are p25, p28 
(genes encoding for the two major ookinete surface molecules) and others previously shown to 
be translationally repressed [49]. 
In a subsequent study, the protein CITH (C. elegans CAR-1 and fly Trailer hitch 
Homologue) was shown to play a role in the silencing of Plasmodium maternal mRNAs [108]. 
CITH/CAR-1/Trailer hitch are Scd6 family members and contain an Lsm (like-Sm) domain and 
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Figure 3 – Putative mRNP responsible for translational repression in Plasmodium berghei 
female gametocytes. 
A pool of mRNAs (depicted by the purple string) interacts with the different components of the repressor 
complex via their 5’ and/or 3’ UTRs. Main constituents of the complex are depicted. DOZI: development 
of zygote inhibited; CITH: CAR-1/Trailer hitch homologue; HoBo: homologue of Bruno; HoMu: 
homologue of Musashi1; PABP: poly(A)-binding protein (possibly interacts with the poly(A) tail of 
mRNAs); 4E: eukaryotic translation initiation factor 4E (eIF4E); PGAM: phosphoglycerate mutase family 
member; DARF: unidentified DOZI-associated repressor factors; RBP: other unidentified RNA binding 
proteins. [Image credits: Gunnar R. Mair, unpublished] 
an FDF amino acid motif. Lsm domains interact with each other [113] and both Lsm and FDF 
domains are required for the binding of these proteins to RNA [114]. The FDF motif of S. 
cerevisiae Edc3p is also known to bind to Dhh1p [115]. Scd6 proteins have also been shown to 
associate with mRNAs in mRNPs, which suggests that they function in the control of mRNA 
translation and/or degradation. Moreover, in D. melanogaster oocytes Trailer hitch co-localises 
with mRNP particles containing Me31B, while in C. elegans developing oocytes and embryos 
CAR-1 localizes to P-body-related granules containing CGH-1, indicating that Scd6 proteins 
may bind specific mRNAs and control their translation [113]. Indeed, mass-spectrometry 
analysis of Plasmodium female gametocyte P granules determined that these contain 16 core 
factors and that DOZI and CITH co-localise in these complexes (Figure 3). Among those 16 
mRNP components other RNA binding proteins were found, such as HoBo (Homologue of 
Drosophila Bruno) and HoMu (Homologue of Musashi1) [108]. Musashi1 is known to contribute 
to the immature state and self-renewal activity of neuronal stem cells through TR by competing 
with eIF4G for binding to PABP [116]. Remarkably, PABP is also present in the Plasmodium 
female P granules, while eIF4G is absent [108]. Moreover, three (out of four) P. berghei Alba-
domain proteins (acetylation lowers binding affinity) also take part in this mRNP; these are 
homologues of the archaeal protein Alba, a DNA/RNA-binding protein thought to maintain the 
stability of RNA and ribosomes, as well as to play a role in establishment or maintenance of 
chromatin architecture and thereby in transcription repression [117-120]. While some of the 
identified factors are known RNA binding proteins, others have an obscure function in TR. 
Enolase and PGAM (phosphoglycerate mutase family member) are glycolytic enzymes but were 
also found in the repressor complex. However, it is well established that enolase can participate 
in other biological processes such as transcription and heat-shock, and also plays a part in the 
bacterial degradasome [121]. On the other hand, PGAM family members are known to 
participate in complexes responsible for repressing gene transcription [122]. 
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The depletion of CITH resulted in the downregulation of 183 transcripts in female 
gametocytes. This is substantially less (49%) than the number of downregulated mRNAs in 
Δdozi parasites (370). However, of these, 117 are common between the two lines. This is a 
remarkable overlap and clearly indicates that DOZI and CITH assist each other in the 
stabilisation of large numbers of mRNAs but do not have redundant functions as one cannot 
compensate for the other. Nonetheless, there is a considerable pool of mRNAs that are only 
affected by the absence of either DOZI (253/370, 68%) or CITH (66/183, 36%). This 
observation suggests that there may be different mRNP complexes within the parasite 
cytoplasm, possibly with distinct functions, and containing different subsets of mRNAs that 
depend on DOZI, CITH or both proteins for their stabilisation. Independent results indicate that 
there may be multiple compositional and functional classes of CGH-1- and CAR-1-containing P-
body-like granules in C. elegans [113]. 
The phenotype of Δcith parasites is very similar with that of those lacking DOZI. Both 
result in complete abortion of ZOT. However, the absence of DOZI is more severe for parasite 
development as zygotes do not perform meiosis and remain diploid, while Δcith parasites 
complete meiotic DNA replication and establish tetraploidy [108]. Interestingly, similar gene 
deletion phenotypes for DOZI and CITH homologues have also been reported in C. elegans, 
where depletion of CGH-1 or CAR-1 causes defects in cytokinesis and apoptosis [123]. These 
studies pinpointed TR as a central feature of sexual development and malaria transmission to 
the mosquito vector, probably acting upon several hundreds of mRNAs. 
TR is believed to take place as well in Plasmodium sporozoites. In P. berghei, the 
absence of PbPuf2 results in transcriptional changes in the salivary gland sporozoite, which 
precedes visible morphological changes reminiscent of sporozoite to liver stage transformation, 
when the parasite is still present in the mosquito salivary glands. Upregulated genes in Δpuf2 
sporozoites are a signature of increased metabolic activity, while genes encoding for inner 
membrane complex (IMC) components and motility and invasion-related proteins (e.g., CelTOS, 
SPECT, SPECT2, TRSP, S6/TREP, P36p) are downregulated. Consequently, Δpuf2 
sporozoites are impaired in gliding motility and host cell traversal and invasion [124, 125]. 
Overall, the lack of Puf2 renders parasites incapable of remaining in the quiescent state 
characteristic of wild-type (WT) salivary gland sporozoites, which suggests that Puf2 is 
responsible for the TR of key factors in the transition from the sporozoite to early hepatic stages 
[124]. On the other hand, PbPuf1, originally referred to as UIS9 (upregulated in infectious 
sporozoites 9) [126], was shown to have a redundant function throughout the parasite’s life 
cycle [124, 125]. Very similar observations were made in the rodent malaria parasite P. yoelii. 
One interesting result from this study is that dozi was upregulated in Δpypuf2 sporozoites, 
pinpointing for the first time a potential role for DOZI in the sporozoite, possibly related with the 
function of Puf2 [127].  
The function assigned for P. falciparum Puf2 is however quite different. PfPuf2 is 
expressed in both male and female gametocytes and regulates sexual development and sex 
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differentiation; its deletion promoted gametocytogenesis and differentiation of microgametocytes 
[128]. In agreement with these results, pfpuf2 mRNA but also the corresponding protein had 
previously been shown to be upregulated in P. falciparum gametocytes [129]. Despite of acting 
in a very distinct phase of the life cycle when compared to PbPuf2 and PyPuf2, the data 
obtained for PfPuf2 confirm that Plasmodium Pumilio 2 proteins exert the conserved function of 
suppressing differentiation. PfPuf1 and 2 were first characterised in 2002 [130] and both of them 
interact with the NREs in the hunchback mRNA of D. melanogaster [129, 130], confirming their 
evolutionarily conserved function as RNA binding proteins and likely translational repressors. 
Regardless of the many studies done on the characterization of Plasmodium Puf2, no direct 
evidence to date implicates Puf2 as a bona fide translational repressor. 
Another protein known to be a determinant for sporozoite latency is the eukaryotic 
translation initiation factor 2α (eIF2α) kinase (IK2), initially termed UIS1 [126]. This kinase 
phosphorylates eIF2α and leads to general inhibition of protein synthesis and accumulation of 
stalled mRNAs into granules. eIF2α is dephosphorylated upon hepatocyte invasion and TR is 
alleviated. As in Δpuf2 parasites, Δik2 sporozoites suffer premature metamorphosis into EEFs 
in the mosquito and loose infectivity although not as significantly as in the absence of Puf2 
[131]. How Puf2 and IK2 coordinate translation inhibition and developmental arrest is not 
known, neither is it clear whether the role of Puf2 is mediated through eIF2α. It is although worth 
noting that Δpuf2 sporozoites do downregulate ik2 [124, 125]. 
Interestingly, the consequence of interfering with TR in Plasmodium gametocytes and 
sporozoites is quite different. While in the case of gametocytes, absence of DOZI and CITH 
leads to the loss of otherwise quiescent mRNAs and complete abolishment of ZOT [107, 108], 
the lack of Puf2 in sporozoites leads to premature developmental progression [124], likely by 
alleviating Puf2-dependent TR of factors necessary for sporozoite transformation into EEFs. It 
was hypothesised that mistimed translation of otherwise repressed transcripts encoding these 
factors takes place, instead of the mRNA loss happening in gametocytes. 
TR was shown to depend on uridine-rich regions present on either 5’ or 3’ UTRs of 
certain genes [49, 132]. These are for instance present in the 5’ UTR of p25 and in the 3’ UTR 
of p28 and are sufficient to target transgenes for TR specifically in female gametocytes [132]. 
More recently, TR of at least part of the uis4 mRNA pool in salivary gland sporozoites was 
demonstrated to depend on its open reading frame (ORF), whereas the 5′ and 3′ UTRs are 
dispensable for its silencing [133]. Whether uis4 is maintained in a quiescent state until after 
invasion of hepatocytes through the interaction with Puf2 remains to be elucidated but it is 
interesting to note that several uis genes were downregulated in Δpypuf2 sporozoites [127]. 
uis4 was however not differentially regulated in Δpbpuf2 parasites [125] but UIS4 protein was 
upregulated in Δpbik2 salivary gland sporozoites [131]. 
How silenced Plasmodium mRNAs are activated for translation is not fully understood, 
but it has recently been shown to depend on the parasite calcium-dependent protein kinase 1 
(CDPK1) during parasite sexual development [134]. For instance, translational activation of 
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certain transcripts in Xenopus oocytes involves phosphorylation of the RNA binding protein 
CPEB (cytoplasmic polyadenylation element binding protein) [135]. It is possible that CDPK1 
regulates translational activation by phosphorylating a component of the repressor complex. 
 
IV.3 – TRANSLATIONAL REPRESSION AND MALARIA TRANSMISSION BLOCKING VACCINES 
In Plasmodium, the hallmarks of translationally repressed genes are p25 and p28. 
These genes are involved in ookinete survival in the mosquito midgut, penetration of midgut 
epithelium and development into oocysts [136, 137]. Some insight has been made in the 
putative interaction of P25 and P28 with the mosquito midgut. Pvs25 (P25 orthologue in 
Plasmodium vivax) has been shown to interact in vitro with Anopheles albimanus calreticulin, a 
molecule expressed in midgut microvilli [138], while Pb25 binds to laminin γ1 in the midgut 
basal lamina of A. gambiae [139] but also to collagen IV [140]. On the other hand, anti-annexin 
antibodies inhibit P. berghei oocyst development in mosquitoes and confocal microscopy 
analysis of infected midguts showed a co-localisation of Pb28 with annexin, suggesting that P28 
binds to Anopheles annexin [141]. 
Because of their function and even and abundant distribution over the entire ookinete 
surface [142], P25 and P28 have been the leading target candidates for malaria transmission 
blocking vaccines (MTBVs). MTBVs rely on the presence of antibodies against Plasmodium 
antigens that, when taken up by a female mosquito during a blood meal, bind to the developing 
parasite preventing infection of the vector and subsequent transmission of the parasite to naïve 
human hosts [143]. The target molecules of a MTBV, unlike other malaria vaccines, are proteins 
expressed in sexual and ookinete stages of the parasite. Some of these are transcribed but not 
translated during mammalian host-associated life cycle stages [144]. Consequently, these 
proteins are not under immune selection and may represent good TB antigens [144, 145]. 
Therefore, MTBVs are promising agents of malaria control, especially when used in conjunction 
with other intervention strategies [143]. Indeed, the presence of anti-P25 and anti-P28 
antibodies during a blood meal clearly reduces mosquito infection [144, 146-151]. So far, only 
Pfs25- and Pvs25-based TB strategies have gone through phase 1 clinical trials. Different 
immunisation schedules, doses and adjuvants have been tested but local and systemic mild to 
adverse effects and suboptimal TB effects have been reported [143, 152, 153]. Nonetheless, 
mathematical modelling suggests that current formulations of Pfs25 are likely to achieve useful 
malaria transmission reduction in the field [154]. Other theoretical studies have predicted that 
TB interventions could significantly impact the number of malarial cases in the field under a 
variety of transmission rates and even if at low intervention efficacy and coverage [155, 156]. 
Notably, malaria elimination could be successfully achieved in laboratory populations of mice 
and Anopheles stephensi over three transmission cycles conditions using a mildly effective TB 
drug under low bite rates [48]. 
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The MTBV concept started almost 40 years ago when Robert Gwadz and Richard 
Carter showed that immunising chickens with P. gallinaceum gametocytes generated antibodies 
that killed the parasite not when still circulating in the blood, but after it had egressed from the 
RBC in the mosquito blood meal [157, 158]. MTBVs are an unusual vaccine type and are often 
called ‘altruistic’ vaccines, as they cannot affect the course of infection in a vaccinated 
individual. Instead, they would benefit others by means of reducing parasite transmission rates. 
In the perspective of national health programmes this should however not induce ethical 
rejection as protection of communities as wholes is intended [159]. Nevertheless, a number of 
challenges are posed to the development and application of such vaccines. For example, 
natural boosting for antigens that are never expressed in human hosts will not occur and so a 
MTBV would have to generate long lasting antibody titres. A considerable population-wide 
vaccination effort would also have to be undertaken to guarantee that an effective fraction of 
gametocyte carrier individuals generate TB immunity [160]. This means that the impact of 
MTBVs is exclusively based on herd immunity. But reducing malaria transmission in particular 
endemicity scenarios could also be dangerous. By interfering with the acquisition of natural 
immunity, the number of life threatening disease cases may increase [161]. 
MTBV target antigen research has focused on few surface and soluble molecules 
belonging to two groups: pre-fertilisation antigens, expressed in gametocytes and gametes, or 
post-fertilisation antigens, expressed in zygotes and ookinetes [142, 145]. Pre-fertilisation 
antigens include P48/45 [162-166] and P230 [167-170], while P25 and P28 (see above), CHT1 
(chitinase) [171-173], CTRP [172] and WARP [172, 174] are post-fertilisation antigens. 
However, several more proteins (e.g., SOAP, MAOP, PbSub2, LAPs, CelTOS, PPLPs and 
PSOPs) have been shown to contribute for mosquito infection using gene knock-out (KO) 
parasites [142, 160, 175, 176]. Different production methods, adjuvants and immunisation 
routes have been tested for the several MTBV candidates mentioned above. Antigens have 
been produced using insect and mammalian viruses [165, 177-181], bacteria [162, 164, 174, 
182, 183], yeast (either Saccharomyces or Pichia [146, 148, 151, 153, 166, 184-186], algae 
[187-189], as well as plant virus-based [190, 191] and wheat germ cell-free expression systems 
[169]. More recently, DNA-based vaccination strategies have also been developed [147, 192-
195]. Most of these studies used intramuscular immunisation route, while others have tested 
intranasal [178, 196-198], intradermal [193], subcutaneous [198] and oral [189] administrations, 
but also skin/muscle electroporation [192, 193, 195]. Besides the common aluminium-based 
[184, 199, 200] and water-in-oil Montanide emulsion [149, 150, 152, 199] adjuvants, several 
studies have assayed Alhydrogel [150, 153, 201] and bacterial proteins/toxins [189, 197, 198, 
200-203]. 
Some of the above mentioned malaria TB targets are ookinete micronemal proteins: 
circumsporozoite- and TRAP-related protein (CTRP), chitinase (CHT1) and von Willebrand 
factor A domain-related protein (WARP) [172]. Micronemes are secretory organelles of the 
malaria invasive stages (merozoites, ookinetes and sporozoites) that are necessary for parasite 
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motility (in the case of ookinetes and sporozoites) and host cell invasion [204]. Interestingly, 
warp is downregulated in the absence of DOZI or CITH, suggesting it is also translationally 
repressed [107, 108], and the protein is only detectable several hours after gametocyte 
activation [205]. Transcription of these genes but also of soap (secreted ookinete adhesive 
protein) was shown to be regulated by AP2-O, while storage of ap2-o mRNA in female 
gametocytes is itself dependent on DOZI [107]. Independently on whether DOZI and CITH act 
directly to repress micronemal genes or control their expression by regulating AP2-O, it is 
evident that TR is paramount for the timely production of parasite molecules that otherwise 
could raise TB antibodies with deleterious consequences for Plasmodium infection of the 
mosquito. 
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V – MALARIA CRYSTALLOID BODIES 
mRNAs that rely on the translational repressors DOZI and CITH for stability in P. 
berghei female gametocytes (and are thus putative or known translationally repressed gene 
products) include (among others) those encoding for surface coat antigens (P25, P28), 
transcription factors (AP2-O), micronemal proteins (WARP) and proteins linked to ookinete 
motility and invasion such as IMC proteins (IMC1b), alveolins and proteins of the gliding motility 
molecular motor (MyoA, GAP45, MTIP). The list is extensive and comprises as well three 
transcripts that encode for members of the LCCL protein family (also known as LAP family in P. 
berghei [206] and CCp family in P. falciparum [207]) [107, 108]. These are pblap4, pblap5, and 
pblap6 and indeed these genes have been shown to be translationally repressed as 
corresponding proteins were detected in mature ookinetes but not in gametocytes [208]. LCCL 
proteins are modular proteins with multiple adhesive-type domains implicated in the binding of 
proteins, lipids and carbohydrates [209, 210]. This family comprises six proteins and all with no 
exception have been found to localise to the ookinete crystalloid bodies (CBs) [208, 211, 212]. 
The CB is an enigmatic organelle. It is a short-lived, cytoplasmic, subunit-based 
inclusion easily visualised under live differential interference contrast (DIC) microscopy that 
assembles during ookinete development and dissociates in the growing oocyst [210]. The 
malaria CB is formed by electron-dense, 25 to 42 nm-wide particles arranged in a tight 
honeycomb pattern [210, 213] and whether it possess or not a surrounding membrane is still a 
matter of debate [210]. CBs vary in size between 0.5 µm and 2.0 µm [214] and represent a 
conserved feature of Plasmodium species [210]. In P. berghei, haemozoin-containing vacuoles, 
remnants of the blood stage food vacuole where haemoglobin is digested, accumulate around 
the edges of the crystalloid inclusion bodies [215, 216]. CBs are sometimes found in association 
with smooth endoplasmic reticulum and Golgi-like vesicles [215-218]. This can indicate that 
crystalloids have their origin on these subcellular compartments. The CB persists until the early 
stages of oocyst maturation [210]. While in the ookinete crystalloids are highly organized, in the 
oocyst CB particles are more randomly assembled and can be found dispersed in the parasite 
cytoplasm. As the oocyst matures, CBs disassemble and subunit-like particles are observed at 
the edges of P. berghei, P. gallinaceum and P. cynomolgi older oocysts [219, 220]. 
The geometrical arrangement of CB particles in electron microscopy samples (hence 
the name ‘crystalloid’) led some researchers to postulate that the CB was the result of a viral 
infection taking place within the mosquito midgut, thus explaining its transient nature [221, 222]. 
However, the fact that CBs can also be observed when ookinetes are cultured in vitro posed a 
problem to this theory [213], and the definitive proof that CBs are not of viral origin came with 
the report of the first parasite protein, LAP1 or PbSR (another member of the LCCL family), with 
essential role in CB biogenesis [211]. 
The exact function of the CB is still elusive. CBs are believed to function as temporal 
storage compartments, acting as an atypical trafficking route for (lipo)proteins from the female 
gametocyte to the oocyst that will be necessary for oocyst maturation and sporozoite 
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development [210, 215, 223]. However, the CB proteome is poorly determined, and includes 
only the six members of the LAP protein family [208, 211, 212]. Nonetheless, all P. berghei LAP 
proteins studied to date by reverse genetics (LAP1 or PbSR, LAP2 and LAP4-6) revealed a 
crucial role during sporogony in mosquitoes [176, 211, 224-226], although under certain in vitro 
culture conditions PbSR KO oocyst sporulation rates are comparable to that of WT parasites 
[211]. On the contrary, deletion of P. falciparum CCp2 (ortholog of PbLAP4) and CCp3 (ortholog 
of PbSR) did not affect oocyst sporulation. Rather, KO sporozoites were not able to invade the 
mosquito salivary glands [207]. Despite these discrepancies, it seems clear that LCCL proteins 
have key roles in the development of infective sporozoites, having the oocyst as their likely site 
of action [210]. 
As mentioned above, the formation of the ookinete relies on numerous translationally 
repressed mRNAs provided by the female gametocyte; they are translated following fertilisation 
and are crucial for morphogenesis [107, 108, 134]. Among the set of repressed mRNAs are also 
such that are translated but redundant for ookinete formation, invasion of the midgut epithelium 
or establishment of the oocyst. This is the case, for example, of pblap4-6 [208]. The remaining 
members of the LAP family (PbSR [211] and PbLAP2-3 [212]) are not targets of TR and protein 
can be found throughout the macrogametocyte cytoplasm that is later on redirected to the CB 
upon ookinete development. 
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VI – PROTEIN PALMITOYLATION IN PLASMODIUM AND RELATED APICOMPLEXA 
 In the list of downregulated genes in Δdozi parasites one can find three encoding for 
palmitoyl-S-acyl-transferases belonging to the DHHC family (DHHC2, DHHC3 and DHHC10), 
suggesting an involvement of protein palmitoylation in the development of the parasite within 
the mosquito vector. While the essential nature of this post-translational modification (PTM) has 
recently been determined for P. falciparum blood stages [227], its role in malaria life cycle 
progression in the mosquito remains completely unexplored. 
 The morphological changes during ZOT and the formation of thousands of individual 
sporozoites from a single oocyst requires extensive protein translation and trafficking as well as 
membrane biogenesis to support the generation of organelles and plasma membrane (PM) 
surrounding each new parasite. A large proportion (36%) of proteins found in the oocyst and 
oocyst-derived sporozoites (midgut sporozoites) of P. falciparum are putatively membrane-
bound, based on the presence of a signal peptide (SP) and transmembrane (TM) domains [51]. 
Out of 482 proteins detected in both these parasite life cycle stages, 96 have a SP and 139 
have at least one TM domain; 63 contain both SP and TM domains (PlasmoDB version 11.1). 
Correct permanent targeting of such proteins into the membrane of newly formed organelles 
requires the presence of TM domains, while temporary membrane association can also be 
achieved through PTMs such as prenylation, glypiation, cholesteroylation and fatty acid 
acylation [228, 229]. These PTMs are collectively known as lipidation and increase the affinity of 
a modified protein to membranes. 
Fatty acid acylation is the addition of fatty acids to specific amino acids. Two processes 
of fatty acid acylation can be distinguished, myristoylation and palmitoylation; the latter is the 
reversible addition of long chain (16-carbon) saturated fatty acids to cysteine residues via a 
thioester bond or less frequently to N-terminal amino acids via amide bonds [229]. The most 
common added lipid moiety in palmitoylation reactions is palmitic acid (also known as palmitate 
or hexadecanoic acid), although stearic acid can also be used [230]. This PTM is also 
responsible for changing the subcellular localization of its protein targets [231, 232]. Being the 
sole known reversible lipidation PTM, palmitoylation enables a dynamic regulation of protein 
localisation and stability, influencing protein interactions and function, as well as gene 
expression [227, 229, 230, 233]. For example, reversible palmitoylation/depalmitoylation was 
shown to fine tune host cell invasion by the apicomplexan parasite Toxoplasma gondii [234]. 
Palmitoylation is catalysed by TM-spanning enzymes called palmitoyl-S-acyl-
transferases (PATs) but rare events of spontaneous palmitoylation are also reported [229]. 
PATs are divided into two families: DHHC and MBOAT. DHHC-PATs are characterised by a 
highly conserved inter-TM cysteine-rich domain (CRD) domain comprehending the Asp-His-His-
Cys (DHHC) motif, normally facing the cytosol, and are responsible for the palmitoylation of 
intracellular proteins, while membrane-bound O-acyl-transferases (MBOAT-PATs) modify 
secreted proteins and are mostly involved in the N-terminal-linked palmitoylation. Both families 
share an even number of TM domains, ranging from four to six in the case of DHHC-PATs [227, 
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229, 230]. DHHC-PAT-driven palmitoylation is highly conserved throughout evolution with 25 
human and 7 Saccharomyces cerevisiae factors known; 12 are described in P. falciparum and 
18 in T. gondii [227, 233]. Regardless of the organism in question, DHHC-PATs are essential 
for key biological processes. For example, Saccharomyces cerevisiae Pfa3 is responsible for 
the palmitoylation of the armadillo repeat protein Vac8. This event leads to Vac8 recruitment to 
the yeast vacuole, facilitating vacuolar fusion [235, 236]. In T. gondii, the activity of TgDHHC7 
(homologue of yeast Pfa3), which localises to rhoptries, is necessary for invasion but not egress 
from host cells [233, 237], and tachyzoites treated with 2-bromopalmitate (2-BMP), an 
irreversible inhibitor of PATs [238, 239], show altered motility, invasion, replication and 
morphology [240]. 
The global extent of palmitoylation in asexual blood stages of P. falciparum comprises 
several hundred proteins; they include factors involved in gliding motility, invasion, adhesion, 
IMC function, signalling (kinases) and proteolytic activity (rhomboid proteases), but also 
chaperones, proteins targeted to the surface of an iRBC, transporters and factors within the 
secretory pathway [227]. Treatment of P. falciparum in vitro cultures with the PAT inhibitor 2-
BMP causes schizont developmental defects and subsequent inhibition of RBC invasion by 
newly released merozoites through the destabilisation of the gliding motor components GAP45 
and MTIP [227]. 
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Figure 4 – Model for the Plasmodium gliding motility apparatus. 
(1) A direct link between the motor complex and the cytoskeleton 
may exist. (2) MyoA is stabilized by MTIP and interacts with GAP45 
and GAP50. (3) Formin1 and profilin initiate actin polymerization. (4) 
MyoA drives ATP-dependent directed force through F-actin. (5) 
TRAP adhesin moves rear-wards through the parasite PM and its 
attachment to the host cell surface propels the parasite forwards. (6) 
Adhesin disentangle involves the shedding activity of , for example, 
rhomboid proteases. (7-8) Depolymerisation of F-actin is likely to 
occur via cofilin and cyclase-associated protein (CAP). MTs: 
subpellicular microtubules; IMC: inner membrane complex; PM: 
plasma membrane. [Adapted from Baum et al., Trends Parasitol 
2008, 24(12): 557-63] 
VII – MOTILITY AND INVASION OF MALARIA PARASITES 
While proteins involved in invasion by the merozoite and sporozoite (and in gliding by 
the sporozoite as well) are believed to be transcribed and translated when needed, continuous 
studies highlight mRNAs encoding known motility and invasion proteins of the ookinete to be 
stored and translationally repressed in the female gametocytes by the RNA binding proteins 
DOZI and CITH. These include gliding molecular motor proteins such as MyoA and MTIP but 
possibly also alveolins and microneme proteins [107, 108]. Translational activation of these 
transcripts takes place during ookinete development and is dependent on the protein kinase 
CDPK1 [134]. 
Plasmodium parasites rely on gliding motility for migration through, and invasion of 
diverse host cells in two fundamentally different host species [204]. Ookinetes and sporozoites, 
the migrating forms of the malaria parasite, are morphologically distinct but share essential 
components of the gliding 
motility apparatus (Figure 4). 
Briefly, this machinery is 
composed of an actin-myosin 
motor (or glideosome) 
consisting of Myosin A 
(MyoA) molecules bound to 
actin filaments. MyoA is 
secured via association with a 
light chain called MyoA tail 
domain interacting protein 
(MTIP) to the glideosome-
associated proteins (GAP) 45 
and 50. GAP45 and GAP50 
in their turn link the molecular 
motor to the IMC, while 
alveolins are the bridges that 
connect the IMC to the 
underlying cytoskeleton 
subpellicular microtubules. 
Towards the surface of the 
parasite, the glideosome is 
connected to surface 
adhesins on the PM that 
allow interaction with the 
substrate. For example, the 
membrane-spanning protein 
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TRAP (thrombospondin-related anonymous protein) is connected to the actin filaments via 
aldolase [204]. Controversially, a recent study using T. gondii aldolase (TgALD) KO parasites as 
well as mutants that disrupt its binding to adhesins showed that this enzyme is not necessary 
for motility or invasion [241]. In both ookinetes [242] and sporozoites [243] the IMC is a single 
inner vacuole below the PM, sealed by a prominent suture running obliquely to the longitudinal 
axis of the cell. Due to its flattened morphology, this structure is normally seen in electron 
microscopy studies as two apposed phospholipid membranes below the PM [204]. Uniquely 
among all other apicomplexan motile stages, the IMC of Plasmodium ookinetes presents large 
pores scattered throughout the cell that are thought to constitute an alternative pathway for the 
transport of molecules between the cortical and inner cytoplasmic compartments, namely 
surface and motor proteins [242]. 
Gliding motility is a unique type of locomotion used by apicomplexan parasites [244] 
(and also by some free living protists such as raphid diatoms and the green alga 
Chlamydomonas [245]) to migrate through cells and tissues and is characterised by the 
absence of any cell shape modification. It was long believed to be the driving force for host cell 
invasion [246] that, in contrast to most intracellular pathogens, does not depend on active 
uptake of the parasite by endocytosis or phagocytosis [247, 248]. Reverse genetics studies 
targeting components of the gliding machinery have however revealed that invasion is still 
possible when parasites have lost their ability to move or breach host cells, uncoupling these 
two fundamental cellular processes [249]. 
The invasive stages of Plasmodium parasites contain secretory vesicles that discharge 
their contents during gliding motility and host cell invasion. For example, micronemes and 
rhoptries assist each other in providing invasion-related proteins, such as adhesins and 
proteases, but at the same time rhoptries, together with dense granules, are primary 
contributors to the formation of the parasitophorous vacuole (PV) that surrounds the intracellular 
parasite stages. While micronemes and rhoptries deliver their contents during parasite motility 
and invasion, proteins contained within dense granules are released after the invasion process 
is concluded to remodel the host cell environment. It is worth noting that while sporozoites (as 
well as merozoites, the red blood cell invasive stage) bear all three types of organelles, 
ookinetes only harbour micronemes [204]. The lack of rhoptries and dense granules in 
ookinetes is biologically meaningful as ookinete-derived oocysts do not develop inside cells and 
thus do not need to form a PV upon midgut invasion [250]. Interestingly, sporozoites do not 
always develop a PV when penetrating host cells. For instance, during invasion of the mosquito 
salivary glands, the sporozoite is initially surrounded by a second membrane [251] but this is 
subsequently disintegrated by an unknown mechanism, allowing the sporozoite to exit the cell 
into the secretory cavities of the salivary gland [252]. Although the nature of this membrane is 
unclear, it has been postulated to be a transient PVM [253]. When at the liver, the sporozoite 
also traverses a few cells without the need of a PV until it finally invades a hepatocyte with 
concomitant establishment of a PV inside of which the parasite develops and multiplies [37, 38]. 
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Another organelle of sporozoites and merozoites but not ookinetes are the exonemes, which 
release proteases into the PV prior to microneme secretion and initiate parasite egress from 
host cells [204]. 
During gliding and invasion, many proteins are secreted from micronemes through the 
parasite apical pore. For instance, micronemal secretion in Toxoplasma is upregulated when 
parasites make contact with host cells [254]. While some of these proteins are discharged into 
the extracellular milieu  for example SOAP [255] and WARP [172, 205]  others are inserted 
into the PM where they engage host receptors [256]. Translocated backwards along the cell 
surface during gliding these TM proteins are shed by rhomboid and subtilisin-like serine 
proteases [204, 257, 258] and deposited along the parasite gliding trails, as are the cases of 
TRAP and CelTOS [175, 259, 260]. 
The apical to rear redistribution of parasite surface molecules led researchers to 
propose a capping model of gliding and invasion by apicomplexans. In this model, parasite 
ligands would bind the substrate at the anterior pole of the zoite and be transported to the 
posterior pole, while propelling the cell body forward [261, 262]. The first Plasmodium protein 
shown to be subjected to this process was the circumsporozoite protein (CSP) [263], being 
released onto the substrate along the gliding trails of the parasite [264]. This is a feature that is 
used in assays to measure the gliding motility of Plasmodium sporozoites. 
Micronemal proteins of the ookinete include CTRP, WARP, SOAP, CHT1 and MAOP; in 
the sporozoite they are AMA1, TRAP, MAEBL, SPECT, SPECT2 and P52; only CelTOS is 
present in both [204, 265]. If and how these factors interact with each other and with host 
receptors to coordinate efficient gliding motility and invasion is largely unknown. It is also very 
likely that additional proteins are required in these complex cellular processes. The individual 
functions of micronemal proteins have however been the subject of many studies and found to 
affect parasite motility, host cell traversal and invasion as well as transmission to and from the 
mosquito vector. 
Disruption of cht1 reduces ookinete infectivity to mosquitoes [266, 267]. On the other 
hand, deletion of warp did not result in obvious phenotypic difference from WT parasites [176]. 
However, antisera produced against PfWARP, PgCTRP and PgCHT1 significantly reduced the 
infectivity of P. gallinaceum to Aedes aegypti and P. falciparum to Anopheles mosquitoes [172]. 
This study showed that ookinete micronemal proteins are good malaria TB targets. 
AMA1 (apical membrane antigen 1) is expressed in both merozoites and sporozoites 
[204]. Although anti-AMA1 antibodies were shown to inhibit hepatocyte invasion by sporozoites 
in vitro [268], disruption and conditional deletion studies of ama1 indicate that it has no role in P. 
berghei sporozoite infectivity to liver cells as mutants showed normal hepatocyte traversal and 
invasion and develop normally into EEFs, both in vitro and in vivo [269, 270]. AMA1 was 
however shown to play a major role in the attachment of erythrocytic and hepatic merozoites to 
RBCs, resulting in highly reduced RBC entry rates in one of the studies [270] and complete lack 
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of blood stage infection in the other [269]. This phenotype was similarly observed in P. 
falciparum, where the conditional KO of Pfama1 affected erythrocyte invasion by merozoites 
and reduced parasite blood stage growth by 40% [271]. 
CTRP is required for normal ookinete motility [272-274] while MAOP (membrane-attack 
ookinete protein) is essential for midgut epithelial cell entry [275]. SOAP (secreted ookinete 
adhesive protein) has also been implicated in midgut invasion by ookinetes as well as 
differentiation into oocysts [255]. MAEBL (merozoite adhesive erythrocytic binding-like protein) 
is predominantly expressed in midgut sporozoites and is vital for attachment to and invasion of 
mosquito salivary glands but does not participate in sporozoite motility or infectivity to the 
vertebrate host [276, 277]. SPECT [278] (sporozoite microneme protein essential for cell 
traversal) and SPECT2 [279] are salivary gland sporozoite-specific proteins specifically involved 
in cell traversal ability that do not participate in gliding or invasion. P52 (also known as P36p) 
and its P36 counterpart are members of the Plasmodium 6-cysteine domain-containing protein 
family [280]. Similarly to SPECT proteins they are also exclusively expressed in salivary gland 
sporozoites and have been specifically implicated in hepatocyte invasion, more precisely in 
commitment to hepatocyte infection. Without shifting from a cell migrating to a hepatocyte 
invasive status, P. berghei disruptants for these genes showed increased cell traversal activity, 
both in vitro and in vivo. Whereas P52 is present in micronemes and translocated to the 
parasite surface upon gliding, the subcellular localisation of P36 could not be determined [265]. 
Curiously, another study using independently-generated Δp52 P. berghei parasites describes a 
role for P52 in parasite development within the hepatocyte but not in hepatocyte invasion. 
Hepatocyte traversal was also not affected by the absence of P52 in this study [281]. 
Contradictory results were also found for P36, where another P. berghei line lacking expression 
of this protein showed no differences comparing to WT parasites throughout the entire life cycle 
[282]. In agreement with these ulterior studies on P36 and P52, P. berghei double KO parasites 
for P36 and P52 only showed a developmental defect within hepatocytes [283] but deletion of 
both these molecules in P. yoelii resulted in a 50% reduction in hepatocyte invasion apart from 
the expected developmental impairment [284]. The reasons for these discrepancies remain to 
be elucidated but it is likely that at least P52 plays a role in both invasion of host hepatocytes 
and intracellular development [38]. TRAP is expressed in both midgut and salivary gland 
sporozoites and is known to influence sporozoite gliding as well as invasion of both salivary 
glands and hepatocytes in vitro. Disruption and loss-of-function mutations of TRAP resulted in 
decreased levels of transmissibility to naïve hosts, and in some cases transmission was 
completely abolished [259, 260, 285-287]. CelTOS (cell-traversal protein for ookinetes and 
sporozoites) is shared between the ookinete and sporozoite stages and was shown to play a 
major role in midgut epithelium and liver sinusoidal cell traversal [175]. 
Proteins other than those secreted by micronemes have also been implicated in 
parasite motility and host cell invasion events, both in the mosquito vector and vertebrate host. 
Examples include, for instance, S6/TREP [288, 289] and TLP [290-292], two sporozoite TRAP 
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family members with predicted surface localisation. S6 (sporozoite-specific gene 6) or TREP 
(TRAP-related protein) is mostly detected in salivary gland sporozoites and, as MAEBL, plays a 
major role in salivary gland invasion, but also in gliding motility. The absence of S6/TREP also 
decreases the capacity of parasites to invade hepatoma cells in vitro while leaving cell adhesion 
unaltered. Transmission to naïve rodents is however still achievable [288, 289]. On the other 
hand, the role of TLP (TRAP-like protein) is not completely clear. While some authors have 
shown that disruption of tlp decreases the cell traversal and in vivo infectivity capacities of 
sporozoites and does not alter in vitro sporozoite motility or hepatocyte invasion [290], others 
claim that this protein is only implicated in gliding motility on glass surfaces and is redundant 
throughout the parasite life cycle [291]. A follow-up review on this subject suggests that most 
likely TLP is important for sporozoite infectivity when these are injected into the skin but mildly 
relevant when these are injected directly into the blood [292], an interpretation that links the 
gliding and traversal phenotypes. 
TRSP (thrombospondin-related sporozoite protein) is also structurally related to TRAP 
and has been first found in P. yoelii midgut and salivary gland sporozoites. Immunofluorescence 
assays showed a distinct subcellular staining pattern regarding CSP and TRAP proteins and 
was suggested to indicate rhoptry localisation [293]. A follow-up work on P. berghei has shown 
that TRSP has no effect on sporozoite gliding motility but has a significant role in hepatocyte 
entry, both in vitro and in vivo [294]. 
On the other hand, members of the Plasmodium cysteine repeat modular protein 
(PCRMP) family are involved in salivary gland invasion. PCRMP1 and 2 are expressed in 
merozoites and PCRMP2 was also shown to localize at the surface of hemolymph and salivary 
gland sporozoites. Both these proteins are key players in sporozoite targeting into the mosquito 
salivary glands, as gene deletion parasites are rarely found in these organs [295]. 
RON4 (rhoptry neck protein 4), a rhoptry-resident protein that, together with other 
proteins, namely the micronemal AMA1, compose the tight junction (TJ) of invading T. gondii 
[296, 297] and P. falciparum [298] parasites was shown to play an important and likely essential 
role in hepatocyte invasion by P. berghei sporozoites [269]. The TJ is an electron-dense ring-
like structure formed by the plasma membranes of both parasite and host cell that connects the 
parasite motor to the host cell actin, and through which the motile zoite glides into a PV [204, 
299]. 
Finally, conflicting results were obtained for another the Plasmodium inhibitor of 
cysteine proteases (ICP). In P. yoelii, it was observed in sporozoite rhoptries and dispersed 
throughout the cytoplasm, but shown to be essential for asexual blood stage replication [300]. 
On the other hand, the P. berghei ortholog did not shown any growth defect in the blood but 
severely impairs sporozoite motility and completely blocks mosquito salivary gland and 
hepatocyte invasion, leading to transmission blockade to naïve hosts. Interestingly, the lack of 
PbICP led to increased CSP proteolytic processing in oocyst-derived but not in hemolymph 
sporozoites, which might be responsible for the salivary gland invasion defect [301]. 
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The invasion of both mosquito salivary glands and vertebrate liver is thought to be 
mediated by specific molecular interactions, and both CSP and TRAP have long been 
implicated in binding to these organs [302]. Although not secreted through any of the secretory 
organelles present in sporozoites, competition experiments using recombinant CSP as well as 
CSP peptides have shown that these can bind to the mosquito salivary glands and 
consequently inhibit invasion of these organs by the sporozoite [303, 304]. The demonstration 
that CSP binds to mosquito heparan sulphate suggests that this could play a role in targeting 
sporozoites to the mosquito salivary glands [305]. Similarly, peptide competition assays, genetic 
mutations in TRAP and down-regulation of saglin suggest that TRAP directly interacts with 
saglin on the surface of the salivary gland, thus allowing for efficient invasion of this organ [306]. 
In the liver, heparan sulphate proteoglycans (HSPGs) on the surface of different resident cells 
(hepatocytes, Kupffer cells and stellate cells) but also on the extracellular matrix have been 
proposed to be the main receptors for sporozoites. While present in most tissues, the sulphation 
levels of HSPGs in liver cells are particularly high, possibly explaining how sporozoites 
successfully target this organ. Here as well, both CSP and TRAP seem to be key players in 
sporozoite sequestration by interacting with the organ’s HSPGs [38, 307], but also with the 
glycoprotein fetuin-A on hepatocyte membranes in the case of TRAP [308]. TRAP recombinant 
protein and peptides were also shown to bind to human hepatoma Hep G2 cells [309-311]. 
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AIMS OF THIS THESIS 
In the present thesis we aimed at characterising the roles of novel P. berghei putative 
translationally repressed gene products during parasite transmission and development in the 
anopheline mosquito vector. We have restricted our candidate gene selection to those 
transcriptionally upregulated in gametocytes but downregulated in Δdozi and/or Δcith parasites 
and absent from published blood stage proteomes. Such mRNAs are likely to be stored in a 
translationally quiescent form in female gametocytes in a DOZI- and CITH-dependent manner. 
From this list we have chosen those with orthologs in P. falciparum and P. vivax with the goal of 
providing insights into conserved mechanisms that Plasmodium species use for life cycle 
progression in the mosquito. A further selection criterion was the presence of few non-
synonymous single nucleotide polymorphisms (SNPs) in different P. falciparum strains 
according to the Plasmodium genomics resource PlasmoDB (plasmodb.org). This feature may 
be an extra indication of translational repression (TR): genes under TR are not expressed as 
proteins while the parasite is in the mammalian host, and are therefore not exposed to the 
host’s immune system; as a consequence there is no selective pressure on these genes to 
mutate. They are therefore attractive transmission blocking (TB) antibody targets. Indeed, 
translationally repressed genes that are also malaria transmission blocking vaccine (MTBV) 
candidates have been shown to bear few sequence polymorphisms [312-315]. Finally, we have 
chosen gene products with predicted surface targeting signals such as signal peptide and/or 
transmembrane domains as a suggestive signature of secreted or integral membrane proteins 
that could be developed as targets of TB strategies, namely by TB antibodies. 
 Specifically, we aimed to determine the mRNA expression profile of each selected gene 
and unequivocally demonstrate that these are indeed translationally repressed and present in 
translationally quiescent messenger ribonucleoproteins (mRNPs). For this purpose we 
performed reverse transcriptase-polymerase chain reactions (RT-PCRs) to detect the mRNAs of 
interest in different life cycle stages, as well as in DOZI and CITH immunoprecipitation (IP) 
eluates. Green fluorescent protein (GFP)-tagged lines were generated for each of the proteins 
to assess protein expression during the transition from the female gametocyte to the ookinete 
by live imaging and/or immunofluorescence assay. The same GFP reporter lines were also 
used to identify the expression patterns and subcellular locations of these proteins along the 
parasite life cycle. 
 The functional importance of these translationally repressed molecules during mosquito 
stage development was determined by generating gene deletion parasite lines that were 
phenotypically screened throughout the entire life cycle. More specifically, null mutants were 
analysed in vitro and in vivo for any defects at the ookinete, oocyst, sporozoite and liver stage 
levels. Experiments were performed to evaluate the consequence of gene deletion for parasite 
transmission to naïve hosts. 
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ABSTRACT 
Malaria parasites transit from a vertebrate host and an invertebrate vector. Plasmodium 
ookinetes, the true mosquito-infective parasite forms, assemble an enigmatic organelle called 
crystalloid body (CB) that persists until the early, now sessile oocyst stage that develops below 
the midgut epithelium. While the exact function of this organelle is not understood, it is known 
that sporozoite formation requires proteins contained within and provided by the ookinete CB. At 
present, only the six members of the LCCL protein family are known to be targeted to CBs and 
the absence of any of these proteins invariably results in lack of oocyst sporulation. Here we 
describe a novel CB component from the rodent malaria parasite Plasmodium berghei which we 
call EPSF (Essential Protein for Sporozoite Formation) with a vital role for oocyst sporulation 
and progression of the parasite life cycle in the mosquito. epsf is transcribed in the female 
gametocyte, but kept translationally repressed until translated during ookinete formation. Δepsf 
mutants establish normal oocyst numbers but fail to develop sporozoites, remain vacuolated 
and continue to increase in size without concomitant DNA replication or circumsporozoite 
protein expression. Consequently, Δepsf parasites are completely blocked in transmission. Our 
data further establish an important function for CB-resident proteins in oocyst sporulation. 
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METHODS 
Experimental animals 
Female Balb/c ByJ and OF-1 (6–8 weeks bred at Charles River, France) mice were 
used. Animal experiments performed in Leiden University Medical Center (LUMC, Leiden, The 
Netherlands) were approved by the Animal Experiments Committee of the Leiden University 
Medical Center (DEC 10099; 12042; 12120). In Instituto de Medicina Molecular (IMM, Lisbon, 
Portugal) animal experimentation protocols were approved by the IMM Animal Ethics 
Committee (under authorisation AEC_2010_018_GM_Rdt_General_IMM), the Portuguese 
authorities (Direção Geral de Alimentação e Veterinária) and performed according to European 
Union regulations. 
 
Reference P. berghei ANKA lines 
Six reference P. berghei ANKA parasite lines were used. Details of most lines can be 
found in the RMgmDB database (www.pberghei.eu). Line 683cl1 (DOZI::GFP; RMgm-133) [107] 
expressing a C-terminally GFP-tagged version of dozi (PBANKA_121770); line 909cl1 
(CITH::GFP; RMgm-358) [108] expressing a C-terminally GFP-tagged version of cith 
(PBANKA_130130); line HPE, a non-gametocyte producer clone [316]; line 820cl1m1cl1 (Fluo-
frmg; RMgm-164) [108] expressing RFP under the control of a female gametocyte specific 
promoter and GFP under the control of a male gametocyte specific promoter; line 259cl1 
(PbGFPcon; RMgm-5) expressing GFP under the control of the constitutive eef1a promoter; 
and line cl15cy1, which is the reference parental line of P. berghei ANKA [317]. Line Fluo-frmg 
contains the transgenes integrated into the silent 230p gene locus (PBANKA_030600) and does 
not contain a drug-selectable marker. 
 
Reverse Transcriptase-PCR (RT-PCR) 
Immunoprecipitation (IP) of DOZI::GFP and CITH::GFP parasite lysates, and 
subsequent RNA extraction and RT-PCR were performed as described [108]. To investigate the 
transcription pattern of epsf by RT-PCR, RNA from different life cycle stages were obtained 
using TRIzol
®
 Reagent (Ambion
®
, #15596). Reverse transcription was done with random 
primers and oligo-d(T) using SuperScript
® 
II Reverse Transcriptase (Invitrogen™, #18064). RNA 
sample origins were as follows: asexual blood stages from line HPE; mixed blood stages 
(asexuals & gametocytes) and oocysts d12 post-infection (p.i.) from line Fluo-frmg; in vitro-
cultured ookinetes at different time points from line cl15cy1; midgut sporozoites d20 p.i. and 
salivary gland sporozoites d20 p.i. from line PbGFPcon; and exoerythrocytic forms from line 
PbGFPcon at different time points after mouse infection. Primers used in RT-PCRs are shown 
in Table S1a. 
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Generation of epsf gene deletion mutants 
To disrupt the gene encoding epsf (PBANKA_072090) we constructed a standard 
replacement construct [318] using plasmid pL0001 (www.mr4.com) which contains the 
pyrimethamine resistant Toxoplasma gondii (tg) dhfr/ts as a selectable marker cassette. See 
Table S2 and Figure S4A for the name and details of the construct. Target sequences for 
homologous recombination were PCR amplified from P. berghei wild-type (WT) genomic DNA 
using primers specific for the 5′ or 3′ flanking regions of epsf (see Table S1b for the sequence 
of the different primers). The PCR–amplified target sequences were cloned in plasmid pL0001 
either upstream or downstream of the selectable marker to allow for integration of the construct 
into the genomic target sequence by homologous recombination. DNA construct used for 
transfection was obtained after digestion of the replacement construct with the appropriate 
restriction enzymes (Table S2). Transfection, selection and cloning of mutant parasite lines 
were performed as described [318]; see Table S2 for details of the transfection experiments 
performed. Correct deletion of the epsf gene was confirmed by diagnostic PCR (for primers see 
Table S1c) and Southern analysis of Field-Inversion Gel Electrophoresis (FIGE)-separated 
chromosomes (Figure S4B).  Chromosomes were hybridized with a probe recognizing the 
tgdhfr/ts selectable marker cassette. Absence of epsf mRNA was determined by RT-PCR 
analysis (Figure S4C) using RNA collected from infected blood containing asexual blood stages 
and gametocytes (see Table S1c for primers used for RT-PCR). Two cloned lines were used for 
further phenotype analyses:  2099cl1m7 (Δepsf-a) and 2100cl1m1 (Δepsf-b), both in the Fluo-
frmg background. 
 
Generation of transgenic line expressing GFP-tagged EPSF 
In situ C-terminal GFP tagging of epsf was performed by single cross-over homologous 
recombination into the corresponding locus. See Table S2 and Figure S3A for the name and 
details of the construct. The construct contains the tgdhfr/ts selectable marker. Primers used to 
amplify the targeting region of epsf, corresponding to the 3' end of the open reading frame 
(ORF) excluding the stop codon are listed in Table S1b. The targeting region was cloned in 
frame with gfp. Linearised plasmid was transfected into cl15cy1 parasites using standard 
methods. Transfection, selection and cloning of resulting mutant parasite line was performed as 
described [318], resulting in the transgenic line 2182cl2m2 (epsf::gfp). See Table S2 for details 
of the transfection experiment performed. Correct integration of the construct was confirmed by 
diagnostic PCR (for primers see Table S1c) and Southern analysis of FIGE-separated 
chromosomes using a probe for the tgdhfr/ts selectable marker cassette (Figure S3B). 
Transcription and processing (splicing) of the gfp fusion was confirmed by RT-PCR using RNA 
from mixed blood stage forms (Figure S3C). Primers used for RT-PCR are listed in Table S1c. 
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In vivo multiplication rate of asexual blood stages 
The multiplication rate of asexual blood stages in mice is determined during the cloning 
procedure of gene-deletion/transgenic parasites [319] and is calculated as follows: the 
percentage of infected erythrocytes in OF-1 mice injected with a single parasite is quantified at 
days 8–11 on Giemsa-stained blood films. The mean asexual multiplication rate per 24 h is then 
calculated assuming a total of 1.2×10
10
 erythrocytes per mouse and a blood volume of 2 mL. 
The percentage of infected erythrocytes in mice infected with reference lines of the P. berghei 
ANKA strain consistently ranges between 0.5 and 2% at day 8 after infection, resulting in a 
mean multiplication rate of 10 per 24 h [319, 320]. 
 
Oocyst production, sporozoite production and transmission experiments 
Oocyst and sporozoite production of the mutant parasites was analysed by performing 
standard mosquito infections. Naïve female Balb/c ByJ mice were infected intraperitoneally (i.p.) 
with 10
6
 infected red blood cells (iRBCs) of each line. On days 4-5 p.i., these mice were 
anesthetised and Anopheles stephensi female mosquitoes allowed to feed for 30 min. Twenty-
four hours after feeding, mosquitoes were anesthetised by cold shock and unfed mosquitoes 
were removed. Oocyst and sporozoite numbers were counted at days 11-13 and 20-22 after 
mosquito infection, respectively. Oocyst sizes over time were determined at days 12 and 21/22 
p.i. Oocysts were counted after mercurochrome staining and measured using ImageJ 1.47n 
software (imagej.nih.gov/ij). Sporozoites were counted in pools of 3 to 24 mosquitoes. To test 
the infectivity of sporozoites, 10 infected mosquitoes were allowed to feed for 30 min on 
anesthetised naïve female Balb/c ByJ mice on days 20-21 p.i. Successful feeding was 
confirmed by the presence of blood in the abdomen of mosquitoes. Blood stage parasitaemias 
in these mice were followed up to 33 days post-bite. 
 
Western analysis of CSP expression in Δepsf oocysts 
To determine circumsporozoite protein (CSP) expression, Fluo-frmg- and Δepsf-a-
infected midguts were dissected at day 13 p.i. and resuspended in 1X Laemmli buffer. Samples 
were adjusted to 200 mM DTT, boiled and loaded onto SDS-PAGE gels. Nitrocellulose 
membranes were blocked for 1 h at room temperature (RT) with 5% skim milk/PBS-Tween 20 
(0.05%), probed overnight at 4 
○
C with 3D11 mouse anti-CSP [321], 0.17 µg/mL in blocking 
solution) or parasite-specific 2E6 mouse monoclonal anti-PbHSP70 [322], 7.5 µg/mL in blocking 
solution) as primary antibodies, and 1h at RT with goat anti-mouse IgG-HRP [Santa Cruz 
Biotechnology, Inc.
®
, #sc-2005, 1:5000-1:10000 in PBS-Tween 20 (0.05%)] as secondary 
antibody. Westerns were developed with Immobilon™ Western Chemiluminescent HRP 
Substrate (Millipore, #P36599). Staining with the antibody recognizing P. berghei HSP70 was 
used as loading control. 
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Live imaging of blood stages and ookinetes and immunofluorescence assays 
(IFAs) of oocysts 
Live imaging of transgenic parasites expressing GFP-tagged EPSF was done by 
collecting tail blood samples from infected mice and mosquito blood meals at 16 h p.i. and 
staining with 1 µg/mL of Hoechst 33342/PBS. To detect CSP expression in Fluo-frmg and 
Δepsf-a oocysts by IFA, parasites at day 14 p.i. were stained with 3D11 mouse anti-PbCSP 
[321] (10 µg/mL) as primary antibody and goat anti-mouse IgG-Cy™3 (Jackson 
ImmunoResearch Laboratories, Inc., #115-166-003; 1:400) as secondary antibody. In these 
IFAs, samples were fixed with 4% PFA/PBS for 10 min at RT and simultaneously permeabilised 
and blocked for 1h at RT with a mixture of 0.5% TritonX-100/PBS and 1% BSA/PBS. All 
antibody incubations were done in permeabilising/blocking solution for 1h at RT and 5 ug/mL of 
Hoechst-33342/PBS was used to stain nuclei. Images were taken with a Leica DM5000B or 
Zeiss Axiovert 200M fluorescence microscope and processed using ImageJ 1.47n software 
(imagej.nih.gov/ij). 
 
Multiple sequence alignments 
Protein sequences in Figures 1A and S1 were retrieved from EuPathDB 
(eupathdb.org). Clustal W alignments were done at EMBnet server (embnet.vital-
it.ch/software/ClustalW.html) and shaded according to protein similarity levels with BOXSHADE 
3.21 (www.ch.embnet.org/software/BOX_form.html). 
 
Statistical methods 
Statistical analyses of oocyst and sporozoite numbers as well as oocyst sizes were 
performed using Mann-Whitney test as part of Prism software package 5 (GraphPad Software). 
 
RESULTS 
EPSF is conserved in Apicomplexan parasites 
EPSF (PBANKA_072090) is present in all Plasmodium species sequenced to date, as 
well as in related apicomplexan parasites such as Babesia bovis and Theileria parva 
(EuPathDB version 20). The similarity between the proteins from the rodent and human malaria 
parasites is 68% (Figure 1A) and is also high when compared to many other orthologs (Figure 
S1). Plasmodium berghei epsf is a 1775 base pair-long gene composed of nine exons 
(conserved in P. falciparum) (Figure 1B), and codes for a protein with a 22 amino acid-long, N-
terminal signal peptide, a transmembrane domain and a weak TPM-similar domain 
(Pfam:PF04536), previously known as DUF477 or Repair PSII domain (Figures 1A and C). In 
plants, this domain is involved in the photosystem II (PSII) repair cycle. 
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Figure 1 – Organisation of epsf gene and protein and its 
mRNA expression profile. 
(A) Protein alignment of EPSF orthologs from P. berghei 
ANKA and P. falciparum 3D7 strains. “+” indicates the 
extent of the signal peptide (SignalP 4.0), “X” indicates the 
extent of the transmembrane domain (TMHMM 2.0) and § 
denotes a TPM similar domain (Pfam:PF04536) in P. 
berghei EPSF. (B) The P. berghei epsf gene (1775 bp) is 
composed of 9 exons (shaded bars) and 8 introns (lines); 
this organisation is conserved in P. falciparum. (C) Modular 
architecture of EPSF. SP: signal peptide; TPM: TPM similar 
domain; TM: transmembrane domain. (D) RT-PCRs of epsf 
along the life cycle. Asexual: asexual blood stages; mixed: 
asexuals and gametocytes; ook: ookinetes (8 and 16 hours 
after gametocyte activation); MG spz: midgut sporozoites; 
SG spz: salivary gland sporozoites. 18S rRNA and hsp70 
serve as loading control genes. +: RT positive reaction; -: 
RT negative reaction. 
epsf mRNA is present in gametocytes and early ookinetes but absent from asexual 
stage parasites. Upon ookinete formation, the transcript is almost absent. mRNA is synthesised 
again in sporulating oocysts and, although less 
abundant, it is still detected in midgut and salivary 
gland sporozoites (Figure 1D). epsf transcripts were 
not detected in in vivo-developed exoerythrocytic 
forms (Figure S2) suggesting a role for the protein 
during parasite development within the mosquito 
vector. There is no documented protein expression for 
the P. berghei, P. falciparum or the avian parasite P. 
gallinaceum proteins at any parasite life cycle stage 
([49, 323-326] and PlasmoDB version 11.0). 
 
epsf is transcribed in gametocytes and 
translationally repressed in DOZI/CITH-defined 
messenger ribonucleoproteins (mRNPs) 
In the female gametocyte epsf has previously 
been found to rely for stability on the translational 
repressors DOZI [107] and CITH [108]; 
downregulation in the absence of these proteins 
reaches WT versus knock-out (KO) ratio log2 values 
higher than 2, similar to the hallmark mRNAs p25 and p28. Using IP of DOZI::GFP and 
CITH::GFP followed by RT-PCR of bound RNAs we found epsf to interact, directly or indirectly, 
with repressors, suggesting storage of this mRNA for translation during ookinete formation in a 
manner similar to p25 and p28 (Figure 2A). 
To test whether DOZI/CITH-bound epsf is indeed translationally repressed in 
gametocytes we generated a parasite line expressing a C-terminally GFP-tagged version of 
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Figure 2 – epsf is translationally repressed in 
gametocytes and expressed in ookinetes. 
(A) RT-PCR analysis on DOZI::GFP and CITH::GFP 
gametocyte immunoprecipitation (IP) eluates shows 
that epsf as well as p25 and p28 mRNAs (known to be 
translationally repressed) co-precipitate with DOZI and 
CITH. dozi, cith and alba-3 are translated in 
gametocytes and are not enriched in the IP-GFP 
fractions. Input: total gametocyte mRNA; IP-GFP: IP 
with anti-GFP antibody; IP-c-myc: IP with anti-c-myc 
antibody; IP beads: no antibody used for IP. (B) RT-
PCR analysis shows absence of WT epsf and presence 
of correctly spliced epsf::gfp mRNA in blood stages of 
epsf::gfp parasites. p28 serves as control gene. (C) 
Live imaging of epsf::gfp parasites shows no EPSF 
expression in gametocytes while EPSF::GFP (in green) 
is localised to discrete foci in blood meal retrieved 
ookinetes. Arrowheads indicate DIC-visible haemozoin 
clusters. ♀ Gam: female gametocyte; Ook: ookinete. 
Scale bar = 5 µm. (D) Mice bitten by epsf::gfp-infected 
mosquitoes develop normal blood stage infection. 
Mean parasitaemias are shown by the dots, while SEM 
values are shown by the vertical lines. WT (2 
independent experiments, n=2); epsf::gfp (1 
experiment, n=1). iRBCs: infected red blood cells; 
tRBCs: total red blood cells. 
EPSF (Figure S3). While the fusion transcript can be detected by RT-PCR in gametocytes 
(Figure 2B), we did not observe EPSF::GFP expression in live gametocytes. EPSF::GFP was 
however detected in mature ookinetes and was restricted to discrete foci that co-localised with 
haemozoin clusters visible under DIC microscopy 
(Figure 2C), suggesting CB localisation. In 
addition, epsf::gfp parasites completed the life 
cycle, including transmission to a naïve mouse 
host by mosquito bite, indicating no deleterious 
effect of the GFP tag for normal parasite life cycle 
progression (Figure 2D and Table S3). Although 
epsf is transcribed to a certain extent in 
sporulating oocysts, midgut sporozoites and 
salivary gland sporozoites (Figure 1D), we were 
unable to detect EPSF::GFP fusion protein in 
these developmental stages, either by live 
imaging or IFAs (data not shown). 
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Figure 3 (legend next page) – Δepsf-a oocysts do not sporulate and lack circumsporozoite protein. 
EPSF is necessary for sporozoite formation 
To dissect the function of EPSF, we generated two independent epsf gene deletion 
parasite lines: Δepsf-a and Δepsf-b (Figure S4). While Δepsf-a showed a 30% reduction in 
oocyst burden compared to WT parasites (Figure 3A), the same analysis with the Δepsf-b line 
did not corroborate this result (Figure S5A). Strikingly however, none of the lines showed 
midgut or salivary gland sporozoites as late as days 20-22 post-infection (p.i.) (Figures 3B-C 
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Figure 3 (previous page) – Δepsf-a oocysts do not sporulate and lack circumsporozoite protein. 
(A) Δepsf-a parasites show slightly reduced oocyst numbers on days 12 to 13 p.i. WT (6 independent 
experiments, n=88); Δepsf-a (5 independent experiments, n=92). (B) Δepsf-a parasites do not develop any 
midgut sporozoite (MG Spz). Absolute numbers of sporozoites per mosquito from 4 independent 
experiments are presented for both WT (n=5) and Δepsf-a (n=10) parasites. (C) Δepsf-a parasites do not 
develop any salivary gland sporozoite (SG Spz). Absolute numbers of sporozoites per mosquito from 5 
independent experiments are presented for both WT (n=6) and Δepsf-a (n=11) parasites. (D) Δepsf-a 
oocysts lack signs of sporulation throughout time and appear ‘empty’ or vacuolated (arrowheads). On the 
contrary, most WT oocysts have already formed sporozoites by days 12 to 16 p.i. (arrows). Scale bar = 30 
µm. (E) At day 12 p.i. Δepsf-a oocysts have normal sizes (upper plot) but by days 21/22 p.i., KO oocysts 
are clearly enlarged when compared to WT oocysts (bottom plot). (A-C, E) Mean and SEM values are 
shown by the lines; p-values for Mann-Whitney test are shown above the data sets. (F) 
Immunofluorescence assay of oocyst-infected midguts at day 14 p.i. shows strongly reduced CSP 
expression (in red) in Δepsf-a parasites. DNA replication in also decreased in KO oocysts, as seen by 
Hoechst-33342 staining (in blue). Scale bars = 20 µm. (G) Western blot analysis of oocyst-infected midguts 
at day 13 p.i. confirms diminished CSP expression in Δepsf-a mutants. HSP70 serves as parasite loading 
control. (F-G) Note that when CSP is detected in Δepsf-a oocysts, signal coming from WT oocysts is 
already saturated. 
and S5B-C). 
WT oocysts sporulate as early as day 12 p.i. On the other hand, Δepsf parasites 
showed no signs of sporozoite formation at this stage. Instead, mutant oocysts remain ‘empty’ 
and vacuolated up to day 21 p.i. (Figure 3D) and outgrow WT cysts in size (Figure 3E). Indeed, 
Δepsf oocysts are significantly larger than WT parasites already at day 14 p.i. (data not shown). 
CSP expression is normally detected soon following oocyst formation and is an 
essential factor for sporozoite development [327].  For these reasons, we analysed the 
expression of this sporozoite coat protein in WT and Δepsf parasites by IFA (Figure 3F) and 
Western blot (Figure 3G). Both methodologies showed that CSP is barely expressed in mutant 
oocysts on days 13-14 p.i. Furthermore, DNA staining with the dye Hoechst-33342 revealed 
that DNA replication in Δepsf parasites is reduced when compared with WT oocysts of the same 
age (Figure 3F). 
Ultimately, the complete failure of Δepsf parasites to colonise the salivary glands of their 
invertebrate host resulted in absence of transmission to naïve mice through the bite of infected 
female mosquitoes (Figure S6). 
 
DISCUSSION 
Many parasite genes important for ookinete formation and functionality (e.g., gliding 
motility and capacity to invade the mosquito midgut) are transcribed in blood stage female 
gametocytes but kept quiescent through binding to the translational repressors DOZI and CITH 
[107, 108]. Among these genes are those encoding the major ookinete surface proteins P25 
and P28, alveolins, components of the gliding molecular motor and inner membrane complex 
(IMC) [108]. Plasmodium calcium-dependent protein kinase 1 (CDPK1) is then involved in the 
translational activation of these transcripts during ookinete development [134]. Interestingly, a 
large proportion of the transcripts bound by the RNA binding proteins DOZI and/or CITH, and 
thus thought to be subjected to translational repression (TR), encode for proteins with predicted 
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surface localisation signals, such as N-terminal signal peptides and/or transmembrane (TM) 
domains. For example, of the 114 mRNAs downregulated in both DOZI and CITH gene deletion 
mutants, 44 (approximately 38%) encode for known or putative surface molecules [107, 108]. 
Among these 44 transcripts one can find epsf, encoding for a protein with predicted signal 
peptide and C-terminal TM domain, but also those encoding for PbLAP4-6. Concordantly, 
pblap4-6 have recently been shown to be translationally repressed [208]. 
Here we show that EPSF is also a target of TR in P. berghei macrogametocytes by 
interacting with both translational repressors DOZI and CITH, which is in agreement with 
previous studies from our group showing that epsf was downregulated in the absence of either 
protein [107, 108]. While not detected in gametocytes, the localisation of EPSF in ookinetes was 
restricted to one or two discrete cytoplasmic foci and greatly resembled that observed for the 
CB-resident proteins PbLAP1-6 [208, 211, 212]. Moreover, these foci co-localised with large 
haemozoin clusters easily recognisable under DIC microscopy. Therefore we concluded that 
EPSF is indeed targeted to CBs. EPSF represents an addition to the so far small repertoire of 
CB-associated proteins [208, 211, 212]. Besides being present in ookinetes, PbLAP1-3 are 
already scattered throughout the cytoplasm of female gametocytes, being later on recruited to 
the ookinete CBs [211, 212]; on the other hand, epsf is translationally repressed in gametocytes 
and thus behaves like pblap4-6 [208]. 
The presence of a TPM-similar domain in EPSF is intriguing. In plants, the TPM 
domain-containing proteins TLP18.3 and Psb32 are implicated in the photosystem II (PSII) 
repair cycle. This domain may be involved in the regulation of synthesis/degradation of the D1 
protein of the PSII core and in the assembly of PSII monomers into dimers in the grana stacks 
[328]. In the model nematode Caenorhabditis elegans, the MOLO-1 protein also contains a 
TPM domain and is an auxiliary subunit that positively modulates the gating of levamisole-
sensitive acetylcholine receptors [329]. The function of this domain in other organisms is 
unknown. Given the highly distinct roles of the TPM domain-containing proteins in the two 
organisms mentioned above, it is at the moment difficult to understand how this domain could 
be implicated in the ascribed function of EPSF for parasite biology. 
Our results show that EPSF is absolutely essential for the development of midgut 
sporozoites. The precise cellular function of this protein remains however unknown. Gene 
deletion studies have highlighted PbLAPs [176, 211, 224-226], plasmepsin VI [176], rhomboid 3 
[330] and CSP [331] in the development of midgut sporozoites. The phenotypes of such mutant 
parasites include lack of DNA replication, highly vacuolated oocyst appearance (a sign of 
degeneration) and reduced CSP expression. It is known that CSP levels markedly influence the 
degree of sporozoite formation by affecting the development of inner membranes in the 
sporulating cyst [327]. All these phenotypes were also verified in Δepsf parasites. Moreover, the 
oocyst enlargement reported here was also ascribed for KO parasites of PbSR, a P. berghei 
member of the LCCL protein family [224]. One particular contrasting feature of Δpbsr parasites 
is the substantial DNA replication observed in KO oocysts [224]. It thus seems that the absence 
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of PbSR has an impact on cytokinesis rather than on nuclear division. Insterestingly, it was also 
shown that PbSR loss-of-function and gene deletion ookinetes are devoid of CBs [211]. Why 
exactly the lack of EPSF affects oocyst nuclear multiplication is not known and whether Δepsf 
ookinetes present CBs remains to be determined. 
Nonetheless, the present study reinforces the crucial role of Plasmodium CBs in 
parasite biology and in malaria transmission through the mosquito vector in particular. 
Additional studies on these peculiar organelles are therefore highly desirable to increase our 
current knowledge on CB biology, and are likely to highlight CBs as potential malaria 
intervention targets. By targeting CB proteins such as EPSF one could prevent the development 
of infectious sporozoites and consequently block malaria transmission. 
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Figure S1 – EPSF is conserved in apicomplexan parasites. 
Protein alignment of EPSF orthologs from 8 different Plasmodium species and strains as well as from the 
related apicomplexan parasites Babesia bovis and Theileria parva. “+” indicates the extent of the signal 
peptide (SignalP 4.0), “X” indicates the extent of the transmembrane domain (TMHMM 2.0) and § 
denotes a TPM similar domain (Pfam:PF04536) in P. berghei EPSF. 
Figure S2 – epsf is not transcribed in liver stages. 
RT-PCR analysis of epsf in in vivo-developed P. berghei exoerythrocytic forms 
(EEFs) at different time points after sporozoite injection. 18S rRNA serves as 
loading control gene. +: RT positive reaction; -: RT negative reaction. 
SUPPLEMENTARY FIGURES AND TABLES 
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Figure S3 – Generation and genotyping of epsf::gfp parasite line. 
(A) epsf GFP tagging construct pLIS0081 (i) was obtained by cloning the last 982 bp of epsf ORF 
excluding the stop codon upstream and in frame with the gfp gene. This construct includes the 
Toxoplasma gondii dhfr/ts selectable marker cassette under the control of P. berghei dhfr/ts 5' and 3' 
UTRs. The construct was integrated into the epsf locus (ii) of cl15cy1 by single homologous 
recombination, resulting in the fusion of epsf to gfp in epsf::gfp parasites (iii). (B) Correct tagging of epsf 
was shown by Southern analysis of separated chromosomes (left) and diagnostic PCR analyses (right). 
Hybridisation of separated chromosomes from uncloned epsf::gfp parasites with a probe against the 
tgdhfr/ts selectable marker cassette recognised integrated pLIS0081 into chromosome 7 and circular 
plasmid with higher molecular weight. PCR analyses confirm 5' and 3' integration (int.) of pLIS0081, 
absence of WT epsf ORF and presence of tgdhfr/ts gene. (C) Absence of WT epsf and presence of 
epsf::gfp mRNA was confirmed in cloned epsf::gfp mixed blood stages by RT-PCR. p28 and RNA 
polymerase II serve as control genes. Primer g1205 only anneals with epsf cDNA. 
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Figure S4 – Generation and genotyping of Δepsf parasite lines. 
(A) epsf gene deletion construct pLIS0092 (i) was obtained by cloning epsf 5' and 3' targeting regions 
(TR) upstream and downstream of  the Toxoplasma gondii dhfr/ts selectable marker cassette, 
respectively. tgdhfr/ts gene is under the control of P. berghei dhfr/ts 5' and 3' UTRs. The construct was 
integrated into the epsf locus (ii) of Fluo-frmg WT line by double homologous recombination, resulting in 
the complete deletion of epsf ORF in Δepsf parasites (iii). (B) Correct deletion of epsf was shown by 
Southern analysis of separated chromosomes (left) and diagnostic PCR analyses (right). Hybridisation of 
separated chromosomes with a probe against the tgdhfr/ts selectable marker cassette recognised 
integrated pLIS0092 into chromosome 7. PCR analyses confirm 5' and 3' integration (int.) of pLIS0092, 
absence of epsf ORF and presence of tgdhfr/ts gene. (C) Absence of epsf mRNA was confirmed in Δepsf 
mixed blood stages by RT-PCR. p28 and RNA polymerase II serve as control genes. 
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Figure S5 – Δepsf-b oocysts do not sporulate. 
(A) Δepsf-b parasites show WT oocyst numbers on days 11 to 13 p.i. Absolute numbers of oocysts per 
midgut from 3 independent experiments are presented for both WT (n=10) and Δepsf-b (n=19) parasites. 
(B) Δepsf-b parasites do not develop any midgut sporozoite (MG Spz). (C) Δepsf-b parasites do not 
develop any salivary gland sporozoite (SG Spz). (B-C) Absolute numbers of sporozoites per mosquito 
from 2 independent experiments are presented for both WT (n=9) and Δepsf-b (n=9) parasites. (A-C) 
Mean and SEM values are shown by the lines; p-values for Mann-Whitney test are shown above the data 
sets. 
Figure S6 – Δepsf mutants do not transmit to naïve 
mice. 
Mice bitten by Δepsf-a-infected mosquitoes do not 
develop blood stage infection. Mean parasitaemias from 
3 independent experiments are shown by the dots while 
SEM values are shown by the vertical lines. 
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ABSTRACT 
Palmitoylation is an important, reversible protein modification that regulates multiple 
biological processes. The post-translational addition of C-16-long chain fatty acids to cysteine 
residues is catalysed by protein palmitoyl-S-acyl-transferases (PATs) and affects the affinity of a 
protein for membranes and therefore its subcellular localisation. In the human malaria parasite 
Plasmodium falciparum palmitoylation is implicated in asexual multiplication and host cell 
invasion. The role, if any, of palmitoylation for other stages within the complex Plasmodium life 
cycle remains elusive. Here we define the role of palmitoylation during several phases of 
mosquito stage infection, from the onset of sexual development in the erythrocyte to sporozoite 
formation and liver cell invasion in the rodent malaria model P. berghei. Using 2-BMP, an 
irreversible inhibitor of PATs, we reveal that palmitoylation is essential for developmental 
progression of zygotes into mature ookinetes. We show that certain PAT enzymes of P. berghei 
are transcriptionally up-regulated in sexual precursor cells (gametocytes) where they are bound 
by the translational repressors DOZI and CITH. One of these, DHHC10, activated translationally 
during ookinete formation is a key factor for sporogony through its central role in the formation 
of crystalloid bodies (CBs) and correct targeting of CB components in the ookinete. Finally we 
demonstrate that dynamic palmitoylation is not required for normal sporozoite gliding motility or 
hepatocyte traversal, but is necessary for optimal hepatocyte invasion. This is the first time that 
key functions are ascribed for a palmitoyl-S-acyl-transferase in mosquito stages of the malaria 
parasite; this report demonstrates the crucial nature of palmitoylation for transmission of the 
malaria parasite to the mosquito vector and its essential role for ookinete and sporozoite 
development. 
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METHODS 
Experimental animals 
Female Balb/c ByJ and OF-1 (6–8 weeks bred at Charles River, France) mice were 
used. Animal experiments performed in Leiden University Medical Center (LUMC, Leiden, The 
Netherlands) were approved by the Animal Experiments Committee of the Leiden University 
Medical Center (DEC 10099; 12042; 12120). In Instituto de Medicina Molecular (IMM, Lisbon, 
Portugal) animal experimentation protocols were approved by the IMM Animal Ethics 
Committee (under authorisation AEC_2010_018_GM_Rdt_General_IMM), the Portuguese 
authorities (Direção Geral de Alimentação e Veterinária) and performed according to European 
Union regulations. At the University of Heidelberg Medical School (Heidelberg, Germany) 
animal work was approved by the German Authorities (Regierungspräsidium Karlsruhe; 
Aktenzeichen 35-9185.81/G-3/11) and performed in compliance with FELASA guidelines and 
regulations. 
 
Reference P. berghei ANKA lines 
Seven reference P. berghei ANKA parasite lines were used. Details of most lines can 
be found in the RMgmDB database (www.pberghei.eu). Line 683cl1 (DOZI::GFP; RMgm-133) 
[107] expressing a C-terminally GFP-tagged version of dozi (PBANKA_121770); line 909cl1 
(CITH::GFP; RMgm-358) [108] expressing a C-terminally GFP-tagged version of cith 
(PBANKA_130130); line HPE, a non-gametocyte producer clone [316]; line 820cl1m1cl1 (Fluo-
frmg; RMgm-164) [108] expressing RFP under the control of a female gametocyte specific 
promoter and GFP under the control of a male gametocyte specific promoter; line 676m1cl1 
(PbGFP-LUCcon; RMgm-29) expressing the fusion protein GFP-Luciferase under the control of 
the constitutive eef1a promoter; line 259cl1 (PbGFPcon; RMgm-5) expressing GFP under the 
control of the constitutive eef1a promoter; and line cl15cy1, which is the reference parental line 
of P. berghei ANKA [317]. Lines Fluo-frmg and PbGFP-LUCcon contain the transgenes 
integrated into the silent 230p gene locus (PBANKA_030600) and do not contain a drug-
selectable marker. 
RNA sequencing (RNAseq) of separated asexual blood stages, gametocytes and 
ookinetes 
RNA was collected from multiple synchronised blood stages: rings, trophozoites and 
schizonts [332], and purified gametocytes and ookinetes [332, 333] of P. berghei ANKA. RNA 
was isolated and sequenced as described [334]. To determine transcript abundance, FPKM 
values were calculated for all genes (FPKM: Fragments Per Kilobase of transcript per Million 
mapped reads) using Cuffdiff 2 algorithm [335]. A cut-off threshold of 21 FPKM was calculated; 
data below this value was considered absence of expression and is not shown. Data presented 
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is from two independent experiments for rings, trophozoites, schizonts, gametocytes and 
ookinetes 16 h, and from one experiment for ookinetes 24 h. 
 
Reverse Transcriptase-PCR (RT-PCR) 
Immunoprecipitation (IP) of DOZI::GFP and CITH::GFP parasite lysates, and 
subsequent RNA extraction and RT-PCR were performed as described [108]. To investigate the 
transcription patterns of the different dhhc genes by RT-PCR, RNA from different life cycle 
stages were obtained using TRIzol
®
 Reagent (Ambion
®
, #15596). Reverse transcription was 
done with random primers and oligo-d(T) using SuperScript
® 
II Reverse Transcriptase 
(Invitrogen™, #18064). RNA sample origins were as follows: asexual blood stages from line 
HPE; mixed blood stages (asexuals & gametocytes) and oocysts d12 post-infection (p.i.) from 
line Fluo-frmg; in vitro-cultured ookinetes at different time points from line cl15cy1; midgut 
sporozoites d20 p.i. and salivary gland sporozoites d20 p.i. from line PbGFPcon; and 
exoerythrocytic forms from line PbGFPcon at different time points after mouse infection. Primers 
used in RT-PCRs are shown in Table S1a. 
 
Generation of dhhc gene deletion mutants 
To disrupt genes encoding the three different DHHC members (dhhc2, 
PBANKA_010830; dhhc3, PBANKA_092730 and dhhc10, PBANKA_051200) we constructed 
standard replacement constructs [318] using plasmid pL0001 (www.mr4.com) which contains 
the pyrimethamine resistant Toxoplasma gondii (tg) dhfr/ts as a selectable marker cassette. See 
Table S2 and Figure S2A for the names and details of the constructs. Target sequences for 
homologous recombination were PCR amplified from P. berghei wild-type (WT) genomic DNA 
using primers specific for the 5′ or 3′ flanking regions of the different dhhc genes (see Table 
S1b for the sequence of the different primers). The PCR–amplified target sequences were 
cloned in plasmid pL0001 either upstream or downstream of the selectable marker to allow for 
integration of the construct into the genomic target sequence by homologous recombination. 
DNA constructs used for transfection were obtained after digestion of the replacement 
constructs with the appropriate restriction enzymes (Table S2). Transfection, selection and 
cloning of mutant parasite lines were performed as described [318]; see Table S2 for details of 
the transfection experiments performed. Correct deletion of the dhhc10 gene was confirmed by 
diagnostic PCR (for primers see Table S1c) and Southern analysis of Field-Inversion Gel 
Electrophoresis (FIGE)-separated chromosomes (Figure S2B).  Chromosomes were hybridized 
with a probe recognizing the 3' UTR of pbdhfr/ts. Absence of dhhc10 mRNA was determined by 
RT-PCR analysis (Figure S2C) using RNA collected from infected blood containing asexual 
blood stages and gametocytes (see Table S1c for primers used for RT-PCR). Two cloned lines 
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were used for further phenotype analyses:  2097cl1 (Δdhhc10-a, in the Fluo-frmg background) 
and 2365cl2 (Δdhhc10-b, in the PbGFP-LUCcon background). 
 
Generation of transgenic lines expressing GFP-tagged DHHC members 
In situ C-terminal GFP tagging of dhhc2, dhhc3 and dhhc10 was performed by single 
cross-over homologous recombination into the corresponding locus. See Table S2 and Figures 
S3 and S5-S8, A for the names and details of the constructs. All constructs contain the tgdhfr/ts 
selectable marker. Primers used to amplify the targeting regions of dhhc2, dhhc3 and dhhc10, 
corresponding to the 3' end of each open reading frame (ORF) excluding the stop codon, as 
well as the 3' UTRs of dhhc2 and dhhc3 are listed in Table S1b. Targeting regions were cloned 
in frame with gfp. Linearised plasmids were transfected into cl15cy1 parasites using standard 
methods. Transfection, selection and cloning of mutant parasite lines were performed as 
described [318], resulting in the following transgenic lines: 2185cl1m1 (dhhc2::gfp), 192cl1m1 
(dhhc3::gfp), 2187cl1m1 (dhhc10::gfp), 202cl1m1 (dhhc2::gfp-3'UTR) and 198cl1m1 
(dhhc3::gfp-3'UTR). See Table S2 for details of the transfection experiments performed. Correct 
integration of the constructs was confirmed by diagnostic PCR (for primers see Table S1c) and 
Southern analysis of FIGE-separated chromosomes using a probe for the 3' UTR of pbdhfr/ts 
(Figures S3 and S5-S6, B). Transcription and processing (splicing) of gfp fusions were 
confirmed by RT-PCR using RNA from mixed blood stage forms (Figures S3 and S5-S8, C). 
Primers used for RT-PCR are listed in Table S1c. 
 
Generation of dhhc10 gene deletion parasites expressing GFP-tagged PbLAP2 
In situ C-terminal GFP tagging of lap2 was performed by single cross-over homologous 
recombination into the corresponding locus using a construct published elsewhere [212]. This 
construct contains the human dhfr/ts selectable marker. Linearised plasmid was transfected into 
Δdhhc10-a parasites using standard methods. Transfection was performed as described [318], 
and selection of mutant parasites was performed with the drug WR99210 [336], resulting in the 
following transgenic line: 2433 (Δdhhc10;lap2::gfp). See Table S2 for details of the transfection 
experiment performed. Correct integration of the construct was confirmed by Southern analysis 
of FIGE-separated chromosomes using a probe for the human dhfr/ts (Figure 7A). 
In vivo multiplication rate of asexual blood stages 
The multiplication rate of asexual blood stages in mice is determined during the cloning 
procedure of gene-deletion/transgenic parasites [319] and is calculated as follows: the 
percentage of infected erythrocytes in OF-1 mice injected with a single parasite is quantified at 
days 8–11 on Giemsa-stained blood films. The mean asexual multiplication rate per 24 h is then 
calculated assuming a total of 1.2×10
10
 erythrocytes per mouse and a blood volume of 2 mL. 
The percentage of infected erythrocytes in mice infected with reference lines of the P. berghei 
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ANKA strain consistently ranges between 0.5 and 2% at day 8 after infection, resulting in a 
mean multiplication rate of 10 per 24 h [319, 320]. 
 
Gametocyte production, in vitro fertilisation and ookinete formation assays 
Gametocyte production of the different parasite lines was determined as described 
[333]. The gametocyte conversion rate is defined as the percentage of ring-forms that develop 
into gametocytes in standard synchronized in vivo infections in mice. In vitro fertilisation and 
ookinete formation assays were performed following published methods using gametocyte-
enriched blood collected from mice treated with phenylhydrazine/NaCl [337]. Briefly, infected 
blood containing gametocytes was mixed in standard ookinete culture medium in 24-well plates 
and cultures were incubated for 18-24 h at 21-22 
○
C. The ookinete conversion rate is defined as 
the percentage of female gametes that develop into mature ookinetes determined by counting 
female gametes and mature ookinetes in Giemsa-stained blood smears 16-18 h after in vitro 
induction of gamete formation. 
 
Palmitoyl-S-acyl-transferase inhibition during ookinete development, sporozoite 
gliding and liver cell traversal and invasion 
To inhibit palmitoylation during ookinete development, 2-BMP (Sigma-Aldrich
®
, #21604) 
was added 1 h after adding dhhc2::gfp infected blood containing gametocytes to standard 
ookinete cultures as described above. 2-BMP was added at final concentrations of 0.01, 0.1, 
0.25, 0.5, 1, 10, 25 and 100 µM. Since 2-BMP is prepared in dimethyl sulfoxide (DMSO), 
control cultures were set up in the presence (+) and absence (-) of DMSO. Eighteen hours after 
drug addition the different developmental stages (zygotes, developing ookinetes and mature 
ookinetes) were counted in Giemsa-stained slides according to the classification in [333]. 
Percentages from 2 independent experiments are presented for 0 (+), 0.01, 0.1, 0.25, 0.5, 25 
and 100 µM 2-BMP, while data for 0 (-), 1 and 10 µM 2-BMP are from 4 independent 
experiments. To test the effect of palmitoylation inhibition on sporozoite gliding, parasites were 
dissected from infected mosquito salivary glands in PBS followed by incubation in RPMI/BSA 
containing 2-BMP for varying concentrations (0, 0.1, 1 and 100 µM) and times (15, 30 and 45 
min). Movies were taken on a Zeiss Axiovert 200M widefield microscope (25X objective); frame-
rate 3 sec for a duration of 4 min. The velocity was determined by using the manual tracking 
plug-in of ImageJ 1.47n software (imagej.nih.gov/ij). To evaluate the importance of 
palmitoylation in the sporozoite ability to traverse and invade hepatocytes in vitro, salivary gland 
sporozoites of line PbGFPcon were dissected and incubated with 100 µM of 2-BMP or 
equivalent volume of DMSO for 45 min on ice. 19000 sporozoites were then loaded, in the 
presence of 0.5 mg/mL of Dextran, Tetramethylrhodamine (Molecular Probes
®
, #D1817), onto 
110000 Huh7 cells plated 16-20 h before in 24 well-plates and incubated for 1 h and 45 min at 
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37 
○
C. In each experiment, 2-3 replicate wells were analysed for both control (DMSO) and 2-
BMP-treated sporozoites. Cells were then washed, trypsinised and analysed in a BD 
Biosciences
®
 FACSCalibur flow cytometer. Percentage of traversal was quantified as the ratio 
of Dextran positive cells per live cells, while percentage of invasion was quantified as the ratio 
of GFP positive cells per live cells. 
 
Transmission electron microscopy of ookinetes 
WT (Fluo-frmg) and Δdhhc10-b in vitro ookinete production followed by transmission 
electron microscopy was performed as previously described [330] with an additional post-
staining step: prior to specimen imaging, 100 nm-thick sections were post-stained for 10 
minutes at room temperature (RT) with 7% uranyl acetate in ultrapure water and 5 minutes at 
RT with lead citrate prepared according to Reynolds’ method [338]. 
 
Oocyst production, sporozoite production and transmission experiments 
Oocyst and sporozoite production of the mutant parasites was analysed by performing 
standard mosquito infections. Naïve female Balb/c ByJ mice were infected intraperitoneally (i.p.) 
with 10
6
 infected red blood cells (iRBCs) of each line. On days 4-5 p.i., these mice were 
anesthetised and Anopheles stephensi female mosquitoes allowed to feed for 30 min. Twenty-
four hours after feeding, mosquitoes were anesthetised by cold shock and unfed mosquitoes 
were removed. Oocyst and sporozoite numbers were counted at days 12-13 and 20-22 after 
mosquito infection, respectively. Oocyst sizes over time were determined at days 14 and 21/22 
p.i. Oocysts were counted after mercurochrome staining and measured using ImageJ 1.47n 
software (imagej.nih.gov/ij). Sporozoites were counted in pools of 5 to 25 mosquitoes. To test 
the infectivity of sporozoites, 10 infected mosquitoes were allowed to feed for 30 min on 
anesthetised naïve female Balb/c ByJ mice on days 20-21 p.i. Successful feeding was 
confirmed by the presence of blood in the abdomen of mosquitoes. Blood stage parasitaemias 
in these mice were followed up to 32 days post-bite. 
 
Western analysis of CSP expression in Δdhhc10 oocysts 
To determine circumsporozoite protein (CSP) expression, Fluo-frmg- and Δdhhc10-a-
infected midguts were dissected at day 13 p.i. and resuspended in 1X Laemmli buffer. Samples 
were adjusted to 200 mM DTT, boiled and volumes equivalent to 2 midguts were loaded per 
SDS-PAGE gel lane for each parasite line. Nitrocellulose membranes were blocked for 1 h at 
RT with 5% skim milk/PBS-Tween 20 (0.05%), probed overnight at 4 
○
C with 3D11 mouse anti-
CSP [321], 0.17 µg/mL in blocking solution) or parasite-specific 2E6 mouse monoclonal anti-
PbHSP70 [322], 7.5 µg/mL in blocking solution) as primary antibodies, and 1h at RT with goat 
68 
 
anti-mouse IgG-HRP [Santa Cruz Biotechnology, Inc.
®
, #sc-2005, 1:5000-1:10000 in PBS-
Tween 20 (0.05%)] as secondary antibody. Westerns were developed with Immobilon™ 
Western Chemiluminescent HRP Substrate (Millipore, #P36599). Staining with the antibody 
recognizing P. berghei HSP70 was used as loading control. 
 
Live imaging and immunofluorescence assays (IFAs) of blood stages, ookinetes, 
oocysts and sporozoites 
Live imaging of transgenic parasites expressing GFP-tagged DHHC-PATs and GFP-
tagged LAP2 was done by collecting tail blood samples from infected mice, samples from 
ookinete cultures or mosquito blood meals at 16 h p.i., as well as dissected mosquito midguts, 
midgut sporozoites and salivary gland sporozoites and staining with 1 µg/mL of Hoechst 
33342/PBS. DHHC2::GFP and DHHC3::GFP expression in live activated male and female 
gametocytes was visualized 10-15 minutes after adding infected blood to standard ookinete 
culture medium. To detect DHHC10::GFP expression in blood stages by IFA, mouse RBCs 
infected with dhhc10::gfp parasites were stained with rabbit polyclonal anti-GFP (Abcam
®
, 
#ab6556; 1:500) as primary antibody. As secondary antibody, goat anti-rabbit IgG-Alexa 
Fluor
®
488 (Jackson ImmunoResearch Laboratories, Inc., #111-545-003; 1:500) was used. To 
detect CSP expression in Fluo-frmg and Δdhhc10-a oocysts, parasites at day 14 p.i. were 
stained with 3D11 mouse anti-PbCSP [321] (10 µg/mL) as primary antibody and goat anti-
mouse IgG-Cy™3 (Jackson ImmunoResearch Laboratories, Inc., #115-166-003; 1:400) as 
secondary antibody. In all IFAs, samples were fixed with 4% PFA/PBS for 10 min at RT, 
permeabilised with 0.1-0.5% TritonX-100/PBS and blocked for 1h at RT with 1-3% BSA/PBS. All 
antibody incubations were done in blocking solution for 1h at RT and 1-5 ug/mL of Hoechst-
33342/PBS was used to stain nuclei. Images were taken with a Leica DM5000B, Leica DM 
IRBE or Zeiss Axiovert 200M fluorescence microscope and processed using ImageJ 1.47n 
software (imagej.nih.gov/ij). 
 
Statistical methods 
Statistical analyses of oocyst and sporozoite numbers, oocyst sizes and in vitro 
hepatocyte traversal and invasion in the presence of the palmitoylation inhibitor 2-BMP were 
performed using Mann-Whitney test as part of Prism software package 5 (GraphPad Software). 
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Figure 1 – Inhibition of protein palmitoylation arrests ookinete development. 
(A) Effect of different 2-BMP concentrations on ookinete (ook) development; blockade of zygote-to-
ookinete transformation is dose dependent. Control cultures were set up in the presence (+) and absence 
(-) of DMSO (vehicle). Bars and lines correspond to mean and SEM values, respectively. (B) 
Representative images of the Giemsa-stained developmental stages observed in cultures treated with 2-
BMP. Stage I/II zygotes often show small protrusions (arrows), while degenerated stage III ookinetes are 
identified by long protrusions and a posterior bulb containing the nucleus (arrowheads). Scale bars = 5 
µm. 
RESULTS 
Palmitoylation is essential for ookinete development 
Palmitoylation is essential for schizogony, the ordered formation of 16-32 progeny from 
a single merozoite by asexual, mitotic division in the infected red blood cell [227]. Here we 
investigated the role of palmitoylation during transmission of the rodent malaria P. berghei 
parasite to the mosquito vector. Following fertilization, the round zygote stage develops into the 
mature, banana-shaped ookinete within 24 hours. To test whether palmitoylation is required for 
this transformation process we used the inhibitor 2-bromopalmitate (2-BMP). 2-BMP was added 
in a 0.01 to 100 µM range to standard in vitro ookinete cultures [333] one hour after activation of 
gametocytes, the time point when gamete formation and fertilisation are completed. The 
development of ookinetes was determined 18 hours later. In control cultures without drug 
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Figure 2 – mRNA expression of P. berghei dhhc genes. 
(A) RNA sequencing (RNAseq) data from blood and early mosquito stages for all 11 P. berghei dhhc 
genes. dhhc2, dhhc3 and dhhc10 are upregulated in gametocytes. Bars and lines correspond to mean 
and SEM values, respectively. Troph: trophozoite; Gam: gametocyte; Ook: ookinete (16 and 24 hours 
after gametocyte activation); FPKM: Fragments Per Kilobase of transcript per Million mapped reads. (B) 
RT-PCRs of dhhc2, dhhc3 and dhhc10 along the life cycle. Asexual: asexual blood stages; mixed: 
asexuals and gametocytes; ook: ookinetes (8 and 16 hours after gametocyte activation); MG spz: midgut 
sporozoites; SG spz: salivary gland sporozoites. 18S rRNA and hsp70 serve as loading control genes. +: 
RT positive reaction; -: RT negative reaction. 
(vehicle only) a mean of 77% (range 68-89%, n=3) of female gametocytes were fertilised and 
developed into mature ookinetes with WT morphology. We observed a clear dose-dependent 
effect of 2-BMP on the transition of zygotes into ookinetes (Figure 1A). Ookinete development 
was completely blocked soon after fertilization at concentrations of 100, 25 and 10 µM resulting 
in the presence of large clusters of stage I/II zygotes (round zygotes or such with small, thin 
protrusions) (Figure 1B). At 1 µM more than 50% of the parasites were arrested at the zygote 
I/II stage; only a small percentage of parasites was able to form mature ookinetes. As little as 
0.25 µM of 2-BMP was effective in interfering with ookinete formation. 
A characteristic feature of the inhibition effect is the small protrusions seen to emanate 
from zygotes; these are normally formed in the transformation from zygotes to ookinetes and 
the developmental arrest at these stage could indicate a membrane and protein trafficking 
defect associated with the inner membrane complex (IMC) or the plasma membrane (PM). 
Overall, these experiments prove that palmitoylation is an essential process for ookinete 
development and morphogenesis. 
 
Candidate palmitoyl-S-acyl-transferases involved in P. berghei mosquito stage 
development 
Having established a crucial role for palmitoylation during ookinete formation we sought 
to identify the DHHC-PATs involved. With 11 described P. berghei DHHC-PATs we reviewed 
published RNA and protein expression data focussing on gametocytes, since many proteins 
and translationally repressed mRNAs are provided by the female gametocyte for post-
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fertilization development [50, 108]. The immediate inhibitory effect of 2-BMP for ookinete 
development supported the involvement of one (or several) PATs with such transcriptional and 
translational profile. 
Three dhhc-pat mRNAs (dhhc2, 3 and 10 according to P. falciparum nomenclature) had 
already been identified with reduced transcript levels in cells that lack the translational repressor 
DOZI [107] (Table S3) pointing towards a possible role of translationally repressed DHHC-PATs 
for ookinete development. Genome-wide RNAseq analysis of gametocytes and ookinetes (T.D. 
Otto, M. Berriman, A. Religa, A.P. Waters W.A.M. Hoeijmakers, H.G. Stunnenberg and C.J. 
Janse, unpublished data) highlighted the same three DHHC-PATs to be transcriptionally 
upregulated in gametocytes compared to asexual blood stages (Figure 2A). We confirmed the 
RNAseq data by RT-PCR and performed additional expression profiling of the three genes 
across the life cycle of P. berghei (Figure 2B). This revealed dhhc2 and dhhc3 expression in 
asexual blood stage forms and young (but not mature) ookinetes with an apparent second wave 
of transcription in oocysts and midgut sporozoites. dhhc10 on the other hand was specifically 
transcribed in gametocytes and immature ookinetes. None of the transcripts could be detected 
in salivary gland sporozoites or liver stage parasites (Figure 2B and Figure S1). 
Five P. berghei DHHC-PATs have recently been detected in blood stage parasites 
using an haemagglutinin (HA) tagging approach [233]; of these, three P. falciparum orthologs 
were known from proteome studies of intraerythrocytic forms and salivary gland sporozoites 
[339-341]. 
Out of the 11 P. berghei DHHC-PATs, only two (DHHC1 and DHHC4) were reported in 
proteome studies from gametocytes, albeit in  ‘mixed gametocyte proteome’ rather than the 
highly purified male- or female-specific proteomes [50] and none were detected in zygote or 
ookinete proteomes [49, 325, 326]. Seven were found to be redundant for blood stage 
development in a gene deletion screen [233] (Table S3). 
 
DHHC2 and DHHC3, but not DHHC10 are required for asexual Plasmodium 
development 
To investigate whether any of the three DHHC-PATs identified above is essential for 
development of the ookinete we attempted to generate null mutants for each gene. Using 
standard methods of P. berghei genetic modification [318] we targeted each gene for deletion 
by double cross-over homologous recombination of a plasmid containing a T. gondii 
dihydrofolate reductase/thymidylate synthase (tgdhfr/ts) selectable marker. Three independent 
transfection experiments for dhhc2 and dhhc3 were unsuccessful (Table S2) suggesting a vital 
role for both proteins during asexual blood stage development; perhaps not surprising given the 
expression profile revealed by RT-PCR (Figure 2B). 
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Figure 3 – Δdhhc10 oocysts do not sporulate and lack circumsporozoite protein. 
(A) Δdhhc10-a parasites show WT oocyst numbers on days 12 to 13 p.i. Absolute numbers of oocysts per 
midgut from 5 independent experiments are presented for both WT (n=70) and Δdhhc10-a (n=48) 
parasites. (B) At day 14 p.i. Δdhhc10-a oocysts have normal sizes (upper plot) but lack signs of 
sporulation and appear ‘empty’ (bottom pictures, arrowheads). On the contrary, most WT oocysts have 
already formed sporozoites inside (arrows). Scale bars = 20 µm. (A-B) Mean and SEM values are shown 
by the lines; p-values for Mann-Whitney test are shown above the data sets. (C) Immunofluorescence 
assay of oocyst-infected midguts at day 14 p.i. shows strongly reduced CSP expression (in red) in 
Δdhhc10-a parasites. DNA replication in both parasite lines is comparable, as seen by Hoechst-33342 
staining (in blue). Scale bar = 20 µm. (D) Western blot analysis of oocyst-infected midguts at day 13 p.i. 
confirms diminished CSP expression in Δdhhc10-a mutants. HSP70 serves as parasite loading control. 
(C-D) Note that when CSP is detected in Δdhhc10-a oocysts, signal coming from WT oocysts is already 
saturated. 
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On the other hand, we were able to select gene deletion mutants for dhhc10 in two 
independent experiments (Table S2). Genotyping by diagnostic PCR and Southern analyses 
confirmed correct disruption of the dhhc10 gene (Figure S2). Phenotype analyses of the two 
independent dhhc10 null mutants, Δdhhc10-a and Δdhhc10-b, during blood stage development 
revealed normal asexual growth/multiplication and gametocyte production rates (Table S4). 
 
DHHC10 is an essential factor for P. berghei sporozoite development 
To establish a possible role for DHHC10 during mosquito infection (ookinete formation, 
midgut invasion and establishment of oocysts) and sporogony, we allowed Anopheles stephensi 
mosquitoes to feed on mice infected with Δdhhc10 parasites. Null mutants produced oocyst 
numbers that were comparable to those after infection with WT parasites (Figure 3A). Δdhhc10 
mutants were thus not compromised in their ability to form infection-competent, motile ookinetes 
and establish oocysts that resist elimination by the invertebrate host’s immune system. 
Following the development of these oocysts up to 22 days post-infection (p.i.) however revealed 
a complete failure in sporulation. Although similar in size to WT oocysts at day 14 p.i., mutants 
displayed an ‘empty’ appearance (Figure 3B) and lacked expression of CSP, the major 
sporozoite surface protein. While CSP is strongly expressed in WT oocysts of the same age, 
neither IFAs (Figure 3C) nor Western analysis (Figure 3D) of protein extracts from pooled 
infected midguts showed persuasive expression of this marker in Δdhhc10 parasites. On the 
other hand, labelling of cells with the DNA-specific dye (Hoechst-33342) revealed extensive 
staining throughout the mutant oocysts, suggesting that DNA replication was not affected in the 
absence of DHHC10 (Figure 3C). 
At days 21/22 p.i. mutant oocysts were still present in mosquito midguts; they were 
enlarged compared to WT oocysts with the same ‘empty’, vacuolated appearance (Figure 4A). 
Indeed, Δdhhc10 oocysts were already significantly enlarged at day 19 p.i. (data not shown). 
Mosquitoes from the same cohort were unable to infect naïve mice (Figure 4B) and both 
midguts (Figure 4C) and salivary glands (Figure 4D) finally revealed a complete absence of 
sporozoites in both Δdhhc10-a and Δdhhc10-b mutants. 
 
GFP tagging of DHHC10 reveals translational repression and highlights 
localisation to the ookinete CB 
The ability of Δdhhc10 mutants to generate normal numbers of  oocysts but failure to 
produce sporozoites was unexpected in view of the tight period of transcription observed by RT-
PCR and RNAseq analyses; mRNA was only detected in gametocytes and young ookinetes but 
absent from all other stages examined (Figures 2A and B). The normal development of 
gametocytes, zygotes and ookinetes suggested that translation of dhhc10 mRNA provided by 
the gametocyte could be postponed as late as oocyst formation. Alternatively, protein translated 
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Figure 4 – Δdhhc10 mutants are impaired in sporozoite development and do not transmit to naïve 
mice. 
(A) At days 21/22 p.i. Δdhhc10-a oocysts are clearly enlarged when compared to WT oocysts (upper plot) 
and often show an ‘empty’, vacuolated aspect (bottom pictures, arrowheads). Scale bars = 20 µm. (B) 
Mice bitten by Δdhhc10-a-infected mosquitoes do not develop blood stage infection. Mean parasitaemias 
from 3 independent experiments are shown by the dots while SEM values are shown by the vertical lines. 
(C) Neither Δdhhc10-a nor Δdhhc10-b parasites develop any midgut sporozoite (MG Spz). (D) Δdhhc10-a 
and Δdhhc10-b parasites do not develop any salivary gland sporozoite (SG Spz). (C-D) WT (5 
independent experiments, n=15); Δdhhc10-a (4 independent experiments, n=10); Δdhhc10-b (1 
experiment, n=10). (A, C-D) Mean and SEM values are shown by the lines; p-values for Mann-Whitney 
test are shown above the data sets. 
in the ookinete may simply be redundant for ookinete development and stored for later use in 
the oocyst. In recent papers we [330] and others [208] had identified genes transcribed in the 
gametocyte to be key factors for sporogony.  
In order to analyse DHHC10 protein expression we generated a mutant that expresses 
a GFP-tagged version of the protein. Tagging was performed using a construct that integrates 
by single cross-over recombination resulting in a C-terminal fusion under the transcriptional 
control of the endogenous promoter and absence of WT gene expression. We were able to 
select a line (dhhc10::gfp) with correct tagging of the gene locus (Figure S3). This mutant 
showed normal progression throughout the life cycle, including ookinete production and 
transmission to mice via mosquito bite (Table S4). GFP tagging of DHHC10 did thus not affect 
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Figure 5 – dhhc10 is translationally repressed in 
gametocytes and expressed in ookinetes. 
(A) RT-PCR analysis shows absence of WT dhhc10 and 
presence of correctly spliced dhhc10::gfp mRNA in blood 
stages of dhhc10::gfp parasites. p28 serves as control 
gene. (B) Immunofluorescence of dhhc10::gfp blood stage 
parasites shows no DHHC10 expression in asexual or 
sexual blood stages while live imaging of in vitro-cultured 
ookinetes shows DHHC10::GFP localisation (in green) in 
discrete foci. DNA was stained with Hoechst-33342 (in 
blue). Troph: trophozoite; Gam: gametocyte. Scale bar = 5 
µm. (C) RT-PCR analysis on DOZI::GFP and CITH::GFP 
gametocyte immunoprecipitation (IP) eluates shows that 
dhhc10 as well as p25 and p28 mRNAs (known to be 
translationally repressed) co-precipitate with DOZI and 
CITH. dozi, cith and alba-3 are translated in gametocytes 
and are not enriched in the IP-GFP fractions. Input: total 
gametocyte mRNA; IP-GFP: IP with anti-GFP antibody; IP-
c-myc: IP with anti-c-myc antibody; IP beads: no antibody 
used for IP. 
protein function or parasite viability. 
Although transcribed in gametocytes and therefore matching WT dhhc10 transcription 
(Figure 5A), DHHC10::GFP was not detected until ookinete formation (Figure 5B). Consistent 
with translational repression (TR) and storage of this transcript in DOZI/CITH-defined 
messenger ribonucleoproteins (mRNPs) for translation in the ookinete, dhhc10 co-
immunoprecipitated with DOZI::GFP and CITH::GFP [107, 108] in a fashion similar to p25 and 
p28, known translationally repressed mRNAs (Figure 
5C). 
In live ookinetes DHHC10::GFP highlighted 
distinct cytoplasmic foci (Figure 5B) known for 
members of the LAP/CCp protein family and thus 
typical for CBs [208, 212]. These transient organelles 
are specific to ookinetes and early oocysts and 
thought to act as a reservoir for proteins necessary 
for oocyst development [210, 215]. Focal localisation 
in one or two spots was observed in 70% of the 
ookinetes (n=60), and these co-localised with 
haemozoin (malaria pigment) clusters as seen by DIC 
microscopy. The remaining 30% showed a somewhat 
diffuse GFP signal throughout the ookinete 
cytoplasm; dim and diffuse fluorescence was also 
present in the ookinetes that presented clear 
DHHC10::GFP foci (Figure S4). GFP fluorescence 
was not observed in live oocysts or sporozoites (data 
not shown), consistent with our RT-PCR data. The 
tagging experiments establish DHHC10 as the first 
enzyme localised to CBs. 
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Figure 6 – Δdhhc10 
ookinetes lack 
crystalloid bodies 
and associated 
haemozoin clusters. 
(A) WT ookinetes (top) 
show clear haemozoin 
clusters under live DIC 
microscopy or Giemsa-
stained specimens 
(arrows). On the other 
hand, both Δdhhc10-a 
and Δdhhc10-b 
ookinetes (bottom) 
show haemozoin 
crystals dispersed in 
the cytoplasm 
(arrowheads and 
boxes). Scale bars = 5 
µm. (B) Transmission 
electron microscopy 
confirms the absence 
of crystalloid bodies 
(CB) and CB-
associated haemozoin 
(Hz) clusters in 
Δdhhc10-b ookinetes. 
No differences were 
observed in the 
nucleus (N) nor in the 
apical complex which 
has a similar 
distribution and 
localization of 
micronemes (Mn) and 
arrangement of 
subpellicular 
microtubules (Mt), 
inner membrane 
complex (IMC) and 
plasma membrane 
(PM). Scale bars = 1 
µm. 
Δdhhc10 ookinetes lack CBs 
In vivo, Δdhhc10 mutants produced WT numbers of oocysts. In vitro, these mutants 
showed normal macrogametocyte to ookinete conversion rates (Table S4). Mutant ookinetes 
displayed a shape consistent with WT development and functionality and efficiently invaded 
mosquito midguts. 
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Figure 7 – Absence of crystalloid bodies in Δdhhc10 parasites leads to mislocalisation of LAP2. 
(A) Correct genomic integration of LAP2 GFP tagging construct into chromosome 13 of Δdhhc10-a 
parasites was confirmed by Field-Inversion Gel Electrophoresis (FIGE) of separated whole chromosomes 
in uncloned Δdhhc10;lap2::gfp parasite line. FIGE was developed using a probe for the human dhfr/ts. (B) 
Live imaging of WT and Δdhhc10;lap2::gfp female gametocytes shows LAP2::GFP expression (in green) 
throughout the gametocyte cytoplasm in both parasite lines. (C) Live imaging of WT and 
Δdhhc10;lap2::gfp in vitro-cultured ookinetes shows typical LAP2::GFP localisation (in green) in crystalloid 
bodies in WT parasites, while localisation in Δdhhc10;lap2::gfp parasites is scattered throughout the 
ookinete cytoplasm. (B-C) DNA was stained with Hoechst-33342 (in blue). Scale bars = 5 µm. 
However, haemozoin clusters that typically surround and highlight CBs in WT P. berghei 
ookinetes [215, 216] (Figure 6A, top) were absent or dispersed throughout the cytoplasm of the 
mutants (Figure 6A, bottom) in live and Giemsa-stained specimens. This suggested that 
DHHC10 and palmitoylation are required for the formation and maintenance of CBs as well as 
the aggregation of haemozoin. However, this clearly did not affect invasion of the mosquito 
vector. 
In transmission electron microscopy of WT ookinetes (Figure 6B, top) CBs appear 
highly ordered and surrounded by specks of haemozoin, the remnant of haemoglobin digestion 
by the intraerythrocytic, female gametocyte. WT parasites also show abundant micronemes at 
the apical complex, which are necessary for gliding motility and midgut epithelium invasion. 
Numerous micronemes can also be seen in the knock-out (KO) mutant (Figure 6B, bottom) 
explaining its WT invasion behaviour in the in vivo transmission experiments (Figure 3A). In 30 
Δdhhc10-b ookinetes analysed however we never observed characteristic CBs; instead, 
haemozoin crystals were scattered throughout the ookinete cytoplasm. 
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Figure 8 – DHHC2 and DHHC3 are expressed in blood and mosquito stages. 
(A) Expression of DHHC2::GFP in live dhhc2::gfp parasites. (B) Expression of DHHC3::GFP in live 
dhhc3::gfp parasites. (A-B) DHHC2::GFP and DHHC3::GFP expression is shown in green while DNA was 
stained with Hoechst-33342 (in blue). Troph: trophozoite; Gam: gametocyte; Act. female: activated female 
gametocyte; Act. male: activated male gametocyte (male gametes projected from the male gametocyte 
are identified by the arrowheads); Ook: ookinete; Oocyst d6, d13 and d21: oocyst at days 6, 13 and 21 
p.i.; MG Spz: midgut sporozoite at day 21 p.i.; SG Spz: salivary gland sporozoite at day 21 p.i. Scale bars 
= 5 µm (blood stages, ookinetes and sporozoites) or 20 µm (oocysts). 
To independently confirm CB absence in Δdhhc10 ookinetes and assess the 
consequences for CB-resident protein localisation we transfected the null mutant with a 
PbLAP2::GFP fusion construct [212]. The resulting Δdhhc10;lap2::gfp parasites (Figure 7A) 
presented PbLAP2::GFP-positive female gametocytes (Figure 7B) where LAP2 is scattered 
throughout the cytoplasm as shown previously. While in WT ookinetes LAP2 is targeted and 
concentrated in CBs [212], the absence of DHHC10 resulted in LAP2::GFP protein remaining 
spread throughout the cytoplasm (Figure 7C), highlighting the importance of palmitoylation for 
CB formation and correct localisation of this known CB component. These experiments 
establish DHHC10 and palmitoylation as essential factors for CB biogenesis and function.  
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DHHC2 and DHHC3 GFP tagging reveals constitutive expression patterns 
Since we were unable to delete dhhc2 and dhhc3, we could not determine their 
potential functions in mosquito stage development. The unsuccessful attempts suggested an 
essential role during asexual blood stage development or perhaps a reduced accessibility of 
these loci for genetic modification. Therefore we targeted both genes for GFP tagging with 
constructs that integrate by single cross-over recombination resulting in a C-terminal fusion. For 
both genes we were able to select mutants (dhhc2::gfp and dhhc3::gfp) with correct tagging of 
the genomic loci proving that both loci are amenable to genetic modification (Figures S5 and 
S6).  Both mutants showed normal blood and mosquito stages with WT morphology (Figure 8 
and Table S4), indicating that the GFP tagging did not affect the function of these proteins. 
Expression of DHHC2::GFP and DHHC3::GFP in different life cycle stages was 
determined by live fluorescence microscopy and displayed a similar pattern. Both DHHC2::GFP 
(Figure 8A) and DHHC3::GFP (Figure 8B) were detected in all asexual blood stages as well as 
in gametocytes and ookinetes. No expression was observed in young oocysts while oocysts 
undergoing sporogony expressed the fusion proteins. Sporozoites showed clear DHHC2::GFP 
signal, especially towards the apex, reminiscent of microneme or rhoptry localisation. On the 
other hand, DHHC3::GFP was evenly distributed throughout the sporozoite cytoplasm. In 
dhhc3::gfp schizonts, the GFP signal distribution towards the edges of the newly formed 
merozoites is indicative of IMC localisation. Localisation of DHHC3::GFP in ookinetes is also 
suggestive of association with the parasite PM or IMC. 
In dhhc2::gfp and dhhc3::gfp parasites, the endogenous 3' untranslated regions (UTRs) 
have been replaced by that of pbdhfr/ts, a gene that does not undergo TR in female 
gametocytes [132]. TR of certain mRNAs in female gametocytes can be exerted through motifs 
found in their 3' UTRs, as in the case of p28 [132]. To be certain that DHHC2::GFP and 
DHHC3::GFP expression in gametocytes reflects the true expression pattern of these proteins 
and rule out that TR-targeting motifs reside within the 3' UTRs of dhhc2 and dhhc3, we 
generated C-terminally GFP-tagged mutants (dhhc2::gfp-3'UTR and dhhc3::gfp-3'UTR) that 
express these genes under the control of their own 5' and 3' UTRs (Figures S7 and S8). In 
these parasites, expression of DHHC2 and DHHC3 throughout the life cycle was confirmed to 
be the same as in lines dhhc2::gfp and dhhc3::gfp (Figures S9A and B). 
Altogether, failure to delete dhhc2 and dhhc3 and successful tagging experiments, 
indicated that both proteins have an essential role in growth and/or multiplication of asexual 
blood stages. The observations of expression of the tagged proteins in mosquito stages, namely 
in oocysts and sporozoites, indicate that these proteins may also play a role in palmitoylation 
during sporogony or sporozoite function. 
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Figure 9 – Sporozoite invasion but not motility is dependent on protein palmitoylation. 
(A) Live gliding motility movies of sporozoites (Spz) taken at different time points after 2-BMP addition in 
different concentrations did not show any differences in comparison with non-treated sporozoites (0 µM). 
Average speed of parasites was approximately 1.5 µm/s. (B) Maximum projections of gliding sporozoites 
in the absence (0 µM) and presence (100µM) of 2-BMP. (C) In vitro hepatocyte traversal is not affected by 
the presence (100µM) of 2-BMP. Dx+ cells: Dextran, Tetramethylrhodamine positive cells. (D) In vitro 
hepatocyte invasion levels are significantly reduced by drug inhibition of palmitoylation (100µM 2-BMP). 
(C-D) Mean percentages are shown by the bars while SEM values are shown by the vertical lines. Data 
corresponds to 3 independent experiments (n=8) for both treated and non-treated sporozoites; p-values 
for Mann-Whitney test are shown above the bars. 
Palmitoylation influences sporozoite infectivity 
The expression of both DHHC2 and DHHC3 in sporozoites suggested a possible role 
for these proteins and therefore for palmitoylation in sporozoite function. More specifically, the 
apical GFP distribution in dhhc2::gfp sporozoites, resembling micronemal or rhoptry localisation, 
pinpointed to a possible role for palmitoylation in parasite motility and/or invasion. To test this 
hypothesis we analysed gliding motility of salivary gland sporozoites in the presence of 
increasing concentrations of the PAT inhibitor 2-BMP for varying periods of time. Gliding motility 
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was assayed by generating 4-minute movies (frame-rate 3 seconds) followed by manual 
tracking of individual parasites. None of the experimental setups revealed any change in the 
number of moving parasites or in the speed or trajectories of treated sporozoites when 
compared to non-treated controls (Figures 9A and B). 
Concordantly, when dissected salivary gland sporozoites were incubated for 45 min with 
100 µM of 2-BMP, corresponding to the harshest condition tested in the above mentioned 
gliding assays, their in vitro hepatocyte traversal ability was not significantly altered (Figure 9C). 
On the other hand, hepatocyte invasion was significantly inhibited when sporozoites were 
treated with 2-BMP in the same way (Figure 9D). Altogether, this data clearly defines a 
functional role for palmitoylation in hepatocyte invasion by sporozoites, while not affecting 
gliding motility or liver cell traversal. 
 
DISCUSSION 
Post-translational modifications play an important role in protein function, localisation, 
trafficking, stability, conformation, interactions and signalling. The lipidation post-translational 
modification (PTM) designated palmitoylation has been the focus of much study in the last 
years. Being a reversible lipidation reaction, palmitoylation is now emerging as a key regulatory 
PTM in known and potentially novel molecular networks [342]. 
Our studies highlight for the first time the essential nature of protein palmitoylation for 
malaria parasite life cycle progression in the mosquito vector. Through the global inhibition of 
PATs and genetic studies we show that S-acylation is essential for zygote to ookinete 
development and sporozoite formation. The key finding of this study is the discovery of a single 
PAT (DHHC10) as an essential factor for the biogenesis of ookinete CBs. In the absence of this 
protein CBs fail to form and the CB-resident protein LAP2 mislocalises. While ookinete 
functionality remains unaffected, Δdhhc10 oocysts fail to undergo sporogony. Furthermore, we 
demonstrate that palmitoylation is required for optimal invasion of hepatocytes by sporozoites 
but redundant for parasite gliding motility. Finally, we provide strong evidence for the essential 
nature of two PATs (DHHC2 and DHHC3) for asexual blood stage development. On one hand 
this work establishes the universal role of palmitoylation as a regulator of key biological events 
during the entire Plasmodium life cycle; on the other hand the expression pattern and essential 
nature of DHHC10 emphasises the evolution of a specific PAT whose function is restricted to a 
very specific, narrowly timed phenomenon (CB biogenesis) that is, in its turn, crucial for 
sporogony. 
We found ookinete formation to be extremely sensitive to the drug 2-BMP, a non-
metabolisable palmitate analogue that blocks palmitate incorporation into proteins [343]. It is 
known that 2-BMP may exert metabolic pleiotropic effects [239]. However, zygote-to-ookinete 
transformation (ZOT) was inhibited at a concentration as low as 0.25 µM, corresponding to 400 
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times less drug than the concentration typically used to inhibit palmitoylation in other systems 
[239], and 200 to 400 times less than the concentrations known to affect P. falciparum blood 
stage schizogony [227]. As palmitoylation is a PTM known to alter protein localization and 
trafficking, the nature of the developmental abnormalities in zygotes/ookinetes following 2-BMP 
exposure suggests that defects in protein and membrane trafficking are responsible for the 
arrest in morphogenesis. While 2-BMP was previously shown to inhibit schizogony, it did not 
block nuclear division [227]. Similarly, we report that absence of sporozoite formation in 
Δdhhc10 oocysts takes place with no apparent arrest in DNA replication. 
The shape of several Plasmodium life cycle stages (merozoite, ookinete and sporozoite) 
depends on the ordered arrangement of the subpellicular network and the IMC beneath the PM. 
At least 23 proteins are known to localise to the subpellicular network or are associated or 
inserted into the IMC (PlasmoDB version 11.0). Fourteen of those were found to be 
palmitoylated in P. falciparum asexual blood stage parasites [227] (Table S5); whether these 
proteins are present and post-translationally modified in the developing zygote/ookinete is not 
known. Of the 13 annotated alveolin/IMC/IMC sub-compartment proteins, 8 were part of the 
global P. falciparum blood stage palmitome. IMC sub-compartment proteins ISP1 and ISP3 
(PF3D7_1011000 and PF3D7_1460600, respectively), which are clearly detected in stage I/II 
ookinetes [344], are palmitoylated [227] as well as myristoylated [344] in blood stage parasites; 
these proteins define and highlight apical polarity in the developing ookinete [344]. In addition, 
glideosome associated protein with multiple membrane spans (GAPM) 2 and 3 
(PF3D7_0423500 and PF3D7_1406800, respectively) (but not 1) as well as glideosome-
associated proteins (GAP) 40, 45 and 50 (PF3D7_0515700, PF3D7_1222700 and 
PF3D7_0918000, respectively) and myosin A tail domain interacting protein (MTIP) 
(PF3D7_1246400) are known palmitoylation substrates. The palmitoylated status of the recently 
identified subpellicular network protein G2 (PF3D7_0929600), subpellicular microtubule proteins 
(SPM) 1 and 2 (PF3D7_0909500 and PF3D7_1230300, respectively), IMC1a 
(PF3D7_0304000), IMC1b (PF3D7_1141900), IMC1h (PF3D7_1221400) and ALV7 
(PF3D7_0621400) was however not reported. 
Only few of these proteins have been shown experimentally to be involved in ookinete 
morphogenesis. Six gene deletion mutants have been generated for four of these targets: 
IMC1b, IMC1h, G2 and ISP3. Among these, two have targeted IMC1h and one is an IMC1b/h 
double KO (RMgmDB, www.pberghei.eu). The phenotypes of these mutants included 
shortened/stunted ookinete morphology and reduced gliding motility leading to lowered 
mosquito infectivity. However, a strong developmental defect as the one observed in our global 
palmitoylation inhibition studies was never reported. It is likely that the global inhibition of 
several (yet unknown) PATs in this study resulted in an additive effect leading to the early 
growth defects. 
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Which specific PAT (or PATs) is required for ZOT remains elusive. Previous work from 
our group identified three pbdhhc-pats (dhhc2, dhhc3 and dhhc10) to rely on the RNA helicase 
DOZI for RNA stability in gametocytes, thus suggesting a role for these three genes/proteins 
during post-fertilization development of the zygote [107]. Such mRNAs are typically subject to 
TR in the female gametocyte; translation and protein function occur after fertilisation within the 
mosquito host allowing successful colonization of the vector [71, 137]. The RNAseq as well as 
RT-PCR data presented here identified each of these three genes to be upregulated in 
gametocytes, and the RNA-immunoprecipitation (RNA-IP) experiments supported a physical 
interaction of DOZI and CITH (a second translational repressor) with dhhc10 (Figure 5C) as 
well as with dhhc2 and dhhc3 (Figure S10). However, only dhhc10 behaves as a typical, 
gametocyte-specific and translationally repressed gene with absence of protein in gametocytes 
and translation of the stored mRNA only in the zygote/ookinete. The GFP tagging experiments 
showed the presence of DHHC2 and DHHC3 in gametocytes. It is possible that both these 
proteins are required during early gametocytogenesis. As a result, mature gametocytes contain 
both protein and translationally repressed mRNAs that are produced in the late gametocyte. 
The clear association of dhhc2 and dhhc3 mRNAs with DOZI and CITH supports this 
interpretation. 
At the transcript level, and based on RNAseq data, P. falciparum dhhc2 is particularly 
upregulated in schizonts, while pfdhhc3 and pfdhhc10 are upregulated in gametocytes [84]. The 
blood stage translational profiles reported herein for DHHC2::GFP and DHHC3::GFP together 
with published observations on expression in P. falciparum blood stages (DHHC2 in rings [345] 
and schizonts [340] and DHHC3 in schizonts [340, 341]; see Table S3) suggest a role for these 
proteins in asexual development and/or red blood cell invasion, and likely explains our failure to 
delete these genes. DHHC10, on the other hand, has not been reported in any of these 
proteomics studies. All three DHHC-PATs analysed here were however absent from the 
datasets of asexual blood stages, as well as mixed and separated male and female gametocyte 
proteomes of P. berghei ([50] and Table S3). The inability to KO dhhc2 and dhhc3 did not allow 
us to assess the contribution of these PATs, if any, to ookinete development. Previous attempts 
to delete these genes have been reported; while dhhc2 deletion failed, dhhc3 deletion was 
reported to be successful [233]. However, this study used a different gene targeting approach 
(PlasmoGEM, plasmogem.sanger.ac.uk, [346]) and lacks detailed genotype and phenotype 
analyses of the selected mutants to confirm correct deletion of dhhc3. Our failure to delete both 
dhhc2 and dhhc3 indicate that these proteins have an essential and non-redundant function in 
blood stage parasites. Further insight into the exact role of these proteins for both asexual and 
sexual stages of Plasmodium will require methodologies for conditional knock-out/down of 
expression in defined life cycle stages through promoter swap (e.g., [134, 347]). 
Analyses of the transgenic parasites expressing GFP-tagged DHHC2 and DHHC3 
showed expression of these proteins in ookinetes and sporozoites. Translation of both genes 
was low (if any) in immature oocysts but was upregulated during sporogony and maintained in 
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midgut and salivary gland sporozoites, matching their “waving” mRNA expression profile 
throughout the parasite’s life cycle. DHHC2 and DHHC3 have also been detected in salivary 
gland sporozoites by mass-spectrometry analyses ([339] and Table S3) in addition to four other 
DHHC-PATs (DHHC1, 4, 7 and 9). 
Our observations showed localisation of DHHC2::GFP at the apex of the sporozoite, 
perhaps in micronemes or rhoptries. DHHC3::GFP protein on the other hand is distributed 
throughout the sporozoite. In blood stages the protein distributes towards the edges of newly 
formed merozoites. This localisation is in agreement with recently reported localisation of HA-
tagged PbDHHC3 in merozoites which co-localised with merozoite surface protein 1 (MSP1), 
suggesting an IMC localisation [233]. In ookinetes, DHHC3::GFP signal is stronger at the 
surface of the parasite, suggesting that DHHC3 could also be localised to the IMC at this stage. 
Based on the expression in merozoites, ookinetes and sporozoites and on their 
subcellular localisation, both DHHC2 and DHHC3 were candidate factors for gliding motility and 
invasion-related events. The absence of an effect of  2-BMP on gliding motility and hepatocyte 
traversal by sporozoites indicate that, in contrast to palmitoylation of GAP45 in T. gondii 
tachyzoites [234], dynamic PAT-mediated protein palmitoylation is not required for motility of 
Plasmodium sporozoites. In contrast, hepatocyte invasion by sporozoites was significantly 
reduced in the presence of 2-BMP indicating that palmitoylation is important for liver cell 
invasion. Together with published data on P. falciparum [227] and T. gondii [234, 237, 240], our 
results confirm palmitoylation of parasite proteins as an important factor for general host cell 
invasion by Apicomplexans. 
For the first time we link a specific PAT to a specific cell biological role during parasite 
development inside the mosquito. We show that DHHC10 is dispensable for normal 
development of asexual blood stages. Concordantly, dhhc10 has previously been targeted for 
deletion and its non essential nature for blood stage parasites was reported [233]. Although 
transcribed in the gametocyte, dhhc10 is a target of TR and plays no immediate role in the 
development of gametocytes or ookinetes as well. DHHC10-deficient parasites produce 
gametocytes that are able to differentiate into fertile gametes, which, in turn mate and form 
zygotes that develop into ookinetes capable of establishing normal number of oocysts. The 
protein has thus no role in ZOT, nor affects traversal or invasion of the midgut wall by the 
ookinete. Oocysts show DNA replication but sporogony is completely aborted in DHHC10-
deficient parasites, resulting in ‘empty’, vacuolated oocysts that outgrow WT oocysts in size. 
Our results show that DHHC10 is essential for the normal formation of CBs, transient organelles 
formed in the ookinete that exert their function in the oocyst. In the absence of DHHC10 no 
typical CBs could be detected at light- and electron-microscopy levels and the CB-resident 
protein LAP2 showed an aberrant localisation. The phenotype of vacuolated oocysts showing 
reduced CSP expression and lacking sporozoite formation has been observed in several other 
gene deletion mutants, some of which are deficient in proteins that associate with CBs. These 
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include members of LCCL protein family, also called LAP proteins in P. berghei [176, 211, 224-
226]. Like dhhc10, certain lap mRNAs, namely pblap4-6 [208], are translationally repressed in 
gametocytes while in ookinetes the proteins become associated with the CB [208]. The aberrant 
oocyst phenotypes described above have also been ascribed to mutant parasites lacking 
expression of plasmepsin VI [176], rhomboid 3 [330] and CSP itself [331]. Interestingly, the 
absence of CBs has only been reported so far for one specific member of the LAP family, PbSR 
[211], making DHHC10 the second protein (and the first enzyme) with vital role in CB formation 
to be reported in P. berghei. Moreover, other phenotypic similarities between PbSR and 
DHHC10 null mutants include the oocyst enlargement while DNA replication continues [224], 
suggesting that the basic expansion program of the oocyst is thus operational while 
morphogenesis and cellularisation depend on the presence of these two CB-resident proteins. 
Based on the notion that CSP levels markedly influence the degree of sporozoite formation by 
affecting the development of inner membranes in the sporulating cyst [327], we analysed CSP 
expression in Δdhhc10 oocysts by Western blot as well as IFA. We concluded by both methods 
that CSP is almost absent from KO cysts, further corroborating the abortive nature of the gene 
deletion cysts. 
Our observations provide additional evidence to support the proposed function of CBs 
as ookinete protein storage organelles [210, 215] and corroborate the importance of CB and 
CB-associated proteins for formation of sporozoites inside the oocyst. Studies on mutants 
lacking LAP proteins and now DHHC10 provide strong support for a central role of CBs in 
sporozoite formation. However, since disruption of the LAP protein PbSR and DHHC10 affects 
correct formation of CB it is not clear whether these proteins have a direct function in sporozoite 
formation or their absence affects the correct storage and transport of other (lipo)proteins or 
lipids that are essential for sporogony. 
Sporogony in the mosquito midgut oocyst involves a several thousand-fold replication 
step that is followed by the generation of individual, motile sporozoites that are capable of 
invading the mosquito’s salivary glands, traverse human/rodent skin, capillaries and liver cells, 
and invade hepatocytes. This step, as well as the formation of the motile banana-shaped 
ookinete from the round zygote, most likely necessitate proper protein trafficking and 
localisation, something that can be achieved for instance through the action of DHHC-PATs. 
The localisation of such PATs within the parasitic cell will of course determine the proteins they 
can modify. A common feature of all PATs is that they are inserted into membranes [229]. 
Indeed, several Plasmodium and Toxoplasma DHHC-PATs have been localized to distinct 
subcellular compartments including the PM, IMC, rhoptries, endoplasmic reticulum and Golgi 
[233, 348], suggesting roles for motility, host cell invasion and protein trafficking. While DHHC10 
localises to CBs in ookinetes, DHHC10::GFP was not detectable by live imaging in immature or 
mature oocysts. Co-localisation IFAs with known organelle markers and immuno-electron 
microscopy on dhhc10::gfp oocysts could be done to further elucidate this question. 
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The targets of protein palmitoylation in ookinetes, oocysts or developing midgut 
sporozoites are at the moment unknown. However, the published P. berghei and P. gallinaceum 
zygote and ookinete proteomes comprehend 277 out of 1368 (20%) P. falciparum orthologs 
found to be palmitoylated in P. falciparum schizonts. A comparison of published oocyst and 
oocyst-derived (midgut) sporozoite proteome data from P. falciparum [51] with the recently 
identified palmitome of P. falciparum schizonts [227] showed that 54 out of the 134 proteins 
detected in 7-8 days old oocysts were targets of palmitoylation in blood stages, while of the 453 
proteins detected in 13-14 days old midgut sporozoites, 176 were also present in the schizont 
palmitome. Of the 5398 protein coding genes in the genome of P. falciparum 3D7 strain, 3689 
have protein evidence in blood stage parasites, including asexual and sexual stages 
(PlasmoDB version 11.0); only 475 of those (13%) were identified to be palmitoylated in the 
above mentioned study [227]. The total number of proteins detected in oocysts and oocyst-
derived sporozoites is low when compared to those identified in blood stage parasites; the 
fraction shown to be potential target of palmitoylation is however extremely high: 40% for 
oocysts, and 39% for midgut sporozoites. These large proportions (if true and not simply the 
result of preferential detection of membrane-bound proteins in midgut-associated parasites) 
could explain the severe developmental failure in the dhhc10 null mutant and the essential role 
of DHHC10 in the modification and trafficking of such proteins prior to and during sporogony. 
Cysteines are the canonical target residues for palmitoylation. However, in silico 
prediction of palmitoylation sites from primary protein sequences is difficult to achieve since 
there are only few poorly defined palmitoylation motifs known to date [349]. Therefore, the 
identification of palmitoylated proteins in different organisms has been done using proteomic 
strategies [227]. One such strategy is called Acyl-Biotin Exchange (ABE), in which the thioester-
linked palmitoyl groups are substituted by biotin, allowing for a streptavidin-based purification of 
palmitoylated proteins, followed by mass-spectrometry [350]. This method has already been 
used to identify the palmitome of P. falciparum schizonts, comprehending over 400 proteins 
[227]. A similar approach could be employed not only to determine the palmitome of P. berghei 
ookinetes and oocysts but also to identify the enzymatic targets of DHHC10 by comparing the 
pool of palmitoylated proteins in Δdhhc10 versus WT parasites. 
The results obtained in the present study clearly show the critical role of PTMs, namely 
protein palmitoylation, in the life cycle progression of malaria parasites within the mosquito 
vector. Although the DHHC-containing domain of DHHC-PATs is highly conserved between 
phylogenetically divergent taxa, their N- and C-termini are usually quite distinct and thought to 
determine substrate specificity [229]. Affecting parasite development in both vertebrate and 
invertebrate hosts, the development of parasite-specific DHHC-PAT inhibitors could be of 
extreme interest in the fight against malaria. 
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Figure S1 – dhhc2, dhhc3 and dhhc10 are not transcribed in liver stages. 
RT-PCR analyses of dhhc2, dhhc3 and dhhc10 in in vivo-developed P. 
berghei exoerythrocytic forms (EEFs) at different time points after sporozoite 
injection. 18S rRNA serves as loading control gene. +: RT positive reaction; -: 
RT negative reaction. 
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Figure S2 – Generation and genotyping of Δdhhc10 parasite lines. 
(A) dhhc10 gene deletion construct pLIS0067 (i) was obtained by cloning dhhc10 5' and 3' targeting 
regions (TR) upstream and downstream of  the Toxoplasma gondii dhfr/ts selectable marker cassette, 
respectively. tgdhfr/ts gene is under the control of P. berghei dhfr/ts 5' and 3' UTRs. The construct was 
integrated into the dhhc10 locus (ii) of Fluo-frmg and PbGFP-LUCcon WT lines by double homologous 
recombination, resulting in the complete deletion of dhhc10 ORF in Δdhhc10 parasites (iii). (B) Correct 
deletion of dhhc10 was shown by Southern analysis of separated chromosomes (left) and diagnostic PCR 
analyses (right). Hybridisation of separated chromosomes with a probe against the 3' UTR of pbdhfr/ts 
recognised integrated pLIS0067 into chromosome 5, the endogenous pbdhfr/ts locus in chromosome 7 
and reporter gene constructs (GFP/RFP or GFP-Luciferase) in chromosome 3. PCR analyses confirm 5' 
and 3' integration (int.) of pLIS0067, absence of dhhc10 ORF and presence of tgdhfr/ts gene. (C) Absence 
of dhhc10 mRNA was confirmed in Δdhhc10 mixed blood stages by RT-PCR. p28 and RNA polymerase II 
serve as control genes. 
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Figure S3 – Generation and genotyping of dhhc10::gfp parasite line. 
(A) dhhc10 GFP tagging construct pLIS0117 (i) was obtained by cloning the last 1116 bp of dhhc10 ORF 
excluding the stop codon upstream and in frame with the gfp gene. This construct includes the 
Toxoplasma gondii dhfr/ts selectable marker cassette under the control of P. berghei dhfr/ts 5' and 3' 
UTRs. The construct was integrated into the dhhc10 locus (ii) of cl15cy1 by single homologous 
recombination, resulting in the fusion of dhhc10 to gfp in dhhc10::gfp parasites (iii). (B) Correct tagging of 
dhhc10 was shown by Southern analysis of separated chromosomes (left) and diagnostic PCR analyses 
(right). Hybridisation of separated chromosomes with a probe against the 3' UTR of pbdhfr/ts recognised 
integrated pLIS0117 into chromosome 5 and the endogenous pbdhfr/ts locus in chromosome 7. PCR 
analyses confirm 5' and 3' integration (int.) of pLIS0117, absence of WT dhhc10 ORF and presence of 
tgdhfr/ts gene. (C) Absence of WT dhhc10 and presence of dhhc10::gfp mRNA was confirmed in cloned 
dhhc10::gfp mixed blood stages by RT-PCR. p28 and RNA polymerase II serve as control genes. 
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Figure S4 – DHHC10 localisation in ookinetes. 
Live imaging of in vitro-cultured dhhc10::gfp ookinetes shows 
DHHC10::GFP localisation (in green) in discrete foci in approximately 
75% of the ookinetes (upper pannel). Remaining parasites only showed 
diffuse cytoplasmic GFP signal (lower pannel) (n=60). DNA was stained 
with Hoechst-33342 (in blue). Scale bars = 5 µm. 
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Figure S5 – Generation and genotyping of dhhc2::gfp parasite line. 
(A) dhhc2 GFP tagging construct pLIS0086 (i) was obtained by cloning the last 1167 bp of dhhc2 ORF 
excluding the stop codon upstream and in frame with the gfp gene. This construct includes the 
Toxoplasma gondii dhfr/ts selectable marker cassette under the control of P. berghei dhfr/ts 5' and 3' 
UTRs. The construct was integrated into the dhhc2 locus (ii) of cl15cy1 by single homologous 
recombination, resulting in the fusion of dhhc2 to gfp in dhhc2::gfp parasites (iii). (B) Correct tagging of 
dhhc2 was shown by Southern analysis of separated chromosomes (left) and diagnostic PCR analyses 
(right). Hybridisation of separated chromosomes with a probe against the 3' UTR of pbdhfr/ts recognised 
integrated pLIS0086 into chromosome 1 and the endogenous pbdhfr/ts locus in chromosome 7. PCR 
analyses confirm 5' and 3' integration (int.) of pLIS0086, absence of WT dhhc2 ORF and presence of 
tgdhfr/ts gene. (C) Absence of WT dhhc2 and presence of dhhc2::gfp mRNA was confirmed in cloned 
dhhc2::gfp mixed blood stages by RT-PCR. p28 and RNA polymerase II serve as control genes. 
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Figure S6 – Generation and genotyping of dhhc3::gfp parasite line. 
(A) dhhc3 GFP tagging construct pLIS0192 (i) was obtained by cloning the last 968 bp of dhhc3 ORF 
excluding the stop codon upstream and in frame with the gfp gene. This construct includes the 
Toxoplasma gondii dhfr/ts selectable marker cassette under the control of P. berghei dhfr/ts 5' and 3' 
UTRs. The construct was integrated into the dhhc3 locus (ii) of cl15cy1 by single homologous 
recombination, resulting in the fusion of dhhc3 to gfp in dhhc3::gfp parasites (iii). (B) Correct tagging of 
dhhc3 was shown by diagnostic PCR analyses, confirming 5' and 3' integration (int.) of pLIS0192 into 
chromosome 9, absence of WT dhhc3 ORF and presence of tgdhfr/ts gene. (C) Absence of WT dhhc3 
and presence of dhhc3::gfp mRNA was confirmed in cloned dhhc3::gfp mixed blood stages by RT-PCR. 
p28 and RNA polymerase II serve as control genes. 
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Figure S7 – Generation and genotyping of dhhc2::gfp-3'UTR parasite line. 
(A) dhhc2 GFP tagging construct pLIS0202 (i) was obtained by cloning the last 1167 bp of dhhc2 ORF 
excluding the stop codon upstream and in frame with the gfp gene and nucleotide positions 36 to 541 of 
dhhc2 3' UTR downstream of gfp. This construct includes Toxoplasma gondii dhfr/ts selectable marker 
cassette under the control of P. berghei dhfr/ts 5' and 3' UTRs. The construct was integrated into the 
dhhc2 locus (ii) of cl15cy1 by single homologous recombination, resulting in the fusion of dhhc2 to gfp and 
maintaining the endogenous dhhc2 3' UTR in dhhc2::gfp-3'UTR parasites (iii). (B) Correct tagging of 
dhhc2 was shown by diagnostic PCR analyses, confirming 5' and 3' integration (int.) of pLIS0202 into 
chromosome 1, absence of WT dhhc2 ORF and presence of tgdhfr/ts gene. (C) Absence of WT dhhc2 
and presence of dhhc2::gfp mRNA was confirmed in cloned dhhc2::gfp-3'UTR mixed blood stages by RT-
PCR. p28 and RNA polimerase II serve as control genes. 
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Figure S8 – Generation and genotyping of dhhc3::gfp-3'UTR parasite line. 
(A) dhhc3 GFP tagging construct pLIS0198 (i) was obtained by cloning the last 948 bp of dhhc3 ORF 
excluding the stop codon upstream and in frame with the gfp gene and the first 391 bp of dhhc3 3' UTR 
downstream of gfp. This construct includes Toxoplasma gondii dhfr/ts selectable marker cassette under 
the control of P. berghei dhfr/ts 5' and 3' UTRs. The construct was integrated into the dhhc3 locus (ii) of 
cl15cy1 by single homologous recombination, resulting in the fusion of dhhc3 to gfp and maintaining the 
endogenous dhhc3 3' UTR in dhhc3::gfp-3'UTR parasites (iii). (B) Correct tagging of dhhc3 was shown by 
diagnostic PCR analyses, confirming 5' and 3' integration (int.) of pLIS0198 into chromosome 9, absence 
of WT dhhc3 ORF and presence of tgdhfr/ts gene. (C) Absence of WT dhhc3 and presence of dhhc3::gfp 
mRNA was confirmed in cloned dhhc3::gfp-3'UTR mixed blood stages by RT-PCR. p28 and RNA 
polymerase II serve as control genes. Primer g1305 only anneals with dhhc3 cDNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
95 
 
Figure S9 – DHHC2 and DHHC3 are expressed in blood and mosquito 
stages. 
(A) Expression of DHHC2::GFP in live dhhc2::gfp-3'UTR parasites. (B) 
Expression of DHHC3::GFP in live dhhc3::gfp-3'UTR parasites. (A-B) 
DHHC2::GFP and DHHC3::GFP expression is shown in green while DNA was 
stained with Hoechst-33342 (in blue). Troph: trophozoite; Gam: gametocyte; 
Ook: ookinete; Oocyst d6, d13 and d21: oocyst at days 6, 13 and 21 p.i.; MG 
Spz: midgut sporozoite at day 21 p.i.; SG Spz: salivary gland sporozoite at 
day 21 p.i. Scale bars = 5 µm (blood stages, ookinetes and sporozoites) or 20 
µm (oocysts). 
Figure S10 – dhhc2 and dhhc3 
transcripts are bound by 
DOZI/CITH-defined mRNPs. 
RT-PCR analysis on DOZI::GFP and 
CITH::GFP gametocyte 
immunoprecipitation (IP) eluates 
shows that dhhc2, dhhc3 as well as 
p25 and p28 mRNAs (known to be 
translationally repressed) co-
precipitate with DOZI and CITH. dozi, 
cith and alba-3 are translated in 
gametocytes and are not enriched in 
the IP-GFP fractions. Input, total 
gametocyte mRNA; IP-c-myc, IP with 
anti-c-myc antibody; IP beads, no 
antibody used for IP. 
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ABSTRACT 
Gliding motility is a type of locomotion used by malaria parasites and related 
apicomplexans such as Toxoplasma to migrate across tissues and invade cells in diverse host 
species. Powered by an actin-myosin motor that is anchored to the inner membrane complex, 
gliding motility requires the secretion of soluble and plasma membrane-resident proteins that 
provide adhesion with the substrate. Here, we highlight a novel Plasmodium berghei surface 
protein, LIMP, with an essential role in gliding motility and host cell adhesion, traversal and 
invasion. The absence of this protein reduces transmission to the mosquito vector by half, 
salivary gland invasion 10-fold and renders parasites unable to infect naïve mice by mosquito 
bite or when injected intravenously. Translationally repressed in gametocytes, LIMP is targeted 
to the ookinete crystalloids, transcriptionally activated a second time during sporogony and 
localized to the sporozoite plasma membrane. While LIMP-depleted parasites display no gliding 
motility, in situ GFP tagging of this 13 kDa (110 amino acids) protein resulted in a limping 
movement characterised by reduced speed and frequent stretching, which has been correlated 
with reduced turnover of parasite-substrate adhesion sites. Our results suggest that LIMP plays 
a critical role in regulating parasite attachment/detachment cycles that supports productive 
gliding motility and invasion of host target cells. 
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METHODS 
Experimental animals 
Animal experiments performed in Leiden University Medical Center (LUMC, Leiden, The 
Netherlands) were approved by the Animal Experiments Committee of the Leiden University 
Medical Center (DEC 10099; 12042; 12120). In Instituto de Medicina Molecular (IMM, Lisbon, 
Portugal) animal experimentation protocols were approved by the IMM Animal Ethics 
Committee (under authorisation AEC_2010_018_GM_Rdt_General_IMM) and the Portuguese 
authorities (Direção Geral de Alimentação e Veterinária).  At the University of Heidelberg 
Medical School (Heidelberg, Germany) animal work was approved by the German Authorities 
(Regierungspräsidium Karlsruhe; Aktenzeichen 35-9185.81/G-3/11) and performed in 
compliance with FELASA guidelines and regulations. All animal work was in accordance with 
European Union regulations. 
 
Reference P. berghei ANKA lines 
Seven reference P. berghei ANKA parasite lines were used. Details of most lines can 
be found in the RMgmDB database (www.pberghei.eu). Line 683cl1 (DOZI::GFP; RMgm-133) 
[107] expressing a C-terminally GFP-tagged version of dozi (PBANKA_121770); line 909cl1 
(CITH::GFP; RMgm-358) [108] expressing a C-terminally GFP-tagged version of cith 
(PBANKA_130130); line HPE, a non-gametocyte producer clone [316]; line 820cl1m1cl1 (Fluo-
frmg; RMgm-164) [108] expressing RFP under the control of a female gametocyte specific 
promoter and GFP under the control of a male gametocyte specific promoter; line 259cl1 
(PbGFPcon; RMgm-5) expressing GFP under the control of the constitutive eef1a promoter; 
and line cl15cy1, which is the reference parental line of P. berghei ANKA [317]. Line Fluo-frmg 
contains the transgenes integrated into the silent 230p gene locus (PBANKA_030600) and does 
not contain a drug-selectable marker. 
 
Reverse Transcriptase-PCR (RT-PCR) 
Immunoprecipitation (IP) of DOZI::GFP and CITH::GFP parasite lysates, and 
subsequent RNA extraction and RT-PCR were performed as described [108]. To investigate the 
transcription pattern of limp by RT-PCR, RNA from different life cycle stages were obtained 
using TRIzol® Reagent (Ambion®, #15596). Reverse transcription was done with random 
primers and oligo-d(T) using SuperScript® II Reverse Transcriptase (Invitrogen™, #18064). 
RNA sample origins were as follows: asexual blood stages from line HPE; mixed blood stages 
(asexuals & gametocytes) and oocysts d12 post-infection (p.i.) from line Fluo-frmg; in vitro-
cultured ookinetes at different time points from line cl15cy1; midgut sporozoites d20 p.i. and 
salivary gland sporozoites d20 p.i. from line PbGFPcon; and exoerythrocytic forms from line 
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PbGFPcon at different time points after mouse infection. Primers used in RT-PCRs are shown 
in Table S1a. 
 
Generation of limp gene deletion mutants 
To disrupt the gene encoding limp (PBANKA_060580) we constructed a standard 
replacement construct [318] using plasmid pL0001 (www.mr4.com) which contains the 
pyrimethamine resistant Toxoplasma gondii (tg) dhfr/ts as a selectable marker cassette. See 
Table S2 and Figure S2A for the name and details of the construct. Target sequences for 
homologous recombination were PCR amplified from P. berghei wild-type (WT) genomic DNA 
using primers specific for the 5′ or 3′ flanking regions of limp (see Table S1b for the sequence of 
the different primers). The PCR–amplified target sequences were cloned in plasmid pL0001 
either upstream or downstream of the selectable marker to allow for integration of the construct 
into the genomic target sequence by homologous recombination. DNA construct used for 
transfection was obtained after digestion of the replacement construct with the appropriate 
restriction enzymes (Table S2). Transfection, selection and cloning of mutant parasite lines 
were performed as described [318]; see Table S2 for details of the transfection experiments 
performed. Correct deletion of the limp gene was confirmed by diagnostic PCR (for primers see 
Table S1c) and Southern analysis of Field-Inversion Gel Electrophoresis (FIGE)-separated 
chromosomes (Figure S2B).  Chromosomes were hybridized with a probe recognizing the 3' 
UTR of pbdhfr/ts. Absence of limp mRNA was determined by RT-PCR analysis (Figure S2C) 
using RNA collected from infected blood containing asexual blood stages and gametocytes (see 
Table S1c for primers used for RT-PCR). Two cloned lines were used for further phenotype 
analyses:  2091cl2m5 (Δlimp-a) and 2090cl2m6 (Δlimp-b), both in the Fluo-frmg background. 
 
Generation of transgenic line expressing GFP-tagged LIMP 
In situ C-terminal GFP tagging of limp was performed by single cross-over homologous 
recombination into the corresponding locus. See Table S2 and Figure S1A for the name and 
details of the construct. The construct contains the tgdhfr/ts selectable marker. Primers used to 
amplify the targeting region of limp, corresponding to the 3' end of the open reading frame 
(ORF) excluding the stop codon are listed in Table S1b. The targeting region was cloned in 
frame with gfp. Linearised plasmid was transfected into cl15cy1 parasites using standard 
methods. Transfection, selection and cloning of resulting mutant parasite line was performed as 
described [318], resulting in the transgenic line 2180cl1m4 (limp::gfp). See Table S2 for details 
of the transfection experiment performed. Correct integration of the construct was confirmed by 
diagnostic PCR (for primers see Table S1c) and Southern analysis of FIGE-separated 
chromosomes using a probe for the 3' UTR of pbdhfr/ts (Figure S1B). Transcription and 
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processing (splicing) of the gfp fusion was confirmed by RT-PCR using RNA from mixed blood 
stage forms (Figure S1C). Primers used for RT-PCR are listed in Table S1c. 
 
In vivo multiplication rate of asexual blood stages 
The multiplication rate of asexual blood stages in mice is determined during the cloning 
procedure of gene-deletion/transgenic parasites [319] and is calculated as follows: the 
percentage of infected erythrocytes in OF-1 mice injected with a single parasite is quantified at 
days 8–11 on Giemsa-stained blood films. The mean asexual multiplication rate per 24 h is then 
calculated assuming a total of 1.2×10
10
 erythrocytes per mouse and a blood volume of 2 mL. 
The percentage of infected erythrocytes in mice infected with reference lines of the P. berghei 
ANKA strain consistently ranges between 0.5 and 2% at day 8 after infection, resulting in a 
mean multiplication rate of 10 per 24 h [319, 320]. 
 
Analysis of Δlimp blood stage development 
Naïve BALB/c mice were infected intravenously (i.v.) with 10
4
 infected red blood cells 
(iRBCs) of either WT (Fluo-frmg) or Δlimp-a parasites. Total parasitaemia as well female and 
male gametocytaemias were determined daily by fluorescence-activated cell sorting (FACS). 
Total parasitaemia was determined using the vital DNA dye Vybrant
®
 DyeCycle™ Ruby stain 
(Molecular Probes
®
, #V10273). Given that both WT and Δlimp-a parasite lines express RFP in 
female gametocytes and GFP in male gametocytes, female gametocytaemias were calculated 
as RFP+ RBCs/total RBCs, while male gametocytaemias were calculated as GFP+ RBCs/total 
RBCs. 
 
Ookinete formation assays 
Ookinete formation assays were performed following published methods using 
gametocyte-enriched blood collected from mice treated with phenylhydrazine/NaCl [337]. 
Briefly, infected blood containing gametocytes was mixed in standard ookinete culture medium 
in 24-well plates and cultures were incubated for 18-24 h at 21-22 ºC. The ookinete conversion 
rate is defined as the percentage of female gametes that develop into mature ookinetes 
determined by counting female gametes and mature ookinetes in Giemsa-stained blood smears 
16-18 h after in vitro induction of gamete formation. 
 
Oocyst and sporozoite production 
Oocyst and sporozoite production of the mutant parasites was analysed by performing 
standard mosquito infections. Naïve female Balb/c ByJ mice were infected intraperitoneally (i.p.) 
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with 10
6
 infected red blood cells (iRBCs) of each line. On days 4-5 p.i., these mice were 
anesthetised and Anopheles stephensi female mosquitoes allowed to feed for 30 min. Twenty-
four hours after feeding, mosquitoes were anesthetised by cold shock and unfed mosquitoes 
were removed. Oocyst and sporozoite numbers were counted at days 12 and 20-21 after 
mosquito infection, respectively. Oocysts were counted after mercurochrome staining. 
Sporozoites were counted in pools of 4-10 mosquitoes. 
 
Transmission experiments 
To test the infectivity of sporozoites, 10 infected mosquitoes were allowed to feed for 30 
min on anesthetised naïve female Balb/c ByJ mice on days 20-22 p.i. Successful feeding was 
confirmed by the presence of blood in the abdomen of mosquitoes. Blood stage parasitaemia in 
these mice were followed up to 34 days post-bite. Transmission of Δlimp-a parasites was also 
assessed by injecting i.v. 3500 salivary gland sporozoites dissected at day 20 p.i. into naïve 
female Balb/c ByJ mice. Livers were extracted at 44 h p.i. and parasite load determined by 
quantitative real-time PCR (qPCR) using specific primers for P. berghei ANKA 18S rRNA gene. 
Mouse hypoxanthine-guanine phosphoribosyltransferase (HPRT) was used as host tissue 
control gene. Primers used for qPCR are listed in Table S1a. Absolute number of mRNA copies 
was determined for each gene using standard curves. Blood stage parasitaemias in littermate 
mice were followed up to 34 days post-bite. Similar experiments were performed with WT (Fluo-
frmg) for comparison purposes. 
 
In vitro sporozoite gliding motility assays 
WT (Fluo-frmg or cl15cy1), Δlimp-a and limp::gfp salivary gland sporozoites were 
dissected at days 20-21 p.i. and their gliding motility assessed in a standard gliding assay [351]. 
Briefly, glass coverslips were coated overnight at room temperature (RT) with a 10 µg/mL 
suspension of 3D11 mouse anti-P. berghei circumsporozoite protein (CSP) monoclonal 
antibody [321]. On the following day, 10000-20000 salivary gland sporozoites of each line were 
loaded per coverslips and incubated for 1 h at 37 ºC, 5% CO2, in the presence of 10% FBS. In 
the case of limp::gfp, sporozoites were also pre-incubated for 1 h on ice in the presence of 
rabbit polyclonal anti-GFP (Abcam
®
, #ab6556; 10 µg/mL) or control rabbit IgGs (Abcam
®
, 
#ab37415; 10 µg/mL) to evaluate possible gliding blockade. Sporozoites were then fixed with 
4% PFA/PBS and an anti-PbCSP immunofluorescence assay (IFA) was performed to detect 
CSP trails (see below for IFA details). Coverslips were analysed in a Leica DM5000B 
fluorescence microscope. Each sporozoite was categorised according to the number of trails it 
formed. Percentages of sporozoites in each category for each line were calculated as the ratio 
between the number of sporozoites in each category and the total number of sporozoites 
analysed. Live motility of WT (Fluo-frmg) and limp::gfp parasites was assessed by imaging 
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dissected salivary gland sporozoites in a Nunc™ MicroWell™ 96-well plate with optical bottom 
(Thermo Scientific™) as described before [352, 353], using an inverted Zeiss Axiovert 200M 
widefield microscope with an XBO75 xenon lamp, the AxioVision 4.7.2 software, a 25X 
objective (LCI Plan-NEOFLUAR ImmKorr NA 0.8, water) (all Zeiss) and a CoolSNAP™ HQ
2
 
high resolution CCD camera (Photometrics). Bright field images were acquired every 3 seconds 
for 5 minutes (101 frames per movie). Sporozoite speed was assessed using the manual 
tracking plug-in of ImageJ 1.44o software (imagej.nih.gov/ij). The imaged sporozoites were 
clustered into three different categories according to [353]: ‘moving’ sporozoites (consistently 
gliding with a speed of at least 0.2 μm/s over a minimum of 150 seconds); ‘partially moving’ 
sporozoites (displaying circular gliding motility, but failing to meet the ‘moving’ requirements); 
and ‘attached/waving’ sporozoites (not showing any circular gliding but attached at either one or 
both ends). 
 
In vitro sporozoite traversal, adhesion and invasion assays 
WT (Fluo-frmg or cl15cy1), Δlimp-a, Δlimp-b and limp::gfp salivary gland sporozoites 
were dissected at day 21 p.i. To test the parasite capacity to traverse human hepatoma cells in 
vitro, 5000 salivary gland sporozoites of the different parasite lines were loaded, in the presence 
of 0.5 mg/mL of Dextran, Tetramethylrhodamine (Molecular Probes
®
, #D1817), onto 110000 
Huh7 cells plated 16-20 h before in 24 well-plates and incubated for 2 h at 37 ºC, 5% CO2. 
Equivalent amounts of non-infected mosquito salivary gland debris were also loaded onto the 
same number of cells to serve as negative control. Cells were then washed, trypsinised and 
analysed in a BD Biosciences
®
 FACSCalibur flow cytometer. Percentage of traversal was 
quantified as the ratio of Dextran positive cells per live cells. To test the parasite capacity to 
adhere to and invade human hepatoma cells in vitro, 5000 WT (Fluo-frmg or cl15cy1), Δlimp-a, 
Δlimp-b or limp::gfp salivary gland sporozoites were loaded onto 25000 Huh7 cells plated 16-20 
h before in black-walled 96 well-plates and incubated for 2 h at 37 ºC, 5% CO2. In the case of 
limp::gfp, sporozoites were also pre-incubated for 1 h on ice in the presence of rabbit polyclonal 
anti-GFP (Abcam
®
, #ab6556; 10 µg/mL) or control rabbit IgGs (Abcam
®
, #ab37415; 10 µg/mL) 
to evaluate possible invasion blockade. Cells were then fixed with 4% PFA/PBS and a dual 
colour anti-PbCSP IFA was performed to distinguish between sporozoites that invaded from 
those that didn´t, following adapted published methods [354]. Briefly, external sporozoites were 
detected before cell permeabilisation using a 10 µg/mL suspension of 3D11 mouse anti-PbCSP 
[321] followed by goat anti-mouse IgG-Cy™3 (Jackson ImmunoResearch Laboratories, Inc., 
#115-166-003; 1:500). Cells were then permeabilised with 0.1% TritonX-100/PBS and total 
sporozoites detected by a second incubation with the same 3D11 mouse anti-PbCSP dilution 
followed by goat anti-mouse IgG-Alexa Fluor
®
488 (Jackson ImmunoResearch Laboratories, 
Inc., #115-546-006; 1:500). Cells were imaged under a Zeiss Axiovert 200M fluorescence 
112 
 
microscope. Adhesion was quantified as the ratio of imaged sporozoites per number of Huh7 
cells in the same optical fields. 
 
In vitro exoerythrocytic form (EEF) development assays 
WT (Fluo-frmg or cl15cy1), Δlimp-a, Δlimp-b and limp::gfp salivary gland sporozoites 
were dissected at day 21 p.i. and tested for their ability to transform into EEFs inside Huh7 cells 
in culture. 5000 salivary gland sporozoites of the different parasite lines were loaded onto 10000 
Huh7 cells plated 16-20 h before in black-walled 96 well-plates and incubated for 45 h at 37 ºC, 
5% CO2. Cells were then fixed with 4% PFA/PBS and an IFA performed to detect parasite 
HSP70 and UIS4 (see below for IFA details). The area of cl15cy1 and limp::gfp EEFs were 
calculated based on HSP70 staining using ImageJ 1.47n software (imagej.nih.gov/ij). 
 
Live imaging and IFAs of blood stages, ookinetes, oocysts and sporozoites 
Live imaging of transgenic limp::gfp parasites was done by retrieving ookinetes from 
mosquito blood meals at 16 h p.i. as well as dissecting infected mosquito midguts at days 13 
and 21 p.i. To detect LIMP::GFP expression by IFA in blood stages, as well as in midgut and 
salivary gland sporozoites, mouse RBCs infected with limp::gfp parasites or dissected midgut 
and salivary gland sporozoites were stained with rabbit polyclonal anti-GFP (Abcam
®
, #ab6556; 
1:500) or mouse monoclonal anti-GFP (Abcam
®
, #ab1218; 1:250) as primary antibody. As 
secondary antibody, goat anti-rabbit IgG-Alexa Fluor
®
488 (Jackson ImmunoResearch 
Laboratories, Inc., #111-545-003; 1:500) or goat anti-mouse IgG-Alexa Fluor
®
488 (Jackson 
ImmunoResearch Laboratories, Inc., #115-546-006; 1:500) was used. IFAs to detect CSP or 
TRAP in limp::gfp salivary gland sporozoites were done using 3D11 mouse anti-PbCSP [321] 
(10 µg/mL) or rabbit polyclonal anti-PbTRAP repeats antiserum [260] (1:100) as primary 
antibodies and goat anti-mouse IgG-Cy™3 (Jackson ImmunoResearch Laboratories, Inc., 
#115-166-003; 1:500) or goat anti-rabbit IgG-Alexa Fluor
®
594 (Jackson ImmunoResearch 
Laboratories, Inc., #111-586-047; 1:500) as secondary antibodies, respectively. IFAs to detect 
HSP70 and UIS4 in in vitro-developed EEFs were done using parasite-specific 2E6 mouse 
monoclonal anti-PbHSP70 [322] at 18.75 µg/mL and polyclonal goat anti-PbUIS4 (SICGEN, 
#AB0042; 2 µg/mL), respectively, followed by donkey anti-mouse IgG-DyLight
®
549 (Jackson 
ImmunoResearch Laboratories, Inc., #745-506-150; 1:500) and donkey anti-goat IgG-Alexa 
Fluor
®
488 (Jackson ImmunoResearch Laboratories, Inc., #705-546-147; 1:500). In all IFAs, 
samples were fixed with 4% PFA/PBS for 10 min at RT, permeabilised with 0.1% TritonX-
100/PBS (or cold absolute methanol in the case of anti-TRAP IFA [260]) and blocked for 1h at 
RT with 1-3% BSA/PBS. All antibody incubations were done in blocking solution for 1h at RT 
and 1-5 ug/mL of Hoechst-33342/PBS was used to stain nuclei. All images were taken with a 
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Leica DM5000B or Zeiss Axiovert 200M fluorescence microscope and processed using ImageJ 
1.47n software (imagej.nih.gov/ij). 
 
Transmission electron microscopy (TEM) and immuno-gold electron microscopy 
(EM) of sporozoites 
Infected mosquito midguts and salivary glands were dissected on days 20-27 p.i and 
fixed for 3 h at 4 ºC in 0.1 M cacodylate buffer, pH 7.4, containing 2.5% (v/v) glutaraldehyde. 
Following 1 h of post-fixation with 1% (w/v) osmium tetroxide and 30 min of staining in 1% (w/v) 
uranyl acetate, samples were dehydrated in ethanol gradient (70-95-100%), transferred to 
propylene oxide and embedded in EPON™ resin. Semi-thin sections (300-400 nm) were 
stained with toluidine blue for light microscope evaluation. Ultra-thin sections (70 nm) were 
collected in copper slot grids and then stained with 2% uranyl acetate and lead citrate 
(Reynolds recipe). For immuno-gold EM, ultra-thin sections (70 nm) collected in Nickel 150 
mesh grids were blocked for 30 min at RT with 0.8% BSA, 0.1% cold water fish skin gelatine, 
and incubated overnight at 4 ºC with rabbit polyclonal anti-GFP (Abcam
®
, #ab6556; 1:50). After 
a new blocking step of 15 min at RT, sections were incubated for 1 h at RT with Protein A 
conjugated to 15 nm gold particles (obtained from Cell Microscopy Center, University Medical 
Center Utrecht, The Netherlands; 1:50). Sections were finally stained with 2% uranyl acetate 
and lead citrate (Reynolds recipe). Antibody and Protein A incubations were done in blocking 
solution. All grids were examined in a Hitachi H-7650 transmission electron microscope at 
100kV acceleration. 
 
Multiple sequence alignments 
Protein sequences in Figure 1B were retrieved from PlasmoDB (plasmodb.org). Clustal 
W alignments were done at EMBnet server (embnet.vital-it.ch/software/ClustalW.html) and 
shaded according to protein similarity levels with BOXSHADE 3.21 
(www.ch.embnet.org/software/BOX_form.html). 
 
Statistical methods 
Statistical analyses were performed using Prism software package 5 (GraphPad 
Software). 
 
 
 
 
114 
 
Figure 1 – Gene and protein structure of limp. 
(A) The P. berghei limp gene (1194 bp) is composed of 6 exons (shaded bars) and 5 introns (lines); 
this organisation is conserved in all other Plasmodium species. (B) Protein alignment of LIMP 
orthologs from 8 different Plasmodium species and strains. “+” indicates the extent of the signal 
peptide in P. berghei. (C) Secondary structure prediction of P. berghei LIMP according to NPS@ 
(npsa-pbil.ibcp.fr). c: random coil; h: alpha helix; e: extended strand. 
RESULTS 
limp is translationally repressed in P. berghei gametocytes and translated during 
ookinete development 
Recent studies on DOZI and CITH gene deletion mutants identified more than 100 
known and putative surface proteins to be under the translational control during transmission of 
P. berghei gametocytes from the rodent to the mosquito host [107, 108]. One of these proteins, 
PBANKA_060580 (LIMP) is conserved among Plasmodium species but lacks homologs outside 
the genus. BlastP and tblastn searches (www.ncbi.nlm.nih.gov) failed to identify T. gondii or any 
other apicomplexan Expressed Sequence Tags (ESTs) with homology to Plasmodium limp. An 
identical search at ToxoDB (www.toxodb.org) that included Toxoplasma, Eimeria, Gregarina 
and Neospora was also negative. A secondary structure prediction [355] indicated that the 
protein consists of an N-terminal signal peptide, a coil domain and a C-terminal alpha-helical 
domain. LIMP is encoded on an 1194 base pair-long gene in the P. berghei ANKA genome with 
syntenic orthologs in the human parasites P. falciparum and P. vivax. The gene comprises 6 
exons and 5 introns and encodes a protein of 110 amino acids with a predicted molecular 
weight of approximately 13 kDa, including a 22 amino acid-long signal peptide (Figure 1). 
 
limp mRNA was found downregulated in Δdozi parasites, suggesting that it might be 
transcribed preferentially in female gametocytes but kept translationally repressed until 
activated during ookinete development [107]. IP of DOZI::GFP- and CITH::GFP-expressing 
parasite lines [107, 108] clearly demonstrated that limp mRNA, like p25 and p28, is bound 
directly or indirectly by DOZI and CITH (Figure 2A). Control transcripts known to be translated 
(dozi, cith and alba-3) did not co-immunoprecipitate with DOZI or CITH. 
115 
 
Figure 2 – limp is translationally 
repressed in gametocytes and expressed 
in ookinetes. 
(A) RT-PCR analysis on DOZI::GFP and 
CITH::GFP gametocyte immunoprecipitation 
(IP) eluates shows that limp as well as p25 
and p28 mRNAs (known to be translationally 
repressed) co-precipitate with DOZI and 
CITH. dozi, cith and alba-3 are translated in 
gametocytes and are not enriched in the IP-
GFP fractions. Input: total gametocyte 
mRNA; IP-GFP: IP with anti-GFP antibody; 
IP-c-myc: IP with anti-c-myc antibody; IP 
beads: no antibody used for IP. (B) RT-PCR 
analysis shows absence of WT limp and 
presence of correctly spliced limp::gfp 
mRNA in blood stages of limp::gfp parasites. 
p28 serves as control gene. (C) 
Immunofluorescence of limp::gfp blood 
stages shows no LIMP expression in 
gametocytes while live imaging of blood 
meal-retrieved ookinetes shows LIMP::GFP 
localisation (in green) in discrete foci. Scale 
bar = 5 µm. 
To confirm unequivocally that limp is translationally repressed in female gametocytes 
but activated during ookinete formation, we GFP-tagged LIMP at the C-terminus leaving the 
gene under the control of its 
endogenous transcriptional promoter 
(Figure S1). In this mutant parasite line, 
blood stage parasites only transcribe 
the tagged limp mRNA (Figure 2B and 
S1C). An IFA confirmed that, as 
expected, LIMP::GFP is not expressed 
in asexual stage parasites (not shown) 
or gametocytes (Figure 2C). limp is 
only translated in the ookinete stage 
and its expression is clearly visible in 
discrete foci resembling crystalloid 
bodies (CBs) (Figure 2C). 
 
limp gene deletion mutants suffer cumulative population loss during mosquito 
passage 
In order to understand the function of LIMP for early mosquito stage development we 
generated two independent knock-out (KO) mutant lines, Δlimp-a and Δlimp-b, in the reference 
line Fluo-frmg [108] by deleting the entire limp ORF (Figure S2). These parasites showed 
normal asexual blood stage development over time as well as gametocyte numbers and 
female/male ratios (Figure S3 and Table S3). The capacity of Δlimp parasites to develop into 
ookinetes was comparable to that of WT lines, as determined by in vitro ookinete conversion 
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Figure 3 – Δlimp parasites suffer 
cumulative population loss during 
mosquito passage. 
(A) Ookinete (Ook) conversion rates of both 
Δlimp-a and Δlimp-b parasites fall within the 
expected range for a WT parasite line (50-
90%, dashed horizontal lines). Mean values 
are shown by the bars, while dots represent 
individual conversion rates. Δlimp-a and 
Δlimp-b (4 independent experiments, n=8). 
(B) Δlimp-a parasites show reduced 
numbers of oocysts per mosquito midgut on 
day 12 p.i. WT (4 independent experiments, 
n=48); Δlimp-a (6 independent experiments, 
n=46). (C) Sporozoite development is 
unaffected in Δlimp-a parasites, as seen by 
the similar number of midgut sporozoites 
(MG Spz) per oocyst in WT and Δlimp-a 
lines. WT (3 independent experiments, 
n=13); Δlimp-a (5 independent experiments, 
n=9). (D) Sporozoite (Spz) release to the 
mosquito hemolymph is comparable 
between WT and Δlimp-a parasites. WT (3 
independent experiments, n=11); Δlimp-a (4 
independent experiments, n=8). (E-F) Δlimp-
a sporozoites are severely impaired in 
salivary gland invasion, as seen by the 
lower number of salivary gland sporozoites 
(SG Spz) per mosquito (E) and per oocyst 
(F) in the KO line. WT (4 independent 
experiments, n=14); Δlimp-a (6 independent 
experiments, n=10). (B-F) Mean and SEM 
values are shown by the lines; p-values for 
Mann-Whitney test are shown above the 
data sets. 
rates ranging from 55 to 91% (Figure 3A). KO ookinetes showed normal WT morphology, 
including the presence of haemozoin clusters suggesting correctly formed CBs (Figure S4) 
[215, 216]. When we characterised Δlimp parasites during mosquito passage we consistently 
found lower oocyst numbers per mosquito when compared to its genetic background WT line 
(Figure 3B); on average, KO parasites developed 52% less oocysts than its WT counterpart. 
Still, the number of oocyst-derived sporozoites (midgut sporozoites) per oocyst was not 
significantly changed in KO-infected 
mosquitoes (Figure 3C), showing that 
development and sporulation 
proceeded normally in the absence of 
LIMP once oocysts had been 
established. Rather, Δlimp sporozoites 
showed a tendency to accumulate in 
the hemolymph (Figure 3D), a feature 
that was accompanied by an almost 
complete failure to invade the salivary 
glands. The number of salivary gland-resident sporozoites per mosquito was reduced 10-fold 
(Figure 3E). A striking reduction was still evident when numbers of salivary gland sporozoites 
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Figure 4 – limp mRNA and protein expression 
profiles. 
(A) RT-PCR of limp along the parasite life cycle. 
Asexual: asexual blood stages; mixed: asexuals and 
gametocytes; ook: ookinetes (8 and 16 hours after 
gametocyte activation); MG spz: midgut sporozoites; 
SG spz: salivary gland sporozoites. 18S rRNA and 
hsp70 serve as loading control genes. +: RT positive 
reaction; -: RT negative reaction. (B) Live imaging of 
limp::gfp oocysts at days 13 and 21 p.i. (upper panel) 
shows LIMP expression (in green) in sporulating 
oocysts. Immunofluorescence assay of limp::gfp 
parasites (lower panel) shows LIMP expression (in 
green) in both midgut sporozoites (MG Spz) at day 24 
p.i. and salivary gland sporozoites (SG Spz) at day 21 
p.i. DNA was stained with Hoechst-33342 (in blue). 
Scale bars = 20 µm (oocysts) or 5 µm (sporozoites). 
were normalised by the number of pre-existing oocysts (Figure 3F). Overall, these results 
clearly suggested a defect in salivary gland invasion by Δlimp parasites but no effect of LIMP 
depletion on sporogony.  
The sporozoite stage phenotype is in 
agreement with the expression profile found for 
limp mRNA. While high in gametocytes, 
transcription of the gene is reduced in mature 
ookinetes, but activated again during sporogony 
where it persists at least until day 20 post-
infection (p.i.) in salivary gland sporozoites 
(Figure 4A). limp transcripts could not be 
detected in liver stage parasites (Figure S5).  
This transcription profile correlated with 
LIMP::GFP expression across the parasite’s life 
cycle; apart from expression in ookinetes protein 
was also detected in sporulating oocysts, as well 
as midgut and salivary gland sporozoites (Figure 
4B). 
In light of the invasion defect observed 
for Δlimp sporozoites, we tested whether this 
was mosquito-specific or also extended to 
invasion of the mammalian host. To this end 
naïve mice were infected by two different routes 
with WT- or KO-infected mosquitoes: (i) 
mosquito bite (Figure 5A) or (ii) i.v. injection of dissected sporozoites (Figure 5B). In both 
cases, WT-infected mice developed normal blood stage parasitemia while KO-infected mice 
never showed parasites in the blood. Moreover, mice injected i.v. with Δlimp salivary gland 
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Figure 5 – Δlimp parasites do not transmit to 
naïve mice. 
(A) Mice bitten by Δlimp-a- or Δlimp-b-infected 
mosquitoes do not develop blood stage infection. 
Mean parasitaemias are shown by the dots, while 
SEM values are shown by the vertical lines. WT 
and Δlimp-a (3 independent experiments, n=3); 
Δlimp-b (1 experiment, n=1). (B) Mice injected i.v. 
with Δlimp-a salivary gland sporozoites also do not 
develop blood stage infection. Mean parasitaemias 
are shown by the dots, while SEM values are 
shown by the vertical lines. WT and Δlimp-a (3 
independent experiments, n=4). (A-B) iRBCs: 
infected red blood cells; tRBCs: total red blood 
cells. (C) Mice injected i.v. with Δlimp-a salivary 
gland sporozoites do not present any parasite load 
in the liver. Mean log10 18S/HPRT absolute copy 
ratio from 2 technical replicates for each mouse is 
represented by the dots. Overall mean and SEM 
values are shown by the lines; p-value for Mann-
Whitney test is shown above the data sets. Note 
that the number of 18S copies per copy of HPRT in 
all Δlimp-a-infected mice was estimated as being 
below 1 (dashed line), meaning that Δlimp-a 
parasites do not establish a successful liver 
infection. 
sporozoites showed no parasite load in the liver at 44 hours p.i. as determined by qPCR of the 
P. berghei ANKA 18S gene (Figure 5C), suggesting an inability of KO parasites to invade and 
establish an infection inside hepatocytes.  
 
Δlimp parasites are impaired in 
hepatocyte transmigration, adhesion and 
invasion and do not develop into 
exoerythrocytic forms 
Corroborating in vivo data, Δlimp 
salivary gland sporozoites were unable to 
develop into EEFs inside Huh7 human 
hepatoma cells in vitro (Figure 6A), 
suggesting either an invasion or 
developmental defect. When we assessed 
hepatocyte invasion at 2 hours p.i. we 
observed that Δlimp parasites are strongly impaired in their capacity to invade Huh7 cells in 
vitro (Figure 6B), explaining the complete absence of Δlimp EEFs at 45 hours p.i. mentioned 
above. Moreover, KO sporozoites showed a complete inability to traverse cells as determined 
by FACS analysis; it is not different from background levels obtained from cells incubated with 
non-infected mosquito salivary gland material (Figure 6C). In addition, Δlimp sporozoites also 
showed reduced adhesion to Huh7 cells in culture (Figure 6D). 
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Figure 6 – Δlimp parasites are severely impaired in establishing liver infection in vitro. 
(A) Δlimp parasites do not form any exoerythrocytic form (EEF) in vitro. Mean numbers of EEFs per 
well are shown by the bars, while dots represent individual data points; p-values for Mann-Whitney 
test are shown above the data sets. WT (1 experiment, n=3); Δlimp-a (4 independent experiments, 
n=10); Δlimp-b (2 independent experiments, n=6). (B) Δlimp parasites are impaired in their 
hepatocyte invasion capacity. WT (4 independent experiments; n = 12; 1292 sporozoites analysed); 
Δlimp-a (5 independent experiments; n = 12; 806 sporozoites analysed); Δlimp-b (2 independent 
experiments; n = 6; 381 sporozoites analysed). (C) Δlimp parasites are impaired in their hepatocyte 
traversal capacity. NISG: cells incubated with non-infected salivary gland material. WT (4 
independent experiments, n=12); Δlimp-a (5 independent experiments, n=10); Δlimp-b (2 
independent experiments, n=6). Dx+ cells: Dextran, Tetramethylrhodamine positive cells. (D) Δlimp 
sporozoites (Spz) are impaired in their cell adhesion capacity. WT (3 independent experiments, 
n=6); Δlimp-a (3 independent experiments, n=8); Δlimp-b (2 independent experiments, n=6). (B-D) 
Mean values are shown by the bars, while SEM values are shown by the vertical lines; p-values for 
Student´s t-test are shown above the bars. 
limp::gfp sporozoites on the other hand were not affected in their host cell traversal 
capability (Figure S6A) and transformed (Figure S6B) and developed (Figure S6C) normally 
into EEFs with WT morphology and clear expression of cytoplasmic heat shock protein 70 
(HSP70) and UIS4 (in the parasitophorous vacuole membrane) (Figure S6D). Concordantly, 
mice bitten by limp::gfp-infected mosquitoes developed blood stage parasitaemia with the same 
prepatent period as WT-infected animals (Figure S6E). 
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Figure 7 – Δlimp parasites are greatly impaired in gliding motility but do not show altered 
cellular ultrastructure. 
(A) Both Δlimp-a and Δlimp-b parasites show significantly reduced gliding motility. Mean percentages of 
sporozoites within each gliding category are shown by the bars, while SEM values are shown by the 
vertical lines; p-value for Kruskal-Wallis test is shown above the bars. WT (4 independent experiments; 
n= 7; 820 sporozoites analysed); Δlimp-a (4 independent experiments; n= 4; 477 sporozoites analysed); 
Δlimp-b (1 experiment; n= 3; 299 sporozoites analysed). (B) Representative images of WT and Δlimp-a 
gliding trails. Scale bars = 10 µm. (C) Detailed cellular ultrastructure of Δlimp-a sporozoites is not 
altered when compared to WT parasites. 1: plasma membrane; 2: inner membrane complex; 3: 
subpellicular microtubules; 4: rhoptries; 5: micronemes. Scale bars = 200 nm. 
Δlimp parasites are severely impaired in gliding motility 
Escape from the blood meal and traversal of the mosquito midgut epithelium by the 
ookinete and invasion of salivary glands by the sporozoite, as well as escape from the host’s 
skin and traversal/invasion of liver cells require gliding motility. The reduced numbers of oocysts 
and near absence of salivary gland sporozoites in the Δlimp strain suggested that LIMP could 
be involved in gliding motility. Therefore, we performed a standard gliding motility assay to 
detect CSP trails deposited on microscope slides by moving sporozoites. KO parasites were 
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severely impaired in gliding motility, evident both by the large number of completely immotile 
parasites as well as the number and length of gliding trails of the few moving parasites (Figures 
7A and B). 
Morphologically, KO parasites appeared normal. TEM studies of Δlimp sporozoites 
revealed no ultrastructural defects. The arrangement of the plasma membrane (PM), inner 
membrane complex (IMC), subpellicular microtubules as well as micronemes and rhoptries (the 
organelles involved in protein secretion during parasite motility and invasion [252, 254, 356]) 
appeared not different from WT parasites (Figure 7C). 
 
LIMP::GFP localisation and motility and invasion by limp::gfp parasites 
In ookinetes, LIMP::GFP localised to CBs (Figure 2C). When we performed IFAs on 
sporozoites from midguts and salivary glands from the same mutant line, fluorescence was 
found in a speckle-like distribution throughout the entire length of the parasite (Figure 4B), most 
likely on or at the cell surface as indicated by staining in the absence of permeabilisation. 
LIMP::GFP did not co-localise with CSP or the micronemal protein TRAP in these assays 
(Figure 8A). 
Consistent with such a surface localisation we found LIMP::GFP to be predominantly 
localised to the parasite PM in an immuno-EM approach using anti-GFP antibody and gold-
conjugated Protein A (Figure 8B). In three independent staining experiments done with three 
different samples, an average of 75.4% of gold particles (from a total of 281 particles) were 
associated with the parasite PM, 11.4% were observed outside of the parasites and 13.2% 
intracellularly though not associated with any specific organelle. In limp::gfp negative control 
preparations where incubation with primary antibody was omitted or in an additional negative 
control where WT parasites (these do not express GFP in sporozoites) were incubated with 
both primary antibody and Protein A-gold, gold particles were few and didn’t show any 
preferential localisation (Table S4). 
Given the surface localisation of LIMP::GFP, we explored the possibility that the protein 
might be secreted or shed from the parasite surface during gliding. We therefore performed a 
gliding assay with limp::gfp salivary gland sporozoites by coating the parasite substrate with the 
same commercial anti-GFP antibody as used for sporozoite IFAs and immuno-EM. No gliding 
trails were detected in this assay, suggesting that the GFP-tagged protein is not shed from the 
parasite surface or is shed at levels below the detection limit of this assay. limp::gfp salivary 
gland sporozoites produced normal numbers and shapes of CSP gliding trails. Moreover, the 
presence of high concentrations of either anti-GFP antibodies or unspecific control 
immunoglobulins (IgGs) did not affect the overall gliding nor CSP shedding in these parasites 
(Figures 9A and B). Similarly, in vitro hepatocyte invasion by limp::gfp sporozoites was 
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Figure 8 – LIMP::GFP 
is localised to the 
parasite plasma 
membrane. 
(A) 
Immunofluorescence 
assays of day 21 p.i. 
limp::gfp salivary gland 
sporozoites with the 
surface marker CSP 
and the 
surface/microneme 
marker TRAP (in red) 
pinpoints to a LIMP 
surface localisation (in 
green), as suggested 
by the detection of 
LIMP::GFP in the 
absence of cell 
permeabilisation. DNA 
was stained with 
Hoechst-33342 (in 
blue). Scale bars = 5 
µm. (B) Immuno-
electron microscopy of 
longitudinal and 
transversal limp::gfp 
salivary gland 
sporozoite sections 
with anti-GFP 
antibodies identifies 
LIMP::GFP (black, 
circular dots) at the 
parasite plasma 
membrane. Scale bars 
= 200 nm. 
comparable to WT parasites and was also not affected by the presence of anti-GFP or control 
antibodies (Figure 9C). 
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While CSP trail-based motility analyses did not highlight significant differences between 
WT and limp::gfp parasites, live motility assays of limp::gfp sporozoites revealed a peculiar 
feature. Compared to the WT line the number of moving parasites was identical (Figure 10A); 
the velocity of these parasites was however reduced by more than 20% (Figure 10B). 
Maximum projections of gliding paths highlighted higher number of parasites with irregular trails 
and wider circumferences instead of tight concentric rings typical for WT parasites (Figure 
10C). While WT parasites continuously move in a circular fashion following their crescent cell 
shape, limp::gfp sporozoites moved with a limp, hence the gene designation limp: the 
movement of limp::gfp parasites is characterised by an accentuated frequency of cell stretching 
events (Figures 10D and E), which result in a transient increase of sporozoite front-to-rear end 
distance termed a limp (Figure 10F). While more than 50% of WT sporozoites did not exhibit a 
limp during 100 seconds of gliding, 50% of limp::gfp sporozoites limped at least four times 
during the same period. This suggests that a functional impairment of LIMP through GFP leads 
to a deficit in detachment at the rear end of the parasite. 
 
DISCUSSION 
Here we have identified a novel and unique Plasmodium protein with a function in the 
transition from the ookinete to the oocyst and salivary gland sporozoite gliding motility, cell 
traversal, adhesion and invasion. 
limp was readily deleted, leaving blood stage parasitaemia and gametocytaemias 
unaffected while being detrimental to mosquito and liver infection. limp mRNA is under 
translational control in female gametocytes and de-repressed in the ookinete, where it seems to 
play a role in mosquito midgut invasion and/or efficient oocyst development. The gene is 
transcriptionally activated a second time during sporozoite formation to promote salivary gland 
and hepatocyte invasion processes. Parasite mutants that lack LIMP are deficient in salivary 
gland invasion and are completely incapable of establishing an infection in hepatocytes, both in 
vitro and in vivo. This ‘waving’ expression pattern translates into successive steps where the 
absence of LIMP results in significant parasite population losses. 
LIMP has not been detected in any proteomics study published so far in P. berghei, P. 
yoelii (rodent malaria species), P. falciparum, P. vivax (human malaria species) or even P. 
gallinaceum (avian malaria species), covering the entire parasite life cycle (PlasmoDB version 
11.1 and [49, 323-326]). It was also not detected in a recent study on translational de-
repression in the ookinete where proteins translated de novo during ookinete development were 
assessed by mass-spectrometry [134]. However, we clearly demonstrate that limp is subjected 
to translational repression (TR) in P. berghei gametocytes and translated in mature ookinetes. 
In our limp::gfp parasite line the endogenous 3' untranslated region (UTR) of limp had been 
substituted with that of P. berghei dihydrofolate reductase/thymidylate synthase (dhfr/ts), known 
to lack TR-targeting motifs [132]. This however did not lead to precocious mRNA translation in 
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Figure 9 – limp::gfp parasites present 
productive gliding and invasion. 
(A) limp::gfp salivary gland sporozoites 
produce normal numbers of CSP gliding 
trails and motility is not affected by the 
presence of anti-GFP antibodies. Mean 
percentages of sporozoites within each 
gliding category are shown by the bars, 
while SEM values are shown by the vertical 
lines. WT (1 experiment; n = 3; 280 
sporozoites analysed); limp::gfp with no 
antibody (Ab) (2 independent experiments; 
n = 5; 492 sporozoites analysed); limp::gfp 
+ anti(α)-GFP (1 experiment; n = 3; 197 
sporozoites analysed); limp::gfp + IgGs  (1 
experiment; n = 3; 234 sporozoites 
analysed). (B) Representative images of 
WT and limp::gfp (no antibody) gliding 
trails. Scale bars = 10 µm. (C) limp::gfp 
salivary gland sporozoites invade 
hepatocytes at WT levels and host cell 
invasion is not affected by the presence of 
anti-GFP antibodies. Mean percentages of 
invading (IN) and non-invading (OUT) 
parasites are shown by the bars, while SEM 
values are shown by the vertical lines. Data 
is from 1 experiment (n = 3) for all parasite 
lines and conditions. Numbers of 
sporozoites analysed: WT = 346, limp::gfp 
with no antibody (Ab) = 763, limp::gfp + 
anti(α)-GFP = 807, limp::gfp + IgGs = 742. 
(A,C) p-values for Kruskal-Wallis test are 
shown above the bars. 
gametocytes, indicating that TR of limp is mechanistically similar to p25, which is dependent on 
RNA motifs located within its 5' UTR [132]. 
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Several translationally repressed genes are known to be necessary for normal ookinete 
development and consequently to the establishment of oocysts in the mosquito midgut basal 
lamina. This is the case, for example, of the ookinete surface antigens p25 and p28 [137] and 
the ookinete-specific transcription factor ap2-o [71]. On the other hand, ookinete invasion-
related genes have been shown to be transcribed de novo after fertilisation [357], including 
SOAP [255] and CTRP [272, 273]. It is thought that the transcriptional activation of such genes 
is mediated by AP2-O [71]. Interestingly, the absence of limp did not lead to reduced numbers 
of ookinetes or ookinetes with abnormal morphology. Instead, a reduction in oocyst numbers to 
half of WT levels was observed which, in light of the phenotype of Δlimp sporozoites, is most 
likely explained by a midgut invasion defect. 
The localisation of LIMP in ookinetes is consistent with CB localization, as observed for 
proteins of the LCCL (LAP, CCp) protein family [208, 211, 212]. Curiously, the LCCL protein 
family members LAP4, LAP5 and LAP6 have been shown to be translationally repressed in 
gametocytes [208]. Regardless of being translationally repressed or not, all CB-associated 
proteins that have been functionally analysed so far are solely necessary for oocyst sporulation. 
This makes LIMP the first Plasmodium CB protein with a function other than formation of 
oocyst-derived sporozoites. 
Furthermore, Δlimp sporozoites are severely impaired in their gliding motility and 
invasion capacities. Both ookinetes and sporozoites present numerous micronemes 
concentrated in the apical end of the cell that are responsible for protein secretion during both 
motility and invasion processes [204, 256], as well as subpellicular microtubules that aid in 
microneme mobilisation and secretion [358, 359]. When we investigated these subcellular 
structures by TEM we could not find any differences between Δlimp and WT parasites that 
could explain the phenotype of Δlimp parasites. Thus, the absence of LIMP seems not to affect 
subcellular structures involved in gliding motility and invasion such as the IMC, the subpellicular 
microtubules, rhoptries or micronemes. 
In situ tagging of LIMP with GFP identified the protein at the sporozoite PM. We cannot 
however assert that LIMP is completely absent from other subcellular compartments, 
specifically the cytosol, as sample processing methodologies employed here could lead to 
cytosolic protein extraction. Nonetheless, in light of LIMP’s mode of action and the phenotypes 
of Δlimp parasites, the PM is the most plausible location for this protein. 
126 
 
Figure 10 (legend next page) – limp::gfp salivary gland sporozoites glide 
with a limp. 
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Figure 10 (previous page) – limp::gfp salivary gland sporozoites glide with a limp. 
(A) Percentage of moving limp::gfp sporozoites is comparable to WT parasites. WT (260 sporozoites 
analysed); limp::gfp (228 sporozoites analysed). (B) ‘Moving’ limp::gfp salivary gland sporozoites show 
significantly reduced gliding speed. Mean values are shown by the bars, while SEM values are shown by 
the vertical lines; p-value for Student´s t-test is shown above the bars. WT and limp::gfp (n=23). (C) 
Maximum projections of WT and limp::gfp ‘moving’ sporozoites tracked in (B). (D) Gliding limp::gfp 
sporozoites show higher frequency of stretching events than WT parasites. Absolute numbers of 
sporozoites within each stretching frequency category are shown by the bars. WT and limp::gfp (50 
sporozoites analysed). (A-D) WT and limp::gfp data is from 3 independent experiments. (E) Consecutive 
bright filed images of representative gliding WT and limp::gfp sporozoites. Arrowhead indicates a stretched 
sporozoite. Scale bar = 5 µm. (F) Distance between front and rear ends of WT and limp::gfp sporozoites 
shown in (E) over 159 seconds. Arrowheads indicate stretching events. 
 In our immuno-EM experiments, the distribution of gold particles along the parasite PM 
was relatively sparse. This can partially be explained by the osmium tetroxide post-fixation step 
used in our protocol. This compound is known to create cross-links with sample molecules 
which can render epitopes inaccessible to antibodies. However, it is particularly useful at 
preserving membranes. Another possible explanation is the use of an epoxy resin (more 
specifically EPON™) for sample embedding. Despite of its good sample impregnation, elasticity 
and stability during sectioning, this resin polymerizes at high temperatures (slow process) and 
this can be harmful to proteins. Nevertheless, the overall protocol employed here is better at 
preserving subcellular structures than conventional immuno-gold procedures, namely lipid 
membranes. It allowed us to detect LIMP::GFP (albeit at low levels) while unequivocally 
identifying it at the parasite PM. This sparse distribution is also in agreement with the staining 
pattern obtained in our IFAs. In these assays, where the overall LIMP::GFP signal along the 
entire parasite is observed, LIMP is not uniformly spread and appears speckled. Consequently, 
when looking at a 70 nm-thick transversal or longitudinal section of a parasite (as was the case 
of the immuno-EM micrographs), one could expect to see just a few gold dots. 
LIMP plays a role in gliding motility, cell traversal, adhesion and invasion, and ultimately 
in overall in vivo infectivity. Several other secreted proteins of parasite origin are known to play 
a role in one or more of these processes: CTRP [272-274], MAOP [275] and SOAP [255] in the 
ookinete; MAEBL [276, 277], SPECT [278], SPECT2 [279], P52 [265, 284] and TRAP [259, 260, 
285-287] in the sporozoite; and CelTOS [175] in both the ookinete and the sporozoite. For 
detailed description of protein functions please see Introduction - MOTILITY AND INVASION OF 
MALARIA PARASITES. 
A common feature to all of these proteins is that they localise to the micronemes. In 
contrast, LIMP does not localise to these organelles and unlike the above mentioned proteins, it 
plays vital roles in all of the cellular processes on which sporozoites rely to successfully infect 
their hosts. Moreover, LIMP is also necessary for efficient ookinete-to-oocyst transformation 
most likely by influencing ookinete gliding and midgut epithelium invasion and traversal. These 
results highlight LIMP as a parasite protein with unique features and crucial impact at several 
steps of the Plasmodium life cycle. 
The underlying requirement for gliding, cell traversal and invasion is that the sporozoite 
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adheres to its substrate, whether it is an artificial one such as glass or plastic, or biological as in 
the case of cells (skin, liver sinusoidal or hepatocytes) [360]. Adhesion of eukaryotic cells is a 
complex cellular mechanism by which surface receptors interact with extracellular ligands 
thereby modulating cytoskeleton organisation within the cell [361, 362]. For motility, adhesion 
sites have to assemble at the leading end of the cell and disassemble at the trailing end [363, 
364]. In the case of Plasmodium sporozoites, adhesion is a stepwise process divided into three 
steps: an initial adhesion occurs at either the apical or proximal (rear) end, followed by a 
secondary adhesion with the opposite end; the apical end then moves slightly forward and the 
sporozoite flips over on one of its sides, thus increasing the area of contact between the 
sporozoite body and the substrate; finally a tertiary adhesion is made at centre of the parasite. It 
is also known that the primary step of adhesion is dependent on the parasite’s actin dynamics, 
as the induction of actin polymerisation leads to weaker adhesion [365]. Not many proteins have 
been reported to play a role in sporozoite adhesion. TRAP and S6/TREP were reported to be 
important for initial in vitro adhesion. It was suggested that this function was associated with the 
interaction of their predicted von Willebrand A extracellular adhesive domains with the substrate 
[365]. Interestingly, TRAP-deficient parasites adhere preferentially with their front end, while 
sporozoites lacking S6/TREP show no preference for apical or rear end initial adhesion. 
Moreover, their differential spatial interaction with cytoskeleton actin filaments suggests these 
proteins cannot compensate for one another during adhesion and motility [360]. TRAP was also 
shown to play a role in detachment of sporozoite adhesion sites. On one hand TRAP-deficient 
sporozoites adhere less well but once attached they fail completely to detach, suggesting that 
TRAP coordinates continuous gliding motility through deadhesion of contact sites [366]. 
On the other hand, the structurally related protein TLP appears to stabilise newly 
formed adhesion sites and/or to increase the speed of adhesion formation, thereby augmenting 
continued adhesion formation during gliding [365]. Finally, parasite HSP20 (heat shock protein 
20) has been implicated in the regulation of the dynamics of parasite adhesion site formation 
and rupture with KO parasites for this protein showing slower and unidirectional gliding motility 
while leaving in vitro cell traversal and invasion unaffected [367]. 
The turnover of adhesion sites is known to be necessary for continuous parasite 
motility. Strong adhesion forces at the rear (but also at the centre) of the sporozoite during 
gliding have been shown to lead to temporary movement arrest and parasite stretching when 
the parasite still tries to pull forward [366]. The phenotype of our limp::gfp parasites may thus 
suggest that LIMP is important for efficient and timely detachment of the sporozoite from the 
substrate, allowing for fast and uninterrupted gliding. This hypothesis could also explain why in 
the complete absence of LIMP, parasites rarely present any motility. On the other hand, the 
observation that Δlimp parasites adhere less to hepatoma cells in vitro implies that LIMP is not 
only necessary for adhesion site turnover but also important for the establishment of initial 
adhesion contacts with the substrate, thereby affecting the subsequent events of motility and 
invasion. In that sense it is a protein with an equivalent function to TRAP. It is possible that 
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LIMP is a regulator of TRAP or acts in conjunction with TRAP and/or other TRAP family 
member. Alternatively, LIMP could be acting completely independently of TRAP. Both scenarios 
highlight how little we understand about formation of adhesion sites, their turnover and the 
generation of force within the parasite. LIMP is currently the most enigmatic and thus interesting 
protein involved in sporozoite motility. As it contains a coil domain and these are known to often 
serve to interact with other proteins, finding LIMP binding partners will constitute the next step to 
unravel its function. 
In summary, LIMP plays an essential role in parasite transmission by facilitating 
productive gliding motility that results in traversal of various mosquito and mammalian tissues 
and invasion of the mosquito salivary glands and liver cells in the vertebrate host. This makes 
LIMP a unique protein with crucial impact on multiple biologically relevant steps that are vital for 
the completion of the parasite’s life cycle. Moreover, LIMP is exclusive to malaria parasites. 
Altogether, these properties highlight LIMP as an exciting target for malaria intervention 
strategies, should we be able to interfere with its function by perhaps the use of small 
molecules, while underlying the importance of interfering with malaria parasite transmission by 
targeting its gliding motility machinery. 
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Figure S1 – Generation and genotyping of limp::gfp parasite line. 
(A) limp GFP tagging construct pLIS0079 (i) was obtained by cloning the last 1149 bp of the limp ORF 
excluding the stop codon upstream and in frame with the gfp gene. This construct includes Toxoplasma 
gondii dhfr/ts selectable marker cassette under the control of P. berghei dhfr/ts 5' and 3' UTRs. The 
construct was integrated into the limp locus (ii) of cl15cy1 by single homologous recombination, resulting in 
the fusion of limp to gfp in limp::gfp parasites (iii). (B) Correct tagging of limp was shown by Southern 
analysis of separated chromosomes (left) and diagnostic PCR analyses (right). Hybridisation of separated 
chromosomes from uncloned limp::gfp parasites with a probe against the 3' UTR of pbdhfr/ts recognised 
integrated pLIS0079 into chromosome 6, the endogenous pbdhfr/ts locus in chromosome 7 and circular 
plasmid with higher molecular weight. PCR analyses confirm 5' and 3' integration (int.) of pLIS0079, 
absence of WT limp ORF and presence of tgdhfr/ts gene. (C) Absence of WT limp and presence of 
limp::gfp mRNA was confirmed in cloned limp::gfp mixed blood stages by RT-PCR. p28 and RNA 
polymerase II serve as control genes. Primer g1265c only binds to limp WT cDNA while primer g1266c 
only anneals with limp::gfp cDNA. 
SUPPLEMENTARY FIGURES AND TABLES 
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Figure S2 – Generation and genotyping of Δlimp parasite lines. 
(A) limp gene deletion construct pLIS0060 (i) was obtained by cloning limp 5' and 3' targeting regions (TR) 
upstream and downstream of  the Toxoplasma gondii dhfr/ts selectable marker cassette, respectively. 
tgdhfr/ts gene is under the control of P. berghei dhfr/ts 5' and 3' UTRs. The construct was integrated into 
the limp locus (ii) of Fluo-frmg by double homologous recombination, resulting in the complete deletion of 
limp ORF in Δlimp parasites (iii). (B) Correct deletion of limp was shown by Southern analysis of separated 
chromosomes (left) and diagnostic PCR analyses (right). Hybridisation of separated chromosomes from 
uncloned Δlimp parasites with a probe against the 3' UTR of pbdhfr/ts recognised integrated pLIS0060 into 
chromosome 6, the endogenous pbdhfr/ts locus in chromosome 7, reporter gene constructs (GFP/RFP or 
GFP-Luciferase) in chromosome 3 and circular plasmid with higher molecular weight. PCR analyses 
confirm 5' and 3' integration (int.) of pLIS0060, absence of limp ORF and presence of tgdhfr/ts gene. (C) 
Absence of limp mRNA was confirmed in cloned Δlimp mixed blood stages by RT-PCR. p28 and RNA 
polymerase II serve as control genes. Primer g0624c only anneals with limp cDNA. 
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Figure S3 – Δlimp parasites develop normal blood 
stage parasitaemia and gametocytaemias over the 
course of infection. 
(A) WT and Δlimp-a total parasitaemias over time. (B) 
WT and Δlimp-a male gametocytaemias over time. (C) 
WT and Δlimp-a female gametocytaemias over time. 
(A-C) Mean values are shown by the dots, while SEM 
values are shown by the vertical lines. WT and Δlimp-a 
(n=6). gams: gametocytes; iRBCs: infected red blood 
cells; tRBCs: total red blood cells. 
Figure S4 – Δlimp ookinetes 
show WT morphology. 
WT and Δlimp-a blood meal-
retrieved ookinetes were 
imaged under DIC microscopy 
and showed similar overall 
morphology, including the 
presence of crystalloid bodies 
(CB) identified by the 
associated haemozoin 
clusters. Scale bars = 5 µm. 
Figure S5 – limp is not transcribed in liver stages. 
RT-PCR analysis of limp in in vivo-developed P. berghei exoerythrocytic forms 
(EEFs) at different time points after sporozoite injection. 18S rRNA serves as 
loading control gene. +: RT positive reaction; -: RT negative reaction. 
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Figure S6 – limp::gfp parasites establish normal 
liver infection. 
(A) Hepatocyte traversal ability of limp::gfp 
sporozoites is comparable to WT parasites. Mean 
percentages of cell traversal are shown by the bars, 
while SEM values are shown by the vertical lines; p-
value for Student´s t-test is shown above the bars. 
WT and limp::gfp (1 experiment, n=3). Dx+ cells: 
Dextran, Tetramethylrhodamine positive cells. (B) 
limp::gfp sporozoites transform normally into 
exoerythrocytic forms (EEFs). Mean numbers of 
EEFs per well are shown by the bars, while dots 
represent individual data points. WT and limp::gfp (1 
experiment, n=3). (C) limp::gfp parasites develop into 
normally sized exoerythrocytic forms (EEFs). Mean 
and SEM values are shown by the lines. WT (1 
experiment, n=79); limp::gfp (1 experiment, n=77). 
(B-C) p-values for Mann-Whitney test are shown 
above the data sets. (D) Representative images of 
WT and limp::gfp exoerythrocytic forms. Scale bars = 
20 µm. (E) Mice bitten by limp::gfp-infected 
mosquitoes develop normal blood stage infection. 
Mean parasitaemias are shown by the dots, while 
SEM values are shown by the vertical lines. WT (2 
independent experiments, n=2); limp::gfp (3 
independent experiments, n=3). iRBCs: infected red 
blood cells; tRBCs: total red blood cells. 
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GENERAL DISCUSSION 
Translational repression (TR) in P. berghei is particularly important during the phases of 
transmission of the parasites: from the vertebrate host to the mosquito vector and back to a new 
host. By accumulating hundreds of mRNAs in a ‘stand-by’ mode, the parasite is in a state of 
molecular preparedness that allows it to quickly adapt to new, distinct environments (blood to 
midgut and salivary glands to liver) and rapidly transform into the next life cycle form, but only at 
the right time, when the right environmental cues are in place. In the mosquito midgut, for 
example, fertilisation of the female by the male gamete takes place within one hour after the 
blood meal, and complete ookinete formation and midgut invasion is accomplished within a day 
[36]. In the rodent host, sporozoites are found inside hepatocytes as fast as two minutes after 
they have entered the bloodstream [368]. Many proteins necessary for these crucial transitions 
are synthesised from repressed mRNAs and therefore independent from de novo transcription. 
The mRNA loss in Δdozi and Δcith gametocytes can be regarded as a foolproof 
mechanism that malaria parasites employ to ensure that certain antigens are not expressed 
before time when they cannot be properly translationally silenced. By doing so, the parasites 
warrant the encoded proteins are not present to be detected by the mammalian host’s immune 
system and therefore prevent adaptive immune responses resulting in the generation of 
potential transmission blocking (TB) antibodies. Such antibodies could block the function of the 
target proteins while inside the mosquito midgut and hence could prevent transmission of the 
current and future parasite populations. Indeed, several rodent and human malaria 
translationally repressed genes in gametocytes are known targets of TB antibodies. 
In the present study we have characterised three genes of previously unknown or 
putative function in the rodent malaria parasite P. berghei: epsf, dhhc10 and limp. Each gene 
revealed an essential or important function during mosquito stage infection. All three genes 
have conserved orthologs in the human malaria parasite species P. falciparum and P. vivax that 
perhaps are equally crucial for life cycle progression. The use of P. berghei for the functional 
characterisation of novel gene products has several advantages: first it is the genetically most 
amenable species easily allowing for the deletion, tagging or conditional knock-out (using the 
site-specific recombination FLP-FRT system [369-371]) and knock-down (by stage-specific 
promoter swap strategies [134] or the tetracycline-repressible transactivator system [372]) of 
specific genes of interest; secondly it is the most tractable parasite throughout the entire life 
cycle, permitting the follow-up of any genetic modification in life cycle stages where P. 
falciparum and P. vivax are not so easily manipulated, namely during development within the 
mosquito vector and in vivo in the vertebrate host’s liver. 
Despite distinct in their structure and function, each of the three genes are subjected to 
TR in female gametocytes. Upon gametocyte activation and ookinete formation, the encoded 
proteins are targeted to a unique ookinete organelle, the crystalloid body (CB). Our data on 
EPSF and DHHC10 support the hypothesis raised by studies on LAP proteins suggesting that 
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CBs act as storage organelles for proteins that are used during oocyst/sporozoite development, 
as the corresponding null phenotypes were only observable during sporogony in the mosquito 
midgut. It is nonetheless worth noting that proteins that are produced within 24 hours after 
fertilisation will only exert their functions several days after mosquito infection. It is even more 
striking to recognize that the corresponding mRNAs are targets of a repressor molecular 
mechanism taking place in blood stage parasites, a process that can be initiated some days 
before the gametocyte is taken up during a blood meal. Alternatively, EPSF and/or DHHC10 act 
early on during mosquito infection leaving a molecular footprint that sets the basis for future 
morphological events. In their absence, the lack of such molecular landscape will only have a 
detrimental impact for parasite survival later in development. Indeed, the lack of CBs in 
Δdhhc10 ookinetes suggests that this might be the case at least for DHHC10. 
While all CB-associated proteins studied so far are indeed involved in oocyst sporogony 
[176, 211, 224-226], the absence of LIMP does not result in abortive oocysts. In fact, Δlimp 
oocysts develop wild-type (WT) numbers of midgut sporozoites. Instead, LIMP has a role in the 
transition from the ookinete to the oocyst and thus challenges the current paradigm of malaria 
CBs acting as mere storage compartments. Alternatively, LIMP does not exert its functions 
while present in the CBs but is rather redistributed to other sites within the cell, possibly the 
ookinete plasma membrane (PM) as suggested by its localisation in sporozoites, but at lower 
levels than those detectable in crystalloids. 
From nine CB components identified to date (LAP1-6 [208, 211, 212] as well as EPSF, 
DHHC10 and LIMP), six are translationally repressed in female gametocytes, including LAP4-6 
[208] and those studied here. As many more uncharacterised gene products are likely to be 
subjected to this mechanism in the transition from host to vector, it will be interesting to know 
how many more of these proteins are targeted to this organelle, and what their roles are during 
parasite development in the mosquito. Such studies would not only expand our understanding 
of the biological relevance of TR but also increase our knowledge on this poorly understood 
subcellular compartment. 
Together with published data on P. falciparum and T. gondii, the present findings 
highlight the impact of post-translational modifications (PTMs), namely palmitoylation, for 
parasite biology. The importance of protein S-palmitoylation has also been studied in a highly 
divergent pathogen, the gut parasitic protozoan Giardia lamblia, the principal cause of non-
viral/non-bacterial diarrheal disease worldwide [373]. In this organism, palmitoylation of the C-
terminal cytoplasmic tails of variant-specific surface proteins (VSPs) is linked to the segregation 
of these proteins to plasma membrane rafts and detection by host antibodies. This antibody 
recognition contributes to antigenic variation in these parasites, a process in which the 
trophozoite continuously changes its surface antigen coat to avoid being detected and 
eliminated by the host’s immune system; by binding to the surface of the parasites, the 
antibodies trigger the elimination of parasite populations expressing the recognised VSPs, 
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which are then replaced by cells expressing unrecognised counterparts. Mutations in the 
palmitoylation site of VSPH7 render parasites resistant to cell death by this complement-
independent, antibody-mediated cytotoxicity without a simultaneous switching of the active VSP 
[374]. A recent study identified nine putative DHHC-PATs in Giardia and showed that the 
developmental transition from the gut-colonising trophozoite to the disseminating, 
environmental-resistant and infectious cyst, a process that depends on de novo generation of 
endomembrane compartments, protein sorting and vesicle fusion, involves substantial 
palmitoylation of parasite proteins. Conversely, drug inhibition of palmitoylation yielded fewer 
numbers of cysts [375]. Like in Giardia, our results support the idea that S-acylation is a PTM 
with major impact in parasite life cycle progression, namely during the formation of the 
infectious and transmissible parasite stages, the cyst in the case of Giardia, and the sporozoite 
in the case of Plasmodium. 
Another reversible PTM, phosphorylation, is also extremely important for mosquito 
stage development of Plasmodium parasites. Just like palmitoylation, the complex, dynamic and 
coordinated addition and removal of phosphate groups to specific amino acid residues by 
kinases and phosphatases, respectively, allows for tight regulation of protein function, hence 
strongly influencing many cellular processes such as sexual and sporogonic development [376]. 
This is the case, for instance, of the activation of the arrested gametocytes by the cyclic 
guanosine monophosphate (cGMP)-dependent protein kinase PKG [377], the initiation of male 
genome replication by the calcium-dependent protein kinase 4 (CDPK4) [378] and the egress of 
male microgametes through the action of the mitogen-activated protein kinase 2 (MAP-2) [379]. 
Moreover, the meiotic division occurring after fertilisation necessitates the function of the Never 
in Mitosis Gene A (NIMA)-related protein kinases, Nek-2 and Nek-4 [380]. While the absence of 
any of these kinases results in parasites that are severely affected in their ability to produce 
ookinetes in vitro, subsequent work identified a serine/arginine (SR)-rich protein kinase (SRPK) 
as an absolute requirement for the completion of this developmental transition in the parasite 
life cycle [376]. On the other hand, ookinete motility relies on CDPK3 [381, 382], and as a 
consequence, the absence of this protein leads to strongly reduced oocyst numbers in vivo 
(less than 10% of WT numbers) [376]. Another two kinase mutants are equally impaired in their 
capacity to develop oocysts: protein kinase 7 (pk7) and cyclin G-associated kinase (gak) gene 
deletion parasites. PK7 is a hybrid kinase with homology to mammalian MEK3/6 and fungal 
protein kinase A in the C- and N-termini of its kinase domain, respectively. GAK on the other 
hand resembles the Ark/Prk group of yeast kinases as well as the cyclin G-associated 
kinase/AP2-associated kinase 1 group in animals, which are involved in the uncoating of 
clathrin-coated vesicles [383]. The few Δpk7 and Δgak oocysts that successfully established in 
mosquito midguts never formed sporoblasts or any sporozoites [376]. Together with our data, 
this observation indicates that PTMs, namely phosphorylation and palmitoylation are of vital 
relevance for Plasmodium sporogony. Interestingly, Δpk7 oocysts stopped growing by day 10 
p.i., while Δgak cysts continued growing and by day 21 p.i. had outgrown WT parasites but 
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remained unsporulated. In both mutants developmental arrest was accompanied by lack of DNA 
replication [376]. Curiously, this is in contrast to what we have observed in our Δdhhc10 oocysts 
but similar to Δepsf parasites. Further studies will be necessary to dissect the pathways 
governing cell cycle progression in the still enigmatic process of sporozoite formation which 
represents one of the vastest mitotic division phases in the Plasmodium life cycle. 
A recent genome-wide functional analysis of Plasmodium protein phosphatases (PPs) 
has also highlighted six PPs essential for sexual development and differentiation of mosquito-
associated parasite stages. Metallo-dependent protein phosphatase 1 (PPM1) is crucial for 
microgametocyte exflagellation, PPM2, kelch-like motifs PP (PPKL) and Shewanella-like PP 1 
(SHLP1) knock-out (KO) parasites are blocked in ookinete-to-oocyst transition, and PPM5 and 
protein tyrosine phosphatase-like A homolog (PTPLA) null mutants do not form midgut 
sporozoites. Some differences exist between Δppm5 and Δptpla parasites. The former 
produces viable ookinetes similar to WT controls but shows markedly reduced numbers and 
sizes of oocysts, resembling the phenotype of Δpk7 parasites. Δptpla mutants on the other hand 
produced WT numbers of oocysts that do not undergo sporulation [384]. These later parasites 
therefore mimic the phenotype we report here for dhhc10 but also epsf gene deletion mutants. 
The similarity between some kinase and phosphatase null phenotypes indicates that signal 
transduction pathways leading to morphological and functional alterations are not simply 
activated by kinases and silenced by PPs. They are rather controlled through a dynamic 
balance between both types of enzymes, with multiple kinases and PPs contributing to certain 
stage-specific pathways. 
Two final interesting general observations can be made from the data presented herein 
on the gene limp. LIMP exerts its function in two very distinct phases of the Plasmodium life 
cycle. First, it is important for the establishment of the sessile oocyst in the basal lamina of the 
mosquito midgut. Later on, it is critical for salivary gland invasion, hepatocyte adhesion, 
traversal and also invasion. Examples of other dual functioning proteins exist in the malaria 
literature. CelTOS, for instance, plays the same fundamental role (host cell traversal) in both 
ookinetes and sporozoites [175]. On the other hand, PbGEST (gamete egress and sporozoite 
traversal) is a Plasmodium-specific conserved protein that is targeted to osmiophilic bodies 
(gametocyte-specific secretory organelles) and the sporozoite micronemes from which it is 
secreted shortly after gametocyte activation and during sporozoite migration, respectively. 
PbGEST is necessary for gametocyte egress from the RBC and for sporozoite cell traversal in 
the skin of the mammalian host [385]. The fact that malaria parasites can use a single protein to 
play roles in distinct life cycle stages raises the possibility that the Plasmodium genome of just 
over 5,000 genes can be greatly potentiated by the addition of a supplementary layer of 
complexity to its proteome. As proteins can have pleiotropic roles and/or act in different 
developmental stages, the parasite is not limited to a 1:1 stoichiometric ration between protein 
coding genes and protein functional/temporal activities. 
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 Another remarkable observation is that despite being expressed in gametocytes and 
sporozoites, limp is translationally repressed in the former and immediately translated in the 
latter. This observation suggests that TR mechanisms in place in these two developmental 
stages of the parasite do not target the same transcripts, even when these are present in both. 
This could be due to at least three reasons: (i) the TR machinery is distinct in the two parasite 
forms and limp mRNA possesses motifs that are recognised by the repressor complexes in 
female gametocytes but not in sporozoites, (ii) alternative transcription initiation and/or 
termination sites exist on limp gene that are used differently in gametocytes and sporozoites or 
(iii) alternative splicing events occur in the untranslated regions (UTRs) of limp in these two 
parasite stages. It the latter two hypotheses, TR-targeting motifs could be present in limp mRNA 
while expressed in gametocytes but not in sporozoites. Follow-up studies will be necessary to 
fully dissect these questions. 
Being specifically transcribed in gametocytes and not in asexual blood stages, it is 
pertinent to emphasise that epsf, dhhc10 and limp were found significantly downregulated in KO 
parasites for the sexual commitment major regulators AP2-G and AP2-G2, together with known 
gametocyte-specific genes. In the absence of these transcription factors, gametocyte production 
is completely abolished (in the case of AP2-G) or highly reduced (AP2-G2) [67, 70]. More 
precisely, mRNA levels of all three genes are diminished in the P. berghei ∆pbap2-g line. 
Moreover, epsf transcripts are reduced more than 2-fold in the absence of P. falciparum PfAP2-
G, while limp is also negatively affected in ∆pbap2-g2 parasites, although less markedly than 
upon depletion of PbAP2-G. Additionally, microarray analyses of three P. berghei gametocyte 
non-producer lines obtained by successive asexual mechanical passage over 52 weeks showed 
that all genes were strongly downregulated in these parasites when compared to their WT 
counterpart, equally or more than in the ∆pbap2-g parasite line. It is thus reasonable to 
hypothesise that epsf, dhhc10 and limp are transcribed at some point during gametocyte 
differentiation by either AP2-G, AP2-G2 or both, and that they may constitute true gametocyte 
signature genes. 
The present essay contributes to increase our knowledge on the relevance of TR and its 
target mRNAs for parasite biology. At the same time it also highlights how little we actually know 
about how this molecular mechanism works and opens many new questions that need to be 
addressed. Unlike several other Plasmodium translationally repressed genes studied to date, 
the three that were the major focus of this work are unlikely to represent attractive malaria 
transmission blocking vaccine candidates. Two main reasons are behind this conclusion. First, 
the encoded proteins are not localised to the ookinete PM and are thus inaccessible to TB 
antibodies. Secondly, interfering with their function only has deleterious effects for the parasites 
at later stages of mosquito infection, namely at the oocyst and sporozoite levels, moments at 
which potentially effective antibodies generated by the mammalian host are no longer available 
inside the mosquito. Nevertheless, this work is a clear further demonstration that interfering with 
TR itself or with its targets can be a powerful tool in the quest against malaria. By inhibiting the 
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function of either EPSF, DHHC10 or LIMP, perhaps by the use of small molecules, but also of 
several other published translationally repressed genes, malaria transmission to and from the 
mosquito vector can be completely blocked, which will certainly represent a strong component 
of our endeavour to eradicate malaria [386, 387]. 
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